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Bioassay-based risk characterization of complex mixtures 
“A daunting enterprise is to consider a very realistic exposure scenario that involve chemical mixtures” 
(Letcher et al. 2010) 
 “A vast number of chemicals pervade our environment.                                  
Exposures, weather simultaneous or sequential, are to chemical mixtures”                                  
(Mumtaz 2010) 
The air we breathe, the food we eat, the medicines we take, the clothes we wear, 
the water we swim and even the surfaces on which we crawl, walk, rest and sleep 
are all composed of a mixture of chemicals. Whether naturally or human produced, 
many are unknown to us, of a fair amount we are aware off, but only from a 
fraction we know their potential effects and interactions on human, wildlife and 
the environment. 
Evaluation of potential human and environmental health hazards from exposure to 
chemical mixtures via the food chain and in the environment presents one of the 
most difficult challenges for risk assessment. While every living organism is exposed 
to mixtures of compounds, these mixtures are never the same. Governmental 
agencies, scientists and ultimately all individuals of our modern society are faced 
with the need of a proper assessment of the risk of complex mixtures to humans or 
the environment. For instance, food to be placed in the market, drinking water to 
be provided to the population and dredged spoils to be dumped; are all matrices 
for which certain risk assessment procedures exist. However, current legislation 
and regulation on risk assessment remain based on applied and basic sciences 
obtained with single substances (Mumtaz 2010). To cover this deficiency, research 
programs on mixture toxicology have been developed in recent years as well as the 
establishment of toxicological evaluation frameworks for chemical mixtures (Feron 
and Groten 2002; Groten et al. 2001; WHO 2009). Developing a suitable testing 
strategy to evaluate the potential risk of mixtures to humans and the environment 
is of very high scientific and societal interest.  
Testing strategies involve chemical and biological methods to characterize the toxic 
potency of mixtures in several steps within the risk assessment cycle including 
hazard assessment, exposure assessment and monitoring. Along with chemical 
methods, in vitro and in vivo bioassays have been developing during the last 
decades to achieve the required quality and assurance standards for complex 
mixture testing (OECD 2012; OSPAR 1997; OSPAR 2009; WHO 2009). 
Sediments are one example of a complex matrix of interest for environmental risk 
characterization. Sediments are fundamental to the wellbeing of aquatic 
ecosystems furnishing support, provision and regulation services (Gerbersdorf et al. 
2011). However, sediments act as a storage compartment, serving as “secondary 
sources” of persistent organic pollutants (POPs) for other environmental 
compartments and organisms (Nizzetto et al. 2010). Not only can this impair the 
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health of the benthic, and thus aquatic, ecosystems, it encompasses an important 
route of exposure for aquatic food chains including fish, birds, mammals and 
eventually humans (Bosveld et al. 2000; de Boer et al. 2001; De Mul et al. 2008; 
Leonards et al. 1997; Moermond et al. 2004; Murk et al. 1998; Nyman et al. 2003; 
Schipper et al. 2009; van Leeuwen et al. 2007; Verslycke et al. 2005). 
In response to the need of sediment risk characterization a series of integrated-
effect based frameworks has been proposed. These include toxicity profiling 
(Hamers et al. 2010), effect directed analysis (EDA) (Brack et al. 2007), and tiered 
alternatives based on a series of tool-boxes combining in vivo and in vitro bioassays 
(Schipper et al. 2010). 
In vitro bioassays have been developed to suit the complex mixture 
characterization needs covering endpoints such as survival, growth, reproduction, 
sensitization, genotoxicity, mutagenicity, neurotoxicity and particularly endocrine 
disruption (ED) (EC 2006; OECD 1992; OECD 2012; OSPAR 1997). In addition to 
general toxicity, assays for more mechanism-specific endpoints such as aryl-
hydrocarbon receptor (AhR) activation, thyroid hormone disruption (THD), 
estrogenicity and steroidogenesis, among others, has been applied for risk 
characterization of mixtures of compounds in several complex matrices including 
sediments. 
Despite the extensive and intensive improvements achieved in the development of 
in vitro methods, still some challenges remain to make them fully applicable for risk 
characterization of complex mixtures (Besselink et al. 2004; Hoogenboom et al. 
2013; Hoogenboom et al. 2006b; Houtman et al. 2006b; Schipper et al. 2010; Van 
der Burg et al. 2010). These issues concern either the relevance or the reliability of 
the bioassay (OECD 2005). This thesis aims to better understand and further 
improve the relevance and reliability of in vitro bioassays for a biobased risk 
characterisation of complex mixtures, with special focus on POPs in sediments. 
Mixture complexity 
Compounds in mixture could greatly influence the behaviour of a potentially toxic 
substance increasing or decreasing its potential to produce an effect. Mixture 
components could influence a compounds fugacity from its exposure matrix, its 
susceptibility to degradation and even its bioavailability (Spurgeon et al. 2011). 
Once within the organism compounds could affect each other their absorption, 
distribution, metabolism, excretion and ultimately their capacity to exert effects at 
target sites. Interesting examples are the reduced absorption of tetracycline by 
several cationic ions due to reduced solubility and chelation (Reviewed by 
Spurgeon et al. 2011), and the increased metabolism of polyaromatic hydrocarbons 
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(PAHs) due to the presence of cytochrome P450 (CYP)-inducing dioxins (Shimada 
and Fujii-Kuriyama 2004). 
Two recent publications compile the current knowledge and perspectives of 
mixture toxicology (Mumtaz 2010; van Gestel et al. 211). Both agree on how much 
we have already advanced in the understanding of chemical mixtures but how large 
is the extent of what we still do not know. 
Complex mixture risk characterization 
Since humans and their environments are exposed to a wide variety of substances, 
there is increasing concern in the general public about the potential adverse effects 
of the interactions between those substances when present simultaneously in a 
mixture. Although interactions between toxic compounds (including antagonism, 
potentiation, and synergism) have been described, they are not likely to occur at 
low exposure levels in a way that they are toxicologically significant (SCHER et al. 
2012). For chemicals with common modes of action it is to be expected that they 
will act jointly to produce combination effects that can be described by 
dose/concentration addition. For current risk assessment of chemical mixtures, 
especially the lack of exposure information is limiting as well as the limited number 
of chemicals for which sufficient information on their mode of action is available 
(SCHER et al. 2012).  
Whenever risk characterization of chemical contaminants is required, regulatory 
standards for environmental mixtures has been and still remains being heavily 
based on targeted chemical analysis. Examples are the water framework directive 
(WFD) (EC 2000), the Air Quality Directive (EC 2008a), Waste Framework Directive 
(EC 2008b), and dredged spoils licensing system (OSPAR 2008). Chemical analysis of 
contaminants has evolved to be a highly selective, exact, and sensitive technique 
for mixture characterization. However, chemical analysis of complex matrices and 
trace contaminants usually requires extensive temporal, technical and human 
resources. In addition, the steady flow of newly identified pollutants, including 
metabolites; adds up to the difficulties because it increases the demand for 
synthesis of pure standards and the need of continuous development of 
purification methods.  Particularly in relation to complex mixture characterization 
another disadvantage of chemical targeted analysis is the inability to detect not yet 
known toxic compounds, including transformation products, or compounds present 
in concentrations below the limit of chemical detection (Schipper et al. 2010). Non-
targeted analysis of emerging contaminants has been proposed as a solution to this 
shortcoming. However, up to date only very few compounds have been identified 
in environmental samples, and there is a need for the development of more 
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databases and libraries, as well as more efficient data mining methods (Zedda and 
Zwiener 2012). 
Moreover, toxicological information about those newly discovered compounds 
often is lacking  and current assessment methods for chemical mixtures based on 
chemical characterization, do not take proper account of joint actions and 
combined effect of chemicals in the mixture (SCHER et al. 2012). 
Application of bioassays for complex mixture characterization 
In addition to chemical methods, another possible approach to risk characterisation 
or safety evaluation of complex mixtures is testing toxic effects of the entire 
mixture (Groten et al. 2001). This approach is suitable for partially characterized 
but also for uncharacterized mixtures (Ragas et al. 2011). In vivo and in vitro 
bioassays, biosensors, and bioassay directed identification methods, have quickly 
evolved as the most important tools for whole mixture testing (Brack 2003; 
Chobtang et al. 2011; Hamers et al. 2010; Hoogenboom et al. 2013; Murk et al. 
2013; Thain et al. 2008). 
Initially, in vivo methods have been developed mainly for chemical risk 
characterisation (OECD 2012). They include assays with a variety of species such as 
annelids, crustaceans, amphibians, insects, fish and birds; and a variety of end 
points such as acute toxicity, growth, development, reproduction and 
metamorphosis (OECD 2012). Several of these assays have been further developed 
for monitoring of aquatic ecosystems (OSPAR 1997; OSPAR 2009), and adapted to 
be used for complex environmental mixtures (Schipper et al. 2009; Thain et al. 
2008; Vethaak et al. 2005).  
In vivo bioassay can provide a stronger relation of causality between contaminants 
and ecological responses and are expected to take bioavailability and toxicokinetics 
into account (Legler et al. 2002b; Maas and Vand den Heuvel-Greve 2005; Schipper 
et al. 2009). However, as stated by John E. Thain, Dick Vethaak and Ketil Hylland 
“As the level of biological complexity increases, so too does the ecological 
relevance of any contaminant effect; however, this is in turn mirrored by 
decreasing responsiveness, detectability, and mechanistic understanding” (Thain et 
al. 2008). Additional challenges of in vivo assays are the occurrence of false 
positives induced by matrix factors that can impair the health of the test animals 
(e.g. sulphur, ammonium or low oxygen levels) and to reduce natural variability. 
Solutions to these problems has been achieved through standardization (Thain et 
al. 2008), the use of cultured species (Schipper et al. 2008) and artificial 
synchronization methods (Gutleb et al. 2007b). 
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Newer developments include in vitro bioassays developed for a suit of toxic 
mechanisms including dioxin-like toxicity and endocrine disruption (ED) (EC 2006; 
OECD 1992; OECD 2012; OSPAR 1997). Among in vitro bioassays for complex 
mixtures, mechanism-based assays have been favoured and applied to several 
fields of complex mixture risk characterization such as EU regulations for food (EC 
1883/2006) and feed (EC 152/2009) (Hoogenboom et al. 2013), sediments (OSPAR 
1997), and dredged materials (OSPAR 2008). In addition, mechanism-based 
reporter-gene assays to test ED endpoints have been successfully applied to human 
fluids (Murk et al. 1997; Van Wouwe et al. 2004b), food and feed (Hoogenboom et 
al. 2006a; Hoogenboom 2002; Hoogenboom et al. 2006b); and to environmental 
matrices including air pollution (Hamers et al. 2000), pore water (Koh et al. 2002; 
Murk et al. 1996), soil (Nording et al. 2007), and sediments (Legler et al. 2002a; 
Stronkhorst et al. 2003). 
Compared with in vivo tests, in vitro bioassays can handle a broader range of doses 
with usually much lower sample quantity. They require less initial investment, 
infrastructure, human resources and time, which make them adaptable to high 
throughput (Blaauboer 2008; Bolt and Hengstler 2008; Murk et al. 2013). A very 
important advantage in developing in vitro bioassays is to accomplish with the 
reduction and ultimately the replacement of animal use for toxicological testing 
(Jacobs et al. 2008). Compared with chemical analysis, in vitro bioassays are 
capable of detecting any potent substance in the mixture, including not yet known 
agonist or substances below chemical detection limits (Schipper et al. 2010). 
Therefore, in vitro bioassays indeed take into account join action and combined 
effect of active compounds in the mixture. In addition, in vitro methods are usually 
performed with extracts which reduces the presence of unwanted matrix factors 
(Schipper et al. 2010). Depending on the compound classes of interest, destructive 
cleaning methods can be applied to further remove matrix components. 
The development of bioassay test methods has focused on standardization, 
transferability and reproducibility (OECD 2005). For instance, an important 
prerequisite for the application of in vitro bioassays in a licensing system is a high 
standard of quality assurance and quality control to guarantee the data on which 
the assessment is to be based (Schipper et al. 2010; Stronkhorst et al. 2003; US EPA 
1995). Hence a great deal of effort has been place to develop standardized 
protocols for in vitro bioassays (Besselink et al. 2004; Hoogenboom et al. 2013; 
Hoogenboom et al. 2006b; Houtman et al. 2006b; Van der Burg et al. 2010). 
Furthermore, emphasise has been placed on standardization of sample preparation 
methods (Houtman et al. 2007; Schwirzer et al. 1998; Seiler et al. 2008; Van 
Wouwe et al. 2004a) as well as an understanding of the assays most critical 
parameters to achieve reliable results (Hoogenboom et al. 2011; Windal et al. 
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2005). However, in vitro bioassay still poses some challenges which can influence 
their relevance and reliability for their use in complex mixture risk characterization. 
Relevance and reliability of in vitro bioassays 
“The committee foresees that in vitro assays will make up the bulk of the toxicity test in its vision”                               
(Committee on toxicity testing and assessment of environmental agents.                               
“Toxicity testing in the 21st century.” (NRC 2007) 
 
The international harmonized criteria for scientific validation and regulatory 
acceptance of hazard test methods defined validation as “the process by which the 
method’s reliability and relevance are established” (OECD 2005).    
Bioassay relevance and the issue of metabolic activation 
The relevance of a test method is defined as “the extent to which the test method 
correctly measures or predicts the (biological) effect of interest, as appropriate.” 
(OECD 2005). It is ultimately an indication of how meaningful and useful are its 
results for the specified purpose. 
Complex mixture frameworks, particularly for environmental applications, have 
addressed the importance of using relevant methods for risk characterization 
(Benedetti et al. 2012; Hamers et al. 2010; Schipper et al. 2010). Particularly 
Schipper and co-workers (2010) have considered the most important elements for 
a rational application of in vitro and in vivo bioassays to dredged sediments 
licensing. 
One of the validation principles in the harmonized criteria (called the “Solna 
Principles”) is the relationship between the test method’s end point and the 
biological phenomenon of interest (OECD 2005). An important aspect of this 
principle is whether metabolic capability is considered within the relevance 
evaluation.  
The importance of biotransformation within the assessment of potential risks of 
substances has been increasingly raised attention and concern (Coecke et al. 2006; 
Murk et al. 2013). In this direction the USA National Research Council has 
emphasized the need to include metabolite function and effects within testing 
strategies (NRC 2007). Currently biotransformation is not generally considered 
within in vitro toxicity testing frameworks; with the exception of genotoxicity and 
hepatotoxicity assays (Coecke et al. 2006). Nevertheless, there are plenty of 
examples of toxic effects depending on biotransformation of parent compounds 
including allergens, polyaromatic hydrocarbons (PAHs), methoxychlor, 
polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) 
(Coecke et al. 2006; Legler et al. 2002a; Marsh et al. 2006; Qiu et al. 2007). 
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An example of particular interest for their thyroid hormone disruptive (THD) 
potency, is the metabolic activation of PCBs and PBDEs into OH-metabolites 
(Brouwer et al. 1998; Meerts et al. 2000). Interestingly, these hormone-like 
hydroxyl (OH-) metabolites are retained in plasma due to their capacity for binding 
to thyroid hormone binding proteins (THBPs) like transthyretin (TTR), thyroxin-
binding globulin (TGB) and albumin (Brouwer and van den Berg 1986). This binding 
protects them from further degradation and excretion, whereas they are 
transported via these proteins to various tissues and over selective barriers to the 
brain and the placenta (Meerts et al. 2002; Morse et al. 1993).  
POP bioactivation and THD effects 
Monitoring programmes of exposed population have shown the accumulation of 
OH-PCBs and OH-PBDEs in humans and wildlife (Bergman et al. 1994; Letcher et al. 
2010; Sandau et al. 2000). Also THD in vitro analysis of pure standards from POP 
metabolites has shown a greater toxicological relevance of OH-metabolites 
compared to the parent compounds  (Freitas et al. 2011; Hamers et al. 2008; Lans 
et al. 1993; Lans et al. 1994; Meerts et al. 2001; Song et al. 2008).  
However, the in vitro analysis of metabolites present in complex, and especially 
biological matrices, has not been straightforward (Hamers et al. 2008; Meerts et al. 
2000; Schriks et al. 2006; Simon et al. 2010; Simon et al. 2011). Several attempts 
has been made to analyse the potency of POP metabolites, either produced with 
exogenous metabolizing systems (Hamers et al. 2008; Meerts et al. 2000; Schriks et 
al. 2006), or from biological matrices such as plasma (Simon et al. 2010; Simon et 
al. 2011). These attempts have been hampered by low biotransformation 
efficiencies, presence and toxicity of parent compounds and interfering matrix 
components; or it has required extensive clean-up procedures which could still not 
prevent the presence of interfering co-extractants in the analysis.  
The limitations of chemical analysis to measure the total burden of POP 
metabolites along with the difficulties experienced in the application of bioassays 
to their total THD potency has opened a debate on the toxicological and health 
relevance of POP metabolites for wildlife and humans (Liu et al. 2012; Wan et al. 
2009; Wiseman et al. 2011).  
Bioassay reliability: achievements and challenges 
The reliability of a test method is defined as “the extent of reproducibility of results 
from a test within and among laboratories over time, when performed using the 
same standardised protocol.” (OECD 2005).  
The tendency of higher quantified potency with in vitro bioassays compared to 
chemical analysis has been labelled as overestimation of the toxicity, and has been 
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used to criticize in vitro bioassays. There are, however, established reasons to 
explain those differences between reporter-gene assays such as the dioxin-
receptor activation assay DR.Luc and the standard chemical analysis with capillary 
gas chromatography coupled to high resolution mass spectrometry (GR-HRMS) 
(Hoogenboom et al. 2011; Windal et al. 2005). Bioassays include the toxicity of 
active compounds even present in levels below the limit of chemical detection, as 
well as unknown compounds or compounds that cannot be analysed due to 
practical reasons. Also potential interactions between compounds cannot be 
excluded, and differences may exist between relative toxic potencies used to 
calculate the total toxic potency of the chemically analysed compounds and the 
relative toxic potencies of those compounds in the in vitro bioassays (Van den Berg, 
1988). In addition to these fundamental issues, a series of technical 
recommendations has been offered to improve reporter-gene assay reliability 
(Hoogenboom et al. 2011; Schipper et al. 2010; Windal et al. 2005), including: 
? The use of cleaned and fractionated extracts to isolate desired active compounds 
? The use of appropriate solvents, absorbents and materials to avoid contamination,  
analysis of procedural blanks for background signal must be included. 
? The relevance of the cellular model for the intended toxicological end-point 
? The variation of response with the analysed dose and the use of multiple sample 
dilutions for reliable potency quantification 
As stated by Goeyens and co-workers “ observed discrepancies should not be 
understood as absence of success in the initial efforts but rather as 
encouragements with positive effects on the pace of further development 
(Goeyens et al. 2010).  
Two aspects that could influence the outcome of in vitro bioassay based 
quantification of toxic potencies are: 1) the occurrence sometimes of responses 
higher than the theoretical maximum based on the positive control for the assay (a 
phenomenon referred to as supramaximal (SPMX) effect) , and 2) the possible 
consequences of overconcentration of sample extracts during solvent change. 
The SPMX effect in in vitro bioassays 
The phenomenon that a response for a particular ligand is significantly higher than 
the maximal response of the endogenous substance, has been observed for in vitro 
estrogenic assays with several pure substances (Freyberger and Schmuck 2005; 
Kitamura et al. 2005; Legler et al. 1999; van Lipzig et al. 2005) and also for reporter-
gene dioxin-like assays in pore water (Jonker et al. 2006), crude and refined 
petroleum products (Vrabie et al. 2009), and sediments (Murk et al. 1996) even 
after thorough clean-up (Baston and Denison 2011).  
General Introduction and thesis outline 
 17 
Weather an SPMX effect is an assay-based artefact or a real-life phenomenon with 
toxicological relevance is still unknow for certain. It has been demonstrated that 
activation of protein kinase C and inhibition of protein synthesis can synergistically 
enhance aryl-hydrocarbon (AhR)-dependent gene expression using purified 
compounds and under experimentally controlled conditions. But the importance 
for the potency quantification for environmental samples remains to be confirmed 
(Baston and Denison 2011). Estrogenic SPMX effect produced by genistein in breast 
cancer cells stably transfected with a luciferase reporter-gene (T47D.Luc) was 
ascribed to post-transcriptional stabilization of the firefly luciferase reporter 
enzyme, increasing the bioluminescence signal which would imply that an SPMX 
effect is not a biologically relevant phenomenon (Sotoca et al. 2010).  
As the quantification of the estrogenic and/or dioxin-like activity of environmental 
contaminants, both individually as well as in mixtures, is based on the response 
relative to that of estradiol or TCDD respectively; an SPMX effect could lead to 
overestimation of the quantified potency. Although a normalization method has 
been offered for potency quantification of SPMX inducer sediments (Baston and 
Denison, 2010), the drivers and underlying causes of SPMX effects in in vitro 
bioassays remain an intriguing and relevant phenomenon for toxicology and 
particularly for toxicological risk characterization. Unfortunately the occurrence of 
SPMX effects has not been consistently reported in scientific literature, making it 
difficult to draw conclusions from the sometimes seemingly contradictory results. 
Influence of stock concentration on the quantification outcome 
It has been observed that original extract stock concentrations can significantly 
influence the observed estrogenic potency of waste treatment plant effluents 
(Murk et al. 2002). The authors suggested a loss of compounds during solvent 
exchange when the maximum solubility is approached. For dioxin-like compounds 
this has not been studied before. Nevertheless, it is a common practice to 
concentrate the sample as much as possible to be able to quantify the toxicity of 
less polluted samples. In practise a range of 1-200 g sediment equivalents/ml of 
DMSO are being used for testing in in vitro bioassays (e.g. Nording et al. 2007; 
Ocampo-Duque et al. 2008) without knowing the consequences for the ultimate 
dioxin-toxicity quantification. In addition, overloading clean-up columns needed for 
preparing samples to be tested in the dioxin-like DR.Luc results in residues of 
unwanted compounds such as PAHs to be present in the final extract (Schwirzer et 
al. 1998), including alkylated- and nitro-PAHs (Dindal et al. 2011). These 
compounds can induce AhR-dependent activity whereas their mechanism of 
toxicity is totally different from that of dioxins (Vondrácek et al. 2001). Most PAHs 
can be metabolised by cytochrome P450 enzymes that are present in H4IIE rat 
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hepatoma cells of the DR-Luc, hence increasing the time of exposure to 24 hours or 
more facilitates more PAHs in the sample to be metabolized reducing their 
influence on the bioassay response (Hamers et al. 2000; Vondrácek et al. 2001). 
It is evident that for reliable in vitro bioassay-based risk characterisation the 
influence of sample preparation, initial sample extract stock concentration, and 
interpretation of SPMX effects need to be properly addressed. 
In vitro bioassay characterization of sediments 
“Secondary sources (of POPs) already represent a significant fraction of the total source 
inventory…” (Nizzetto et al. 2010) 
Sediments probably are one of the most complex matrices for environmental risk 
characterization as they even can accumulate very lipophilic compounds bound to 
organic material including historical contaminations. In addition biotransformation 
products are being formed by local microbial communities. For proper functioning 
of aquatic ecosystems, healthy sediments provide fundamental furnishing support, 
provision and regulation services (Gerbersdorf et al. 2011). Contaminated 
sediments are an important route of exposure for aquatic food chains including 
fish, birds, mammals and eventually humans (Bosveld et al. 2000; de Boer et al. 
2001; De Mul et al. 2008; Leonards et al. 1997; Moermond et al. 2004; Murk et al. 
1998; Nyman et al. 2003; Schipper et al. 2009; van Leeuwen et al. 2007; Verslycke 
et al. 2005). 
Sediment quality guidelines (SQG) have been developed by several governmental 
agencies (Iannuzzi et al. 1995) in order to safeguard a good environmental quality 
and provision of safe food. With few exceptions, including The Netherlands 
(Schipper et al. 2010)), the assessment of sediment compliance remains based on a 
chemical analytical approach (OSPAR 2004; OSPAR 2008). Despite the 
establishment of bioassay response level for assays such as dioxin-like and 
estrogenic activity (Hamers et al. 2010; Stronkhorst et al. 2003).  
In response to the need for demonstration of in vitro bioassay suitability and 
reliability for sediment risk characterization, a series of integrated-effect based 
frameworks has been proposed. These include: 1) toxicity profiling of sediments 
with a battery of specific bioassays (Hamers et al. 2010); 2) effect directed analysis 
(EDA) which integrates toxicity testing, fractionation and non-target chemical 
analysis (Brack et al. 2007); and 3) a tiered alternative based on a series of tool-
boxes combining in vivo and in vitro bioassays (Schipper et al. 2010).  
Sediment hazard assessment, and particularly in relation to endocrine disruption 
(ED) effects (e.g. estrogenic, androgenic, thyroid hormone disturbance), has 
revealed that mainly the compounds in polar fractions of sediment extracts have 
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ED potencies (Brack et al. 1999; Houtman et al. 2006a; Legler et al. 2002a; Legler et 
al. 2003; MODELKEY 2013), particularly after the application of EDA (Brack et al. 
2002; Brack et al. 2005; Higley et al. 2012; Lübcke-von Varel et al. 2011).  
Nonpolar fractions of sediment extracts have been reported to exhibit very little or 
no in vitro ED effects (Higley et al. 2012; Lübcke-von Varel et al. 2011). 
Nevertheless, lipophilic POPs such as PCBs and PBDEs, present within the nonpolar 
fractions of sediments, are known to induce developmental, steroidogenic and THD 
effects in vivo (Chiu et al. 2000; Legler 2008). Even more striking, severe 
perturbations of thyroid hormone-dependent metamorphosis of amphibians 
(Gutleb et al. 2007a; Gutleb et al. 2007b) has been observed after exposure to 
nonpolar sediment extracts, not to the polar ones. This putative contradiction 
between in vitro and in vivo toxic effects of compounds present in the lipophilic 
sediment fraction requires further understanding of the mechanisms underlying 
the false negative in vitro responses and solutions to be able to better apply in vitro 
hazard characterization of sediments.    
Thesis outline  
This PhD aims at increasing the relevance and reliability of in vitro bioassay for 
complex mixtures by bringing further the understanding of above-mentioned 
challenges and developing suitable solutions to them. The focus of the current PhD 
research is on the use of in vitro bioassays for testing POPs for dioxin-like potency 
and for thyroid hormone disruption (THD) in the risk characterization of persistent 
organic pollutants (POPs) in sediment samples. This includes the issues of SPMX for 
which lessons can be learned from the better studied estrogenic compounds; of in 
vitro metabolism for THD compounds; and of sample preparation. The lessons 
learned will also be applicable to POPs in other, often less complex, matrices such 
as sea food. Figure 1 depicts the outline of this PhD study. 
In Chapter 2 a meta-analysis is performed to study the relevance hydroxylated 
compounds in humans and wildlife. . It reviews reported body burdens of 
halogenated phenolic contaminants (HPCs), including OH-POP in different tissues 
from humans and wildlife species. Their concentrations are analysed in relation to 
those of their putative parent compounds and the probable sources of exposure. 
The blood plasma levels are compared with known in vivo and in vitro toxicological 
threshold concentrations. This enables interpretation of the internal exposure and 
the toxicological implications thereof for humans and wildlife. 
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Given the toxicological relevance of the OH-POPs ,Chapter 3 aims at providing 
solutions to the long standing problem of the in vitro production and analysis of 
OH-POP metabolite potency to bind plasma thyroid hormone binding proteins 
(THBPs) when present in biological matrices. In this chapter : 1) co-extractants are 
identified and quantified in the microsomal extracts after in vitro metabolisation; 2) 
the potency of these co-extractants to inhibit the thyroid hormone- transthyretin 
(T4-TTR) plasma carrier protein competitive binding assay are quantified; 3) a 
method is developed to selectively extract metabolites and eliminate disturbing co-
extractants; and 4) the newly developed method is applied to analyze the potency 
of bio-activated extracts from the model compounds CB 77 and BDE 47 . To support 
these objectives, 5) a selective chromatographic method was developed to analyze 
silylated derivatives from CB 77 and BDE 47 OH-metabolites and co-extractants, 
and 6) a non-radioactive T4-TTR competitive fluorescence displacement method 
was set up in a 96-well plate . 
The chapters 4 and 5 are committed to tackle the issues of SPMX and sample 
extract concentration which are crucial to assess the reliability of in vitro bioassays 
for quantification of the toxic potencies of complex mixtures. 
Figure 1 PhD outline and 
chapter’s sequence 
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As the SPMX effect has been more elaborately reported for in vitro estrogenicity 
assays, a detailed meta-analysis was performed of the assays, compounds and 
conditions in which the effect is observed (Chapter 4a). It includes a detailed 
analysis of assay characteristics for the most common SPMX inducers 
diethylstilbestrol (DES), genistein and bisphenol A, and the likelihood of producing 
a SPMX effect.  
Several SPMX inducers also block cellular efflux pumps in vivo and in vitro (Anselmo 
et al. 2012; Georgantzopoulou et al. 2013). Therefore the hypothesis was tested 
that efflux pump blockers present in environmental matrices would increase the 
internal concentration of bioassay agonists and thus cause the SPMX. In Chapter 4b 
a 96-well plate cellular efflux pump inhibition assay (CEPIA) was adapted to the 
DR.Luc cell line and subsequently the influence evaluated of various 
environmentally relevant efflux pump inhibitors on the 2,3,7,8-tetrachlorodibenzo-
p-dioxine (TCDD) response. 
Considering the influence that the contaminant load can have on the performance 
of in vitro bioassays, we hypothesize that the use of overconcentrated stocks of 
sediment extracts can potentially cause wrong quantifications of toxic potencies. 
Chapter 5 reveals the effects of initial stock concentrations, on the quantified 
dioxin-like potency of cleaned nonpolar sediment extracts in an in vitro reporter 
gene assay. In addition the role of including sonication assisted dissolution and 
exposure time are studied. The consequences of sample preparation-related false 
positive or negative quantified toxic potencies of the sediment is related to safe 
levels set in sediment quality guidelines (SQG) and the impact on the management 
decision process. Suggestions are made to improve and standardize sample 
preparation practise and bioassay-based sediment potency quantification 
minimizing their modulating impact on its risk characterization.  
Finally, in Chapter 6 of this thesis, all methods and concepts developed in previous 
chapters are applied to non-polar extracts from highly or less contaminated 
sediments collected in Luxembourg, with the focus on the relevance of metabolic 
activation in in vitro analysis of the THD potency of the sediment extracts in the 
TTR-competitive binding bioassay. The extracts are either roughly split into a 
lipophilic and polar fraction using solvent partition fractionation, or fractionated 
into eight sub fractions with increasing polarity by normal phase HPLC. The model 
compounds CB77, BDE47 and the sediment extract fractions were tested for TTR 
binding potency before and after metabolic activation. The TTR competitive binding 
potency of the metabolic extracts is tested in the recently developed non-
radioactive 96-well plate ANSA-TTR assay, including removal of lipids from the 
extracts to avoid interferences in the assay. 
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Chapter 7 discusses the implications of our results to improve the relevance and 
reliability of in vitro bioassay applied for risk characterisation of complex mixtures 
from sediments and other matrices. It considers various aspects of the newly 
developed methods and knowledge acquired within this PhD project on in vitro 
bioassay risk characterization of sediments and other complex mixtures. It includes 
future perspectives for the application of in vitro bioassays in this field and 
discusses remaining issues of concern and the knowledge gaps to tackle with 
further research. 
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Abstract 
Halogenated phenolic compounds (HPCs) including hydroxylated 
polychlorobiphenyls (OH-PCBs) and hydroxylated polybromodiphenyl-ethers (OH-
PBDEs) can be persistent organic pollutant (POP) metabolites or natural marine 
compounds. Structurally similar to thyroid hormones (THs), they are retained in 
blood, transported through selective barriers, and the cause of endocrine and 
neuronal POP effects. This study presents a meta-analysis of HPC burdens in human 
and wildlife tissues, including OH-PCBs, OH-PBDEs, Pentachlorophenol, and 
polybromophenols. HPC blood plasma levels were also compared to known in vitro 
and in vivo toxicological effect concentrations. Blood, highly perfused, and fetal 
tissues contained highest levels of HPCs. Plasma concentrations of analyzed OH-
PCBs/PBDEs ranged from 0.1 to 100 nM in humans and up to 240, 454, 800, and 
7650 nM for birds, fish, cetaceans, and other mammals, respectively. These 
concentrations fully fall within the in vitro effect concentrations reported in 
literature for HPCs of 0.05–10000 nM. We strongly advise to further study HPC 
blood levels in the general population, children, and fetal tissue to establish 
background levels and the risk at sensitive development stages. As not all HPCs are, 
or can be, chemically analyzed, the application of additional bioanalysis might 
reveal an even greater toxicological relevance of HPCs. In addition, metabolic 
activation should always be included within in vitro hazard assessment of POPs. 
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Introduction 
Persistent organic pollutants (POPs) such as polychlorobiphenyls (PCBs) and 
polybromodiphenyl-ethers (PBDEs) are widely distributed in biotic and abiotic 
compartments, but a reduction or a leveling in biota has been observed during 
recent years (Letcher et al. 2010). However, contaminated environmental 
compartments such as soils and sediments serve as storage and act as “secondary 
sources” (Nizzetto et al. 2010). These POPs are accumulated by the organisms, 
magnified through the food chain (Kelly et al. 2008), and can be transformed into 
hydroxylated- (OH- containing) metabolites (Letcher et al. 2000; Malmberg et al. 
2005; Murk et al. 1994). Monitoring and effects analysis of POPs is mostly focused 
on the parent compounds, for which standards and analytical techniques are 
widely available, extraction procedures are relatively straightforward to apply, and 
environmental concentrations are higher compared to OH-PCBs/PBDEs and other 
halogenated phenolic compounds (HPCs). However, effects of PCBs and PBDEs in 
the endocrine and neuronal systems have been attributed to the action of their 
OH-metabolites (Brouwer et al. 1998; Dingemans et al. 2011; Fonnum et al. 2006).  
Chlorinated and brominated HPCs are usually reported and analyzed in separate 
publications. Among HPCs, OH-PCBs and 4-hydroxy-heptachlorostyrene (4OH-
HpCs) are believed to be metabolites from anthropogenic PCBs and 
octachlorostyrene, respectively (Bergman et al. 1994; Sandau et al. 2000). OH-
PBDEs and bromophenols (BPhs) are naturally present in the marine environment 
(Guitart et al. 2011; Malmvärn et al. 2005; Teuten et al. 2005) or they could be 
metabolites of PBDEs (Marsh et al. 2006; Qiu et al. 2007). A number of tri-BPhs are 
commercially produced as flame retardants and wood preservatives (Howe et al. 
2005). Pentachlorophenol (PCP) was used as wood preservative but is also a 
metabolite from hexachlorobenzene (HCB) (Renner 1988). These HPCs have been 
detected and quantified in blood from humans, other mammals, birds, and fish 
(Athanasiadou et al. 2008; e.g.Sandau et al. 2000; Valters et al. 2005; Verreault et 
al. 2005a). 
The basis for the retention of HPCs is their structural resemblance with the thyroid 
hormones (THs) ??????????????????????????????????????????????????????????????????????????????
????? ?????? ?????. Therefore HPCs with the hydroxyl group in the para or meta 
position, with one, but preferably two, halogens in the adjacent position (Lans et al. 
1993) bind with high affinity to thyroid-hormone-binding proteins (THBP) such as 
transthyretin (TTR), thyroxin-binding globulin (TGB), and albumin (ALB) (Marchesini 
et al. 2008; Ucan-Marin et al. 2010). ????? ????????? ????? ??????????? ?????????????? ????
?????????? by retaining them in blood and facilitating their transport over selective 
barriers to the brain or the fetus (Meerts et al. 2002; Morse et al. 1993).      
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The competition of HPCs with thyroid hormones (THs) for the available transport 
proteins may cause direct effects on thyroid hormone homeostasis (Gutleb et al. 
2010) but more importantly it allows delivery of HPCs instead of hormones to 
tissues (Zoeller et al. 2007), including endocrine targets (He et al. 2008; Meerts et 
al. 2001) and the neuronal system (Dingemans et al. 2011). In fact, endocrine, 
developmental, and behavioral effects were observed upon direct exposure to 4-
OH-CB107 (e.g.Meerts et al. 2004b)  
Three recent publications from 2000, 2005, and 2010 have thoroughly reviewed 
the concentrations of various HPCs in wildlife (Kawano et al. 2005; Letcher et al. 
2010; Letcher et al. 2000). To our knowledge, there is no comparable analysis 
available for human populations. In addition, observed concentrations of HPCs 
either in humans or in wildlife have not been compared with relevant toxicological 
information.  Considering the increasing evidence of HPC toxicity, it is of great 
relevance to review the reported concentrations in relation to their observed 
effects. The aim of this meta-analysis is to review reported tissue-specific HPC body 
burdens of humans and wildlife species, to analyze their concentration in relation 
to their putative parent compounds, and to relate them to relevant toxicological 
threshold concentrations. This will allow a more realistic assessment of the 
potential hazard of this class of compounds and the relevance of metabolic 
activation of POPs. 
Methods 
Literature search. Key words from the references cited by a recent POP exposure 
review (Letcher et al. 2010) were used in a scientific bibliographic search through 
the databases Scopus (Elsevier B.V.) and PubMed (NCBI). The keywords were 
classified into four categories: parent compounds (e.g., PCB or "polychlorinated 
biphenyls"), chemical group (e.g., metabolites or hydroxylated), biological 
compartment (e.g., tissue or blood), and endpoint (e.g., effect or level). From the 
reference and citation list from each retrieved publication, relevant publications 
were also collected. 
Selection criteria. Papers with reported OH-PCB and/or OH-PBDE concentrations in 
tissues, published in peer-reviewed journals in English up to 2012 were included. 
Reports for PCP, tri-BPhs OH-HpCs, and TBBPA were only included in the analysis if 
OH-PCBs and/or OH-PBDEs were also reported. For separate publications reporting 
the same population and same sampling campaign, the first publication from the 
group or that one in which the data had been described with the highest level of 
detail was chosen for the database. 
Collected data. The following information was tabulated from each publication 
when reported: bibliographic data, subject or population data (species, gender, 
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age, year, region, exposure level, and number of individuals), % lipid content, 
individual concentrations of most abundant congeners, as well as lowest, average 
(arithmetic or geometric mean, or median), and highest reported sums of 
congeners from PCBs, PBDEs, OH-PCBs, OH-PBDEs, PCP, tri-BPhs and OH-HpCs 
(database accessible through the WUR library E-depot: 
http://edepot.wur.nl/257263, excel file available upon request to the 
corresponding author). From each publication more than one entry could result 
depending of the number of species, tissues or conditions reported. 
Analysis and calculations. Concentrations were harmonized to ng/g wet weight 
(ng/g ww) for all tissues. When the % of lipid was not reported, an average value 
from similar publications was used. Plasma, serum, and whole blood were all 
considered as blood and its density was set at 1 g/mL. Blood concentrations of 
HPCs were transformed into nanomol/liter (nM) units to allow comparison with in 
vitro toxicity data. The average molecular weights from the collected congeners 
used to calculate the nM values were 378.8 for OH-PCBs and 500.9 for OH-PBDEs. 
Exact molecular weights were used for PCP (266.4), 4-OH-HpCs (361.5), and TBPs 
(330.7). The uncertainty of these calculations could lead to up to 80% variation, 
which is however below the data dispersion within reports. To reduce uncertainty 
from differences in sample composition and detection capabilities, results from the 
lowest, average, and highest reported values were combined in boxplots to show 
the tissue concentrations and variability in humans and wildlife. Graphs and 
regressions were made in SigmaPlot (SPSS). 
Results and discussion 
In total, 75 publications met the inclusion criteria to be in the database. Four 
studies with experimentally exposed animals were included into the database 
because they give insight in the mechanism of retaining and effects of metabolites, 
but not into the quantitative analysis of naturally exposed animals and humans. As 
a result, 211 entries were included in the quantitative analysis (Table 1). Although a 
reduction in OH-PCBs has been observed through the past decade (data not 
shown), reports before 2004 surveyed especially contaminated populations, 
whereas recent studies reported mainly on general populations, confounding a 
potential temporal analysis and perhaps influencing the overall results toward 
higher burdens. 
In addition to the HPCs included in the analysis, data for hydroxyl-
polybromobiphenyls (OH-PBBs) have been reported in polar bear adipose, brain 
and liver, and ringed seal blubber at similar or even higher concentrations 
compared with OH-PBDEs (Gebbink et al. 2008; Letcher et al. 2009). However, OH-
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PBBs seem to have a preference for adipose tissue retention (Gebbink et al. 2008) 
and their potency to bind THBPs is yet to be investigated. 
Species and tissue concentrations of HPCs.   
Reported human and wildlife tissue concentrations were, in general, 10 to 100 fold 
higher for OH-PCBs (Figure 1A) compared to OH-PBDEs (Figure 1B). Blood and 
highly perfused tissues such as liver and brain contained higher OH-PCBs/PBDEs 
compared with muscle, blubber, and adipose tissue (Figure 1). Levels in tissues and 
body compartments with few entries such as human milk and umbilical cord; fish 
eggs, cetacean cerebrospinal fluid, milk and liver; and polar bear brain and liver are 
listed in the Supporting Information but were not used in the analysis. 
Studied human populations were mainly from North America, Japan and Europe 
with a few exceptions from Nicaragua and India. Human OH-PCB/PBDE 
concentrations in tissues were the lowest among species. Values of OH-PCBs in 
plasma from human males were considerably higher compared to those for mixed 
population and females (Supporting Information, Figure SF1). Higher OH-PCBs also 
have been observed in male dolphin plasma (Houde et al. 2006). Although the 
authors attribute this to higher CYP activity induced by elevated PCB burdens, 
lower levels in females could also be the result of maternal transfer to offspring via 
lactation and deposition in eggs (Jörundsdóttir et al. 2009; Jörundsdóttir et al. 
2010).  
 
Figure 1 Distribution of lowest, average and highest reported concentrations of OH-PCB (A) and OH-PBDE (B) 
human and wildlife tissues including blood. Boxplots include data from the highest, average, and lowest sums 
of congeners reported in every entry for a range of tissues from humans and animals discriminated by species 
groups. Cetac. (cetaceans) and O.Mam. (other mammals). Values below boxplots indicate the number of all 
individuals included. Note the different scales. 
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Table 1. 
References of HPCs in human and wildlife tissues discriminated by species group and tissue 
Species 
group Tissue
No 
entries a 
Sum of 
individuals b
References 
??????? ???????????????????????? ?????? ???????? ???????et al.?????????????????et al.?????????????et al.??????
?? ???????? ?????????????? ?????????? ???????????? ??????????et al.????????????????et al.???????????????????????et al.????????????????et al.???????
??
?????? ??? ????? ?????????????et al.???????????????et al.??????????????et al.???????????????????????et al.??????????????et al.???????
???????et al.???????????????????????et al.??????????????et al.????????????????et al.??????????????et al.???????
?????????et al.? ????????????????et al.? ?????????????? ????????????????????????et al.? ???????????????et al.?
??????????????????et al.????????????et al.????????????????et al.?????????????????et al.??????????????et al.???????
?????????????et al.??????????????????et al.??????? ?????et al.????????????et al.??????
?????? ????? ??? ???? ??????????et al.??????????????????????et al.????????????? ?????????et al.???????
?? ?????? ?? ??? ????????et al.??????????????????????et al.??????
?? ?????? ??? ???? ??????????????????????????????????et al.??????????????????????et al.????????????????????????????????????et al.?
?????? ????????et al.???????????????et al.????????????et al.??????????????????et al.???????
????? ???
??????????? ?????? ??????? ??????et al.??????
?? ???????? ?????? ?????? ???????? ??????et al.??????? ???et al.?????????????et al.??????
?? ?????? ??? ??? ?????????et al.??????????et al.????????????????et al.????????????????et al.??????
?????????? ?????????????????? ???? ?????????? ???????????? ?????????et al.?????????????et al.??????? ????????et al.???????
?? ?????? ?? ??? ????????et al.??????? ??????et al.??????
??
?
?????? ??? ???? ????????et al.????????????????et al.?????????????et al.?????????????et al.?????????????et al.????????????????et 
al.?????????????????et al.???????? ?????et al.??????
??????
????????
??
???????????????????????? ?????????? ???????????? ????????et al.???????????????et al.???????????????et al.??????
?????? ?? ??? ????????et al.????????????et al.???????
?????? ??? ???? ????????et al.??????????????????et al.???????????????et al.??????????????et al.????????????????????????????????
???????et al.??????????????et al.???????????????et al.??????????????et al.?????????????????et al.???????? ?????et al.?
?????
Laboratory exposed animals
?????????????????
??????????
?????????????????
??????????????
?????????? ???????????? ?????et al.???????????????et al.???????????et al.?????????????????et al.??????
a An entry is the report of HPCs (OH-PCBs and OH-PBDEs, and PCP, OH-HpCs and tri-BrPhs when included) in a given species and a give tissue. b Total number of individuals for the 
given entries (sum of n) 
b Adipose tissue 
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Only six publications reported HPCs in fish and included mainly trouts, carps, and 
amberjacks whereas sharks and tuna seem to be the only marine species so far 
surveyed (Nomiyama et al. 2011b; Strid et al. 2010; Wan et al. 2009; Wan et al. 
2010). Given their allegedly lower metabolic activity, reported OH-PCBs in fish 
plasma range up to 100 ng/g ww. These might also demonstrate a lower phase II 
metabolic activity. However, these values are highly influenced by two reports from 
Detroit River fish (Li et al. 2003; Valters et al. 2005) while others reported 
concentrations up to 0.4 ng/g ww in fish blood from the Great Lakes and Japan 
(Campbell et al. 2003; Nomiyama et al. 2011b). 
Reported data in birds included, among others, gulls, falcons, eagles, and 
albatrosses. The concentrations of OH-PBDEs in bird eggs were remarkably high, 
averaging around 1 ng/g ww which was double compared to reports of levels in 
blood (Figure 1B). Similar patterns of OH-PCBs and OH-PBDEs in bird blood and 
eggs (Fängström et al. 2005a) and their presence before embryonic development 
(Verreault et al. 2005b) strongly indicate their maternal transfer, but interspecies 
differences remain to be studied (Jörundsdóttir et al. 2010). Furthermore, opposite 
to OH-PCBs, OH-PBDEs concentrations in birds are higher compared to fish, similar 
to cetaceans and to other mammals. 
In the category of other mammals, mainly seals and polar bears plus a few reports 
on cats and dogs were found. They were the highest among the species, while 
these results are strongly influenced by very high polar bear levels. Even after 
removing one outlier entry, (Gebbink et al. 2008) polar bear blood was still up to 
267 ng OH-PCBs/g ww. 
Developments on congener analysis 
Organic synthesis development and resources available to researchers influenced 
the number and type of congeners reported on publications. A number of 31–56 
OH-PCB congeners, mainly tetra to nona chlorinated, were synthesized and 
identified in human and wildlife plasma between 1994 and 2002 (Bergman et al. 
1994; Hovander et al. 2002). From the available standards, approximately 11–18 
congeners were reported in literature until 2009. The most abundant reported 
congeners in humans and wildlife were: 4-OH CB 107, 3-OH CB 153, 3’-OH CB 138, 
4-OH CB 146, and 4-OH CB 187, although the congener profile varies within species 
and locations. Analysis in birds and fish revealed also the importance of 4-OH CB 
120, 4-OH CB 199, and 4-OH CB 202 (Li et al. 2003; McKinney et al. 2006a). In 2006, 
80% of the OH-PCBs in bottlenose dolphins (Trupsiops truncatus) from the Atlantic 
were still  unidentified congeners (Houde et al. 2006), whereas in 2009, 40% of 
measurable OH-PCBs identified in sharks, cetaceans and mammals were mono to 
tetra congeners (Kunisue and Tanabe 2009; Nomiyama et al. 2010a; 2011b). Some 
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of these contributing congeners have been identified as: 4’-OH CB 25/26/31, 2’-OH 
CB 61, 4-OH CB 61, 3-OH CB 66, 4-OH CB69, and 4-OH CB 79. Lower halogenated 
congeners structurally resemble closer T3 than T4 which may result in lower binding 
affinity to plasma THBPs proteins, but reports of this group of congeners in humans 
is still lacking and the collected data in wildlife populations is insufficient to analyze 
the potential hazard implications.  
Lower (Lacorte and Ikonomou 2009; Marsh et al. 2003) and higher (Rydén et al. 
2012; Yu et al. 2010) brominated OH-PBDEs have meanwhile been synthesized and 
identified in humans and wildlife. The most abundant congeners, 4’-OH BDE 17, 2-
OH BDE 68, 4-OH BDE 42, 3-OH BDE 47, 6-OH BDE 47, 4’-OH BDE 49, and 4-OH BDE 
92, have remained the same up to date and therefore big uncertainties are not to 
be expected.  
There is still a large proportion of unidentified congeners, particularly OH-PCBs. 
From the potential 209 PCB and 209 PBDE congeners, only 62 PCB and 12 BDE 
congeners have been consistently reported to be present in human and wildlife 
tissues. Several OH-metabolites may be produced from each of these parent 
compunds (Marsh et al. 2006; Montaño et al. 2012; Murk et al. 1994; Qiu et al. 
2007). Considering the production of 4–6 metabolites per parent compound, the 
total number of metabolites could rise up to 400 congeners. Not all of these 
metabolites will be selectively retained in the blood and transported over placental 
and blood–brain barriers; however, this demonstrates the potential extent and 
complexity of an issue which clearly deserves further studies. 
Relationship to parent compounds.  
Although a relative large number of OH-PCB congeners have not been analyzed, 
their levels in human blood significantly correlated with that of parent PCBs (P < 
0.0001, Figure 2A) in agreement with previous results (e.g.Park et al. 2007). This 
correlation is less evident for blood concentrations in other species and for other 
tissues such as eggs or liver. The ratio of ?OH-PCBs ????PCBs was highest in human 
blood at low PCB burdens (Figure 2B). ???????????????????????????????PCBs/g w.w. 
???????????????????????????????????? ????????????OH-PCBs). This stabilization could 
be the result of equilibrium between phase I and phase II metabolism and the THBP 
carrying capacity. However, several human and wildlife studies comparing control 
and contaminated populations found considerably higher metabolite to parent 
ratios on individuals with higher POP burdens (Athanasiadou et al. 2008; Cuadra et 
al. 2006; Hovander et al. 2006; Routti et al. 2009). Furthermore, rats and sheep 
exposed to PCBs had up to 17 times more OH-PCB than PCB in blood at the end of 
the exposure period (Berg et al. 2010; Bergman et al. 1994).Therefore, it is 
plausible to suggest that at higher PCB burdens, phase II metabolism cannot 
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completely counterbalance the production of metabolites, and also the THBPs can 
transport much higher quantities of metabolites when required. 
The metabolite/parent ratios are important indicators of the balance between 
production, retention and excretion of metabolites, as are important to establish 
?????????? ??????? ??????????????? ???? ???-??????????? ????? ????? ??? ??????? ???????
umbilical cord and eggs (Figure 3A), which is in agreement with a higher burden of 
OH-PCBs in highly perfused tissues and active transport through selective barriers 
(Meerts et al. 2002)???????????????????????????????????????????-????????????????
than adults (Figure 3C). This result may be influenced by studies of particularly 
exposed populations (Cuadra et al. 2006; Fängström et al. 2005b). The ratios 
reported in literature and discussed here probably represent an underestimation, 
particularly on OH-PCBs reports before 2010. 
The tissues with the highest ???-?????????? are blood, brain and especially fetal 
tissue like eggs and umbilical cord (Figure 3B and D). These results therefore 
confirm an important transfer of OH-PBDEs into fetal tissues and suggest higher 
transfer efficiencies compared to OH-PCBs. For coastal and marine populations the 
main source of OH-PBDEs might not be metabolism of PBDEs but direct uptake of 
mainly ortho OH-PBDEs (Figure 4) directly from marine sources (Malmvärn et al. 
2008). This can explain the absence of ???????????? ???????? ???-PBDEs and the 
??????? In blood from inland populations, mainly meta and para OH-BDE 
congeners were present (Figure 4), supporting existing evidence toward 
metabolism from parent BDEs as their source (Marsh et al. 2006; Montaño et al. 
2012; Qiu et al. 2007). 
Figure 2 Correlation between absolute or relative metabolite concentrations and parent compounds for PCBs 
in human blood. Circles represent the average sum of congeners reported from each human entry. The (A) 
???????????????????????????????????????-PCBs (y=0.21 + 0.14*x) and the (B) logarithmic regression between 
???????????????????? to metabolite ratios (y=0.31 - 0.072*log10[x]) were both highly significant, P < 0.0001. 
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Figure 4 Relative presence of OH-PBDE 
congeners in blood calculated based on 
the reported ng/g ww average levels 
per species group distinguishing inland 
and coastal populations. 
?????????????????????-PCBs/-????????????????????? ?????????????????????????????? ?????????????? ?????????
blood (C and D). Boxplots represent the distribution of the ratio from the average sums of (A and C) OH-PCB 
and (B and D) OH-PBDE congeners to the sum of their respective parent compounds. U.Cord. (umbilical cord 
tissue), Hum. (Humans), Cetac. (cetaceans), O.Mam. (other mammals) and P.Fem. (pregnant females). Values 
below boxplots indicate the number of all individuals included. 
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HPC plasma retention  
The increased concentration of HPCs in relation to their putative parent 
compounds mainly in plasma but also in other highly perfused tissues (Figure 2) has 
been explained on the basis of their structural resemblance to thyroid hormones 
and hence their binding to the THBPs (Brouwer et al. 1998; Lans 1995). The main 
purpose of the THBPs is to provide a multicomponent buffer system to assess the 
even distribution of THs through the body (Schreiber 2002) which otherwise will 
permeate into cell membranes and disappear from the bloodstream (Mendel et al. 
1987). 
In general, HPCs competitively bind TTR with similar potency compared to T4 
(Supporting Information, Table ST1) whereas most of them have lower affinity than 
T4 for TBG. However, as the affinity of TBG for T4 is almost 3 orders of magnitude 
higher than that for TTR, similar concentrations of, for example, some OH-PBDEs 
will equally compete with T4 for TTR as they will do for TBG. This indicates that TBG 
contributes as well to the HPCs retention in plasma. ALB demonstrated similar 
affinity for HPCs compared to THs (Ucan-Marin et al. 2010); however, the 
importance of ALB on HPC retention and transport is yet to be asserted. 
The concentrations of thyroid binding proteins vary among species and within 
stages of development (Supporting Information, Table ST2). In combination with 
their binding affinity, it is estimated that in humans TBG, TTR, and ALB carry 65%, 
15%, and 20% of the bound T4, and that one in three TBG molecules, one in 300 
TTR molecules, and one in 3000 ALB molecules carry one T4 molecule bound to it 
under physiological conditions. Therefore, about 100 nM of proteins have bound-
T4, and at least 200 nM of TGB and 4000 nM of TTR are available so a large amount 
of HPCs can be bound without direct competition with THs. This might explain the 
absence of consistent correlations between plasma HPC and TH concentrations 
(Rolland 2000). Instead, the THBPs deliver the HPCs to the tissues where they can 
exert direct effects and/or interfere with TH sensitive processes altering feedback 
balances and hence TH homeostasis (Gabrielsen et al. 2011; Murk et al. 2013). It is 
therefore important to consider the HPC burdens in perspective of their various 
mechanisms of toxicity. 
HPC burdens in relation to effect levels 
Besides OH-PCBs and OH-PBDEss, 4OH-HpCs and halogenated phenols such as PCP, 
TBBPA and triBPhs bind to the THBP (Table 2). PCP was the major HPC found in 
human blood, whereas for all other species OH-PCBs were the most abundant HPCs 
(Figure 5). Birds had relatively higher brominated HPC levels, probably due to the 
fact that most publications reported on piscivorous coastal bird populations 
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characterized by a major exposure to tri-BPhs and OH-PBDEs from marine sources 
(Figure 5). 
 
This study aims at comparing the HPC body burdens of humans and wildlife to 
known effect concentrations. To this end, all reported concentrations were 
expressed in molar units, allowing sensible combination of relatively heavy 
brominated with also much lighter HPCs. The range of HPC concentrations in 
human blood was 0.1–100 nM including PCP and 0.2–20 nM without PCP (Figure 6).  
The total HPC range in human blood is one fold higher when PCP concentrations 
are included. Highest reported PCP values were 187 nM in blood from Swedish men 
(Sjödin et al. 2000). But it seems that PCP concentrations have decreased in recent 
years to levels below 40 nM (approximately 10 ng/mL) (Zheng et al. 2011). The 
results reveal that children and fetal cord blood HPC concentrations are similar to 
those in adults (Figure 6). HPC concentrations in wildlife plasma were in the range 
of 1–240 nM in birds, 0.2–454 in fish, 0.1–800 nM in cetaceans, and were highest 
(0.05–7650 nM) in other mammals (Figure 6); as mentioned before, there is 
apparently still a portion of OH-PCBs not yet quantified. 
Among the relevant in vitro end-points (references in Supporting Information, 
Table ST3), thyroid hormone competitive binding has been most widely studied. 
THBP competition is observed from 5 to 1000 nM, whereas a higher quantity (200–
50000 nM) is generally required to trigger T3 dependent proliferative effects in the 
T-screen (Figure 6). Effects of HPCs on nuclear receptors are structurally dependent 
and required concentrations above 5 nM to act as agonist or above 1000 nM as 
antagonist. However, activation of thyroid hormone receptor (THR) by HPCs has 
Figure 5 Composition of HPC chemical 
groups in blood. The composition is 
?????? ??? ???? ???????? ?????? ????
chemical group for all entries per 
species group, expressed in nM as 
explained in the Methods section. 
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been observed already from 0.03 nM. HPCs inhibit aromatase and other 
steroidogenic enzyme activities from 500 nM, whereas gene expression in the same 
pathway is altered above 1000 nM. Neuronal effects on Ca2+ homeostasis and 
neurotransmitters have been observed above 200 nM; however, abnormal 
dendritic development is shown after exposure to OH-PCB concentrations as low as 
0.005 nM. 
Thyroid hormone homeostasis, estrogenic, behavioral, and neuronal effects were 
observed in offspring from pregnant rats exposed to 4-OH CB107 (Meerts et al. 
2002; Meerts et al. 2004a; Meerts et al. 2004b). Acute toxicity in adults, and 
various developmental effects in embryos were observed on zebrafish exposed to 
6-OH BDE47, while liver concentration were 170–940 nM and 300 nM, respectively 
(Boxtel et al. 2008). Similar developmental arrest was obtained after zebra fish 
exposure to three OH-BDE congeners (Usenko et al. 2012). Finally, exposure to a 
combination of PCB118 and PCB153 during sheep gestation influenced fetal 
growth, adrenal development, cortisol production, (Zimmer et al. 2011) and 
offspring sexual dimorphic behavior (Gutleb et al. 2011). In this case, 3-85 nM 4-OH 
CB107 and 4-OH CB146 metabolites were found in plasma from the same lactating 
ewes 50 days after birth (Berg et al. 2010) (Figure 6). Few in vivo exposure studies 
with either OH-PCBs/PBDEs or parent compounds report plasma effect 
concentrations allowing comparison with OH-PCB/PBDE levels in humans and 
wildlife. 
Conclusions, knowledge gaps and recommendations 
Plasma HPC (OH-PCB, OH-PBDE, PCP, OH-HpCs, and tri-BhPhs) concentrations 
reported ranged from 0.1 to 100 nM in humans and up to 240, 454, 800, and 7650 
nM for birds, fish, cetaceans, and other mammals. Although still only a selection of 
HPCs can be and were analyzed, these concentrations are well within the range of 
observed in vivo and in vitro developmental, endocrine, and neuronal effects. 
Metabolic activation and the retention of OH-metabolites in plasma should be 
more explicitly considered within a more realistic hazard assessment of POPs, 
especially when this is based on in vitro analyses. 
General population studies and the surveillance of a single population are required 
to determine background levels and temporal trends. These studies should 
especially pay attention to levels in fetuses (umbilical cord blood) and children as 
the scarce information present indicate relatively high concentrations of OH-PCBs 
and OH-PBDEs that are of concern. The results of fetal tissues, including human 
cord blood and bird eggs, suggest a greater maternal transfer efficiency of OH-
PBDEs compared to that of OH-PCBs, an important aspect of exposure that must be 
further investigated. 
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Figure 6 HPC concentrations in plasma from humans and wildlife compared to in vitro and in vivo effect 
concentrations. HPCs included reports from OH-PCBs and OH-PBDEs and also PCP, OH-HpCs, tri-BrPhs and 
TBBPA when included. Boxplots represent the distribution of highest, average and lowest sums of congeners in 
blood from humans and animals (nM) calculated from values reported in the literature included in this study. 
Cross-hatched boxes indicate human HPC concentrations without PCP. Lines indicate in vitro effect 
concentrations (nM) for THBP binding, T-screen, thyroid hormone (TH)R, estrogen (E)R and androgen (A)R 
receptor activation, steroidogenesis, neuronal outgrowth, and in vivo effect concentrations for mammalian 
growth and development. Details and references can be found in Supporting information, Table ST3. 
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Arctic top predators hold HPCs concentrations comparable to total TH transport 
protein capacity. Studies on nonarctic top predators and other important piscivores 
and carnivores are warranted. Two studies reported OH-PCB or OH-PBDE plasma 
concentrations in pets. These animals live in close association with house dust and 
lick their fur; they could serve as sentinel species to study indoor exposure of 
especially small children. 
Biological methods should be developed to be able to include the toxic potencies of 
HPCs that cannot be chemically detected because standards do not (yet) exist or 
they occur in levels below the limit of detection while they do contribute to the 
combined HPC risk. Retrospective studies applying those more comprehensive 
methods to stored samples (including blood plasma from in vivo experiments and 
umbilical cord) may reveal an even greater toxicological relevance of OH-
PCBs/PBDEs than already indicated by the results of our current meta-analysis.  
Suporting information 
Available supporting information includes: the list of individual congeners included 
in the database; the concentrations of HPCs not included in Figure 1; Figure S1 
depicting the distribution of reported concentrations of OH-PCBs and OH-PBDEs in 
human plasma; Table ST1 with  the summary of competitive binding parameters of 
hormones and HPCs to transport proteins; Table ST2 with the levels of hormone 
carrying proteins and thyroid hormones in various species and Table ST3 with the 
sources of information for the in vitro effect concentrations displayed in the Figure 
6. This material is available free of charge via the Internet at http://pubs.acs.org.  
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Table ST1. 
Summary of competitive binding parameters of hormones and HPCs to transport proteins a 
Compound or 
group 
TTR TBG Albumin Species References c 
IC50 
b
  (nM) RP 
d IC50 (nM) RP 
d IC50 (nM) RP   
T4 13-260  1-85  7.9  Human 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
 10    5.11  Birds 10, 11 
T3 216-1600  14-30  23.88  Human 4,5,6,8, 10, 11, 12 
 5.99    1.12  Birds 10, 11 
OH-PCBs 7-95 0.4-8 1380 - >10000 > 0.02   Humans 2,4, 13  
 12.5 / 1.1 e 0.8 / 3.1 e   4.19 / 0.89 e 1.2 / 1.2 e Birds 10, 11 
PCP 33 0.6     Humans 5 
4-OH-HPCs 71.74 1.1     Humans 14 
OH-PBDEs 7 - 900 0.2 – 4 60 - >7500 0.01-1.5   Humans 5, 6, 7, 14, 15 
 7.7-12 / 5-69 e 1.3-2 / 0.1-1 e     4-5 / 0.8-1 e 1-1.2 / 1-1.4 e Birds 9, 10 
Tri-BPhs 4 -67 0.9 -10     Humans 3, 5 
PCP * 33.2 0.6 n.r. * - -   Humans 5 
TBBPA * 18.8 1 n.r. * - -   Humans 5 
a For a complete table with data from each reference and each compound see database at Wageningen Library e-depot (www.library.wur.nl)  
b In some publications the IC50 is reported as the Ki (affinity constant) where Ki= IC50/(1+([ligand]/Kd), and Kd is the dissociation constant of the competitor-protein 
reaction.  
c References: 1) Nilsson et al. 1975, 2) Lans et al. 1993, 3) Meerts et al. 2000, 4) Marchesini et al. 2006, 5) Marchesini et al. 2008, 6) Cao et al. 2010,  7) Montaño et al. 2012, 
9) Nilsson and Peterson 1975 , 10) Ucan-Marin et al. 2009 , 11) Ucan-Marin et al. 2010, 12) Ren and Guo 2012a  , 13) Cheek et al. 1999, 14) Sandau et al. 2000, 15) Hamers 
et al. 2008,  16) Weiss et al. 2009.  
d RP values are reported mainly in competition with radioactive T4 (references: 1,2,3,6,9,10,11), with T4 linked to a chip (references: 4 and 5) and with 8-anilino-1-
naphthalenesulfonic acid ammonium salt (ANSA) (references: 6 and 7) 
e Ki in competition with T4 / and Ki in competition with T3 
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Table ST2. 
Levels of hormone carrying proteins and thyroid hormones in various species  
Species Tissue TTR (μM) ???????? Albumin (μM) TT4 (nM) fT4 (pM) TT3 (nM) fT3 (pM) References 
a 
Humans b Plasma 5 0.24-0.5 600 23-200 9-25 1-4 1-9 1, 2, 3, 4, 5    
 Cord plasma  0.6–1.3    0.4-0.8  6 
 Cerebrospinal fluid (CSF) 0.42 0.0028 2.3 2.4 70   1 
Larger mammalsc Plasma + d + + 9-100 9-30 0.5-3.0 2-8 7,8 
Smaller mammalsc 
including rodents 
Plasma + + dev d + 20-80 14-36 0.8-1.7 1-7 7,8 
Seals (Mothers / Pups) Plasma + + + 25 / 60 e  0.8 / 2 e  9 
Birds f Plasma +  + 3-95 1-60 2-8 3-12 8, 10 
Fish Plasma + + dev d + 4-23 2-600 0.3-14 21-419 10, 11 
Amphibians Plasma  + dev d + 0.5-6  0.1-1.5  12 
a References: 1) Schreiber 2002,  2) Dallaire et al. 2009, 3) Hagmar et al. 2001, 4) Nomiyama et al. 2010, 5) Zota et al. 2011, 6) Sandau et al. 2002, 7) Joasoo et al. 1975, 8) Hulbert 
2000, 9) Gabrielsen et al. 2011, 10) Nøst et al. 2012, 11) Blanton and Specker 2007, 12) Fort et al. 2007  
b The euthyroid human range is: 60-140 nM total T4, 10-25 pM  free T4, 1-3 nM total T3 and 3-8 pM free T3 (Hulbert 2000);  
c Larger mamals include (but not exclude): monkey, cattle, sheep, goat, buffalo, horse, swine and dog. Smaller mammals include (but not exclude): cat, rabbit, and rat (Joasoo et al. 
1975)  
d The protein presence has been confirmed (+) and only at a particular developmental stage (+ dev)   
e mothers / pups;  
f THs values reported by Nost and co-workers (2012) in Northern Fulmar are considerably higher compared to values summarized by Hulbert (2000).  
 
?
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Table ST3. 
Sources of information for the in vitro effect concentrations and OH-POP concnetrations 
found after in vivo exposure displayed in the Figure 6. 
End-point References 
In vitro  
THBP binding Cao et al. 2010; Cheek et al. 1999; Hamers et al. 2006; Lans 
et al. 1993; Marchesini et al. 2008; Meerts et al. 2000; 
Montaño et al. 2012; Ren and Guo 2012b; Ucan-Marin et al. 
2009; Ucan-Marin et al. 2010 
T3 dependent proliferation 
 
Ghisari and Bonefeld-Jorgensen 2005; Schriks et al. 2006 
Nuclear receptor interactions 
Thyroid hormone receptor THR Freitas et al. 2011; Kimura-Kuroda et al. 2008; Li et al. 2010 
Estrogen receptor Hamers et al. 2006; Kitamura et al. 2005; Kojima et al. 2009; 
Kramer et al. 1997; Meerts et al. 2001; Mercado-Feliciano 
and Bigsby 2008; Moore et al. 1997 
Androgen receptor Hamers et al. 2006; Kojima et al. 2009 
Steroidogenetic effects Cantón et al. 2006; He et al. 2008; Song et al. 2008 
Nauronal effects Dingemans et al. 2010; Hendriks et al. 2010; Kimura-Kuroda 
et al. 2005; Kimura-Kuroda et al. 2007 
In vivo  
Pregnant rats exposed to 4-OH CB 107 Meerts et al. 2002; Meerts et al. 2004b; Meerts et al. 2004a 
Zebrafish exposed to 6-OH BDE 47 Boxtel et al. 2008; Usenko et al. 2012 
  
Pregnant sheep exposed to a mixture of 
PCB 118 and 153 
Berg et al. 2010; Gutleb et al. 2011; Zimmer et al. 2011 
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
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Abstract 
Polychlorinated biphenyls (PCBs) and polybrominated diphenyl-ethers (PBDEs) are 
metabolized into hydroxylated metabolites (OH-PCBs/PBDEs), which can disrupt 
the thyroid hormone homeostasis. Binding of these metabolites to transport 
proteins such as transthyretin (TTR) is an important mechanism of their toxicity. 
Several methods to quantify the competitive thyroxine (T4) displacement potency 
of pure metabolites exist. However, quantification of the potency of in vitro
metabolized PCBs and PBDEs has drawbacks related to the coextraction of 
compounds disturbing the T4-TTR competitive binding assay. This study identifies 
and quantifies the major coextractants namely cholesterol, saturated 
andnonsaturated fatty acids (SFA and NSFA) at levels above 20 nmolper mg 
equivalent protein following various extraction methods.Their TTR binding potency 
was analyzed in a downscaled, nonradioactivefluorescence displacement assay. At 
concentration factorsneeded for TTR competitive binding, at least 10 ??? ???
thesecoextracts is present, whereas individual SFA and NSFA disturbthe assay from 
??????? ???? ?????????????? ??? the in vitro metabolismand extraction of the model 
compounds CB 77 and BDE 47 waschemically quantified with a newly developed 
chromatographicmethod analyzing silylated derivatives of the OH-metabolites 
andcoextractants. A new method to selectively extract metabolites andlimit 
coextraction of disturbing compounds to less than 5 nmol permg equivalent 
protein is presented. It is now possible to make adose-response curve up to 50% 
inhibition with bioactivated CB 77and BDE 47. The toxic potencies of bioactivated 
persistent organicpollutants (POPs) should be taken into account to prevent 
seriousunderestimation of their hazard and risk. 
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Introduction 
Metabolic activation of polychlorinated biphenyls (PCBs)and polybrominated 
diphenyl-ethers (PBDEs) has attracted scientific and societal interest and concern. 
These persistent organic pollutants (POPs) are accumulated by organisms and 
magnified through the food chain (Kelly et al., 2008). Upon uptake, PCBs and PBDEs 
can be transformed by phase I metabolic enzymes into hydroxylated compounds 
(Marsh et al.,2006; Morse et al., 1995). These metabolites can cause direct effects 
on the thyroid hormone homeostasis (Freitas et al.,2011; Gutleb et al., 2010; 
Meerts et al., 2002), interact with the estrogenic receptor (Hamers et al., 2006; 
Meerts et al., 2001),increase steroidogenic gene expression (Song et al., 2008), and 
might be the underlying cause for observed neurological effects of PBDEs 
(Dingemans et al., 2011). 
Several of the effects of hydroxylated PCB and PBDE metabolites (OH-PCB/PBDEs) 
are driven by their competition with 3,3’,5,5’-tetraiodo-L-thyronine (thyroxine, T4) 
to bind the plasma transport proteins, their subsequent accumulation in tissues, 
and their specific transport over selective barriers (Meerts et al., 2002; Morse et 
al., 1993). OH-PCBs and OH-PBDEs have a structural similarity with the thyroid 
hormones T4 and 3,3’,5-triiodo-L-thyroxine (T3). Therefore, they bind with high 
affinity to specific transport proteins such as transthyretin (TTR) and thyroxin-
binding globulin (TBG) (Lans et al., 1994; Marchesini et al., 2006; Meerts et al., 
2000). As a result of this binding, OH-POP levels have been shown to be similar or 
up to 30 times higher in plasma than the respective parent compounds in mammals 
(up to 2.8 ?g/g wet weight) (Gebbink et al., 2008) and as high as the parent 
compounds in humans (up to 22 ng/g wet weight) (Sjodin et al., 2000). This 
mechanism is then the basis for the selective retention of OH-PCB/PBDEs in various 
tissues and their transport through selective barriers to the brain or the fetus 
(Meerts et al., 2002; Morse et al., 1993). Given the high plasma levels and the 
toxicological relevance of the metabolite effects, it is very important to quantify the 
toxic potencies of these OH-POPs in order to take them into account for 
toxicological hazard and risk assessment of PCBs and PBDEs. 
Mainly three in vitro methods to measure the potency of competitors to displace T4 
from TTR and TBG have been reported. The radio-ligand binding assay (RBA) uses 
radioactive T4 (T4*) in equilibrium with T4, TTR, and the competitor at 4°C. The 
amount of unbound T4* is a measure of the competitor’s potency (Lans et al., 
1993). The plasmon resonance– based biosensor assay (Biacore) uses immobilized 
T4, which interacts with a mobile phase containing TTR or TBG and the competitor. 
The availability of free TTR for binding the immobilized T4 is a measure of the 
competitor’s potency (Marchesini et al., 2006). Finally, the fluorescence 
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displacement method is based on the measurement of the fluorescence emitted by 
a fluorophore when bound to proteins such as TTR, TGB, or albumin. A competitor 
will displace the fluorophore from its position in the protein, thereby reducing the 
fluorescence as a measure of the compound’s potency to displace T4 (Nilsson and 
Peterson, 1975).  
These methods have all been successfully used to measure the competitive binding 
of pure substances, but efforts to measure the metabolite potency of biologically 
metabolized PCBs and PBDEs have encountered several problems. The analysis of 
bioactivated extracts using in vitro biotransformation techniques with microsomal 
fractions has been hampered by the low biotransformation efficiencies, presence 
of toxic parent compound concentrations in the extracts, and the presence of 
interfering matrix components coextracted from the metabolizing system (Hamers 
et al., 2008; Meerts et al., 2000; Schriks et al., 2006). In contrast to the parent 
compounds, the OH-metabolites do not endure destructive clean-up steps, and 
their physical/chemical qualities make it difficult to separate them from potentially 
interfering substances in the extract. Recent attempts to remove the interfering 
matrix components from extracted tissues by exhaustive clean-up procedures and 
30 to 100 times sample dilution have been reported, but these could still not 
prevent interference with the analysis by matrix compounds coextracted from 
plasma and muscle samples (Simon et al., 2010, 2011). 
Well-known compounds that interfere with T4 binding to TTR are the free fatty 
acids. The fact that human plasma free fatty acids present in micromolar 
concentrations can directly inhibit T4 binding to TTR was the reason for the decision 
not to use T4-TTR binding assays to determine the plasma T4 levels in humans in the 
clinical setting (Shaw et al., 1976). In addition, the free T4 * used in the RBA is 
prevented from binding to TTR at higher fatty acid concentrations, and it is 
transported through the column causing an overestimation of the competitive 
potency (Simon et al., 2010; Weiss et al., 2009). However, the identity 
concentration and T4-TTR binding potency of the interfering coextractants from 
bioactivated extracts are not yet known. This information is required in order to 
solve the problem of disturbing coextractants and thus enable to study the toxic 
potencies of the ubiquitous OH-metabolite from POPs, such as PCBs and PBDEs.   
In addition, a method to be able to quantify the TTR binding potency of the OH-
metabolites without the use of radioactivity and expensive equipment and/or in 
relatively great quantities such in cuvettes is desired. 
Therefore, this study aims to (1) identify and quantify the concentration of 
coextractants in microsomal extracts, (2) quantify the potency of coextractants to 
inhibit the T4-TTR competitive binding assay, (3) develop a method to selectively 
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extract metabolites and eliminate disturbing coextractants, and (4) apply the newly 
developed method to analyze the potency of bioactivated extracts from CB 77 and 
BDE 47, which are used as representative model compounds. To support these 
objectives, we developed (5) a selective chromatographic method to analyze 
silylated derivatives from CB 77 and BDE 47 OH-metabolites and coextractants and 
(6) a T4-TTR competitive fluorescence displacement method in a 96-well plate setup 
according to a published method for cuvettes (Nilsson and Peterson, 1975).   
Materials and methods 
Standards and reagents. The model compounds 3,3’,4,4’-tetrachlorobiphenyl (CB 
77, 99.0%) and 2,2’,4,4’-tetrabromodiphenylether (BDE 47, 98.8%) were purchased 
from Sigma-Aldrich Co. (Steinheim, Germany) and Chiron AS (Trondheim, Norway), 
respectively. CB 77 metabolites including 2-OH-3,3’,4,4’-CB (2-OH CB 77) and 5-OH-
3,3’,4,4’-CB (5-OH CB 77) were previously synthesized in our laboratory (Lans et al., 
1993), whereas 4’-OH-3,3’,4,5’-CB 79 (4’-OH CB 79) was purchased from LGC 
Promochem (Middlesex, U.K.). BDE 47 metabolites including 2’-OH-2,3’,4,5’-BDE 
(2’- OH BDE 66) and 6-OH-2,2’,4,4’-BDE (6-OH BDE 47) were provided by Ake 
Berkgman and were synthesized as previously described (Marsh et al., 2003). 6’-OH-
2,2’,4,5’(6’-OH BDE 49), 5-OH-2,2’,4,4’-BDE (5-OH BDE 47), 4-OH-2,2’,3,4’-BDE (4-
OH BDE 42), 4’-OH-2,2’,4,5’-BDE (4’-OH BDE 49), and 3-OH-2,2’,4,4’-BDE (3-OH BDE 
47) were purchased from Accustandar (New Haven, CT). The internal standard for 
chromatographic analysis 2,2’,3,3’,4,4’,5,5’,6,6’ decaCB (CB 209) was obtained from 
Riedel-de Haen (Seelze, Germany). Fatty acids including dodecanoic acid, myristic 
acid, and palmitic acid were purchased from Supelco (Bellefonte, PA), whereas 
linoleic acid, oleic acid, stearic acid, and arachidonic acid were purchased from 
Sigma-Aldrich Co. (Steinheim, Germany). Cholesterol was purchased from Vel 
(Leuven, Belgium). N,O-bis(trimethylsilyl)-trifluoroacetamidetrimethylchlorosilane 
(BSTFA–TCMS) (9:1) solution and lipid removal agent (LRA) were purchased from 
Supelco (Bellefonte, PA). Hexane (dioxin analysis grade) and all other solvents 
(chromatographic grade) were purchased from Biosolve BV (Valkenswaard, The 
Netherlands) or from Sigma-Aldrich Co. (Steinheim, Germany). Stock solutions were 
prepared in dimethyl sulfoxide (DMSO) for bioassays, in iso-octane for storage, and 
in hexane (dioxin analysis grade) for chromatographic analysis. ?-Nicotinamide 
adenine dinucleotide 2’-phosphate reduced tetrasodium salt hydrate (NADPH), 
3,3’,5,5’-tetraiodo- L-thyroxin (T4), prealbumin from human plasma (TTR), and the 
fluorescent probe 8-anilino-1-naphthalenesulfonic acid ammonium salt (ANSA) 
were purchased from Sigma-Aldrich Co. Concentrations of T4 and ANSA were 
routinely determined by UV-visible spectrometry with a Beckman Coulter DU 800 
spectrophotometer. Extinction coefficients were 6180 M??cm?? at 325 nm in buffer 
phosphate and NaOH at pH 11 for T4 (Nilsson and Peterson, 1975) and 6300 
M??cm?? at 350 nm in buffer phosphate at pH 7.5 for ANSA (Cao et al., 2010). All 
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extraction and storage materials were exclusively made of borosilicate glass 
prewashed with hexane, and polytetrafluoroethylene screw cap vials were used 
when required. 
Microsomal incubations. In vitro bioactivation of PCBs and PBDEs has been 
previously described (Murk et al., 1994) and was applied with few modifications 
given below. Compounds were metabolized using liver S9 fraction from ?-
naphthoflavone and phenobarbital-treated Sprague Dawley rats obtained from 
Xenotech (Lenexa, Kansas). Incubations were performed in a borosilicate glass tube 
in 1 ml phosphate buffer (PB, 100 mM, pH 7.5), S9 fraction (1 mg protein/ml), and 
parent compound (10 ?M in 1% DMSO). After 5 min preincubation in a shaking 
water bath at 37°C, the reaction was initiated with the addition of 100 ?l of 10 mM 
NADPH in PB. Additional 100 ?l of 10mM NADPH was added every 20 min during 
the incubation period. Metabolism was stopped after 90 min (Harju et al., 2007) by 
denaturation of microsomal proteins with 700 ?l of ice-cold methanol (negative 
controls at t = 0). Some incubations were spiked with 4-OH CB 79, 2-OH BDE 66, 
and 6-OH BDE 47 (2 ?M) to quantify extraction recovery and to study the potential 
production of dihydroxy metabolites. Coextractants and metabolites were analyzed 
as silylated derivatives by Gas chromatography/mass spectrometry (GC/MS) as 
described further below.  
Metabolite extraction methods. To qualify and quantify the amount of 
coextractants from the incubation mixture, S9 control incubations were spiked with 
2 nmol 4-OH CB 79/mg-eq protein in DMSO and extracted using four methods 
published in literature for POP OH-metabolites. The first method (M1) was a liquid-
liquid extraction from the incubation mixture with diisopropyl ether (DIPE), and 
acidification was performed only during the third extraction step (Murk et al., 
1994). The second method (M2) was a modification of the previous one with a 
centrifugation step before extraction (Hamers et al., 2008). Except for the use of 
methyl tert-butylether (MTBE) instead of DIPE, M1 and M2 were performed as 
published. The third and the fourth extraction methods (M3 and M4) correspond to 
the crude and the phenolic organohalogen extraction methods published by 
Hovander et al. (2000). When required, the protocols were downsized to fit the 
incubation volume. All extracts were evaporated under gentle N2 flow and 
redissolved in 1 ml of hexane for GC analysis or transferred into 50 ?l of MeOH for 
bioanalysis.  
Chromatographic analysis. We developed a selective ion chromatographic method 
to analyze coextractants and metabolites in one run. GC/MS was performed on a 
HP 6890 coupled to an Agilent 5973 mass spectrometer all from Agilent 
Technologies. Helium 99.99% was used as a carrier gas at a constant flow of 1.2 
ml/min; the inlet temperature was set at 250°C, whereas the transfer line was kept 
at 280°C. Injection volume was 1 ?l. Separation was achieved through an Rxi-5ms 
capillary column, 30 m . 0.25 m, 0.25 ?m film thickness (Restek). The temperature 
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30 min. Electron ionization (EI) was used at an ion source temperature of 230°C and 
an electron energy of 70 eV. Chromatographic data were recorded and analyzed 
with Chemstation (Agilent Technologies). High-sensitivity electron impact (EI) mass 
spectra from silylated metabolites were obtained with GC/MS-MS (Supplementary 
data 1).  
Extracts, POP OH-metabolites, selected fatty acids, and cholesterol were silylated 
by mixing 20 ?l of compound standard solution or extract in hexane with 40 ?l of 
BSTFA–TCMS (9:1), which contained 1 ?g/ml of CB 209 as internal standard (IS), in 
GC vials. They were heated on a plate at 70°C for 30 min and then transferred into 
inserts for GC analysis. Identification of coextractants and produced metabolites 
was achieved through analysis of fragmentation patterns and retention time from 
their trimethylsilyl derivatives (Table 1) and their comparison with standards. 
Quantification was done using a multicompound external calibration, which was 
run with every analysis (Fig. 1A). The limit of detection of the OH-metabolites was 
calculated from the blank microsomal extract base line and subsequently 
confirmed by the analysis of three extracts of blank microsomal incubations spiked 
with OH-metabolites at the limit of detection level (Table 1).  
ANSA displacement assay. The basic principle of the fluorescence displacement 
assay is the shift in fluorescence peak of the ANSA fluorescence probe, after 
binding to transport proteins such as human serum albumin, TTR, and TBG. The 
shift in the fluorescence peak is from 515 to 465 nm with a large increase in 
quantum yield. Fluorescent displacement of ANSA bound to TTR by competitors 
has been published using spectrometric detection with cuvettes (Cao et al., 2010, 
2011; Nilsson and Peterson, 1975; Nilsson et al., 1975). We developed a method in 
a 96-well plate setup for TTR binding according to the same principle, which was 
optimized for a variety of method variables including plate type, measurement 
angle, emission filter, and sensitivity settings. The equilibrium between bound and 
unbound ligand is very sensitive for incubation conditions, and therefore, 
incubation volume, time, temperature, reactants, and solvent concentrations were 
optimized and standardized (Supplementary data 2). Subsequently, the ANSA-TTR 
fluorescence coefficient was obtained after titration of increasing ANSA 
concentrations [ANSA] into a 0.5?M TTR solution in PB. From the linear part of the 
curve between [ANSA] and the fluorescence intensity (F?), the fluorescence 
coefficient (B) was obtained (Moller and Denicola, 2002). The amount of bound 
ANSA was then calculated for any given [ANSA] where [ANSA]bound = F?/B. From 
the curve between [ANSA]bound and [ANSA], the ANSA dissociation constant (Kd) 
and the number of binding sites (Bmax) can be calculated after fitting the data to a 
dose-response model. The binding or association constant (Kb) will be the inverse 
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of Kd. The effects of the carrier solvents DMSO and MeOH on the ANSA 
fluorescence and the ANSA-TTR displacement were also evaluated.  
TTR binding experiments. Dose-related binding of T4, coextractants, and 
metabolite standards to TTR was assessed in the ANSA-TTR displacement assay. 
Standard solutions in MeOH (2.5% final concentration) were mixed in a round-
bottom 96-well plate (Greiner Bio-One) with 0.6 ?M ANSA and 0.5 ?M TTR in 100 ?l 
PB at pH 7.5. After 2 h of incubation at 4°C, the plate was gently shaken for 10 s 
and measured in a Biotech Synergy 2 plate reader (Winooski, VT). ANSA 
fluorescence was excited using a 380 ± 20 nm filter, and the emission was 
measured with a 475 ± 20 nm filter. Negative controls without TTR, ANSA-TTR 
positive controls, and T4 0, 100, and 600nM displacement controls were included 
on every plate. Variation coefficients for repeatability and reproducibility were 
determined using replicates on separate plates and separate experiments, 
respectively. The detection limit was set at thrice the SD of the control without TTR. 
Data were expressed as fluorescence relative to the ANSA-TTR maximal 
fluorescence (positive control) unless otherwise stated. The 20 or 50% inhibition 
potency (IC20 or 50) for the competitors was obtained after fitting the dose-related 
decrease in relative fluorescence units (RFU) into a dose-response model using 
SigmaPlot 2001 (SPSS Inc.). Subsequently, the IC50 was used to calculate the 
competitors’ dissociation constant (KdI) (Yung and Prusoff, 1973) and then its 
inverse to render their binding (association) constant KbI. These inhibition 
parameters were compared with the potency of T4 tested under similar conditions.  
New method for low-fat metabolite extraction. A new method for low-fat 
metabolite extraction (M5) was developed based on M3 and M4 (Hovander et al., 
2000), with modifications based on various experiments performed during this 
study. Preliminary T4-TTR competition experiments with microsomal extracts 
performed with the Biacore showed that selected fatty acids and cholesterol bind 
to the dextran-coated chip surface (data not shown). To selectively retain fatty 
acids, the incubation mixture (1 ml) was mixed with 50 ?l of a 10% dextran solution 
from Leuconostoc spp. in phosphate buffer in addition to 50 ?l of 6M HCl for 
acidification. This mixture makes the coextractants precipitate, and the subsequent 
centrifugation (3 min, 1500 g, 4°C) further compacted the flocks. The incubation 
mixture including the flocs was extracted twice with 1 ml of hexane:MTBE (1:1, 
vol/vol). After vigorous vortexing and centrifugation (1 min, 1500 g), the organic 
phases were transferred into a second test tube containing 1 ml of an aqueous KCl 
solution (1%, wt/wt). After gentle mixing and centrifugation (30 s, 1000 g), the 
organic phase was transferred to a clean test tube, and the KCl solution was 
reextracted with 1 ml of hexane:MTBE. The combined organic phases were reduced 
to a 50 ?l extract (20 mg-eq protein/ ml) under gentle N2 flow.  
Fatty acids and other higher molecular weight lipids were separated from the 
metabolites with a LRA minicolumn made with 0.8 g of LRA and 0.3 g of Na2SO4 
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packed on top of a glass wool plug in a Pasteur pipette. The LRA minicolumn was 
washed with 2 ml of hexane:MTBE (1:1) before the 50 ?l extract was transferred to 
the minicolumn. The extract tube was rinsed twice with 150 ?l of hexane:MTBE 
(1:1), which was transferred into the LRA column as well. This eluate from the LRA 
column (350 ?l from the 50 ?l extract and 2 . 150 ?l rinsing) was discarded. Then 
the column was further eluted with 1600 ?l of the same solvent, which was 
collected into a prewashed test tube where it was dried ml) for chemical analysis or 
50 ?l MeOH (20 mg-eq protein/ml) for bioanalysis.  
 
TABLE 1  
Relative retention time (RRT), limit of detection and GC/MS (EI) fragmentation data for CB-77, 
BDE-47 and the trimethylsilylated derivatives from selected fatty acids, cholesterol, and their 
metabolites. 
Original compound RRT a Limit of detection (nmol/mg protein) b 
Quantif. 
m/z 
Qualif. ions MS 
m/z (rel.int. %) 
 CB 77 (3,3’,4,4’) d 0.454 0.30 292 220 (40), 185 (5) 
 BDE 47 (2,2’,4,4’) 0.759 0.10 486 326 (90), 484 (70), 324 (60)  
Silylated derivatives     
Fatty Acids e Dodecanoic acid (12:0) 0.266 0.30 257 272 (2), 117 (70), 73 (70) 
Myristic acid (14:0) 0.304 0.30 285 300 (5), 117 (70), 73 (70)  
Palmitic acid (16:0)  0.363 0.30 313 328 (5), 117 (70), 73 (70) 
Linoleic acid (18:2)  0.447 0.01 337 352 (8), 117 (70), 73 (70) 
Oleic acid (18:1) 0.450 0.01 339 354 (7), 117 (70), 73 (70) 
Stearic acid (18:0) 0.466 0.30 341 313 (20), 117 /(50), 73 (70)  
Archidonic acid (20:4) 0.574 0.01 79 91 (90), 117 (90), 238 (40) 
Cholesterol  1.088 0.003 329 458; 368 
CB-77 
 metabolites 
2-OH CB 77 (3,3’,4,4’) d 0.590 0.03 365 380 (70), 329 (50), 93 (30) 
5-OH CB 79 (3,3’,4,5’) 0.620 0.03 365 380 (70), 329 (50), 93 (30) 
4’-OH CB 79 (3,3’,4,5’) 0.733 0.01 365 380 (70), 329 (50), 93 (30) 
BDE-47  
metabolites 
6'-OH BDE 49 (2,2’,4,5’) 0.872 0.10 559 574 (60), 324 (60) 
6-OH BDE 47 (2,2’,4,4’) 0.877 0.03 559 574 (60), 324 (60) 
5-OH BDE 47 (2,2’,4,4’) 0.931 0.03 574 559 (100), 320 (50) 
2’-OH BDE 66 (2,3’,4,4’) 0.955 0.03 559 574 (60), 324 (60) 
4-OH BDE 42 (2,2’,3,4’) 0.956 0.10 574 559 (90), 320 (40) 
4'-OH BDE 49 (2,2’,4,5’) 0.956 0.10 574 559 (90), 320 (40) 
3-OH BDE 47 (2,2’,4,4’) 0.981 0.03 559 574 (50), 320 (50) 
Internal  
Standard (IS) 
CB 209 
(2,2’,3,3’,4,4’,5,5’,6,6’) 1.00 - - 498 428; 214 
a Retention times relative to CB 209 on a Rxi?-5ms capillary column, 30m x 0.25m x 25 ?m. RRT had a 
variation coefficient within experiments no larger than 1%. b Limit of detection calculated from a blank 
microsomal extract base line and confirmed by extracts from spiked incubations at the limit of detection 
level. As the total protein was 1 mg/mL the units nmol/mg protein are equivalent to ?M.  d PCBs and BDEs 
systematic numbers according to Ballschmiter and co-workers (1980) reviewed by Mills and co-workers 
(2007) followed by the list of numerical chlorine or bromine substituent localizers. e Fatty acid common 
names followed by their structure (number of carbons : number of double bonds) according to R.O. Adolf 
and F.D.Gunstone (http://www.aocs.org/member/division/analytic/fanames.cfm). 
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TTR binding of CB 77 and BDE 47 metabolic extracts. The microsomal blank, OH-
POP spiked incubations, and incubations with CB 77 and BDE 47 were extracted 
with the optimized M5 method. Metabolites were identified and quantified after 
silylation using GC/MS as described above. Extracts in MeOH were serially diluted 
up to 64 times and used to measure their ANSA-TTR fluorescence displacement 
potency relative to that of T4 based on the linear part of the curve. The bioassay T4-
Eq was compared with the T4 equivalents calculated from the chemically analyzed 
metabolite concentrations multiplied by the T4 equivalent factors from our own 
study or from literature (Hamers et al., 2008). In the absence of complete dose-
response curves, significant differences with extraction blanks and negative 
incubations were assessed with ANOVA followed by a LSD post hoc comparison 
(SPSS Inc.).  
Results 
Identification and quantification of coextractants 
After extraction of blank microsomal S9 fraction incubations with four published 
methods, the chromatographic profiles of the extracts included various SFA, NSFA, 
and cholesterol (Fig. 1). For identification, the relative retention times and mass 
spectrometric characteristics were compared with standards when available (Table 
1). 
TABLE 2 
Mean concentration expressed in nmol/mg-eqa protein of fatty acids, cholesterol, and % of 
recovery for 4-OH CB 79 in the extracts obtained with published methods and with the 
developed method  
Compound 
M1 M2 M3 M4 M5 
Murk et al. 
(1994) 
Hammers et al. 
(2008) 
Hoovander et al. (2000) 
New method 
Crude Phenolic 
Dodecanoic (12:0) <LQb <LQ <LQ 0.62 ± 0.57 0.07 ± 0.02 c 
Myristic (14:0) 0.68 ± 0.50 0.40 ± 0.062 0.38 ± 0.25 1.5 ± 0.70 0.19 ± 0.15 
Palmitic (16:0) 12 ± 1.5 7.6 ± 0.62 6.9 ± 0.44 15 ± 4.5 2.47 ± 0.94 
Stearic (18:0) 12 ± 1.3 6.5 ± 0.78 5.2 ± 0.69 11 ± 2.3 1.23 ± 0.67 
Total SFA d 24 ± 2.0 15 ± 1.00 12 ± 0.86 19 ± 5.1 4.0 ± 1.2 
Arachidonic (20:4) 4.9 ± 1.60 2.9 ± 0.58 3.1 ± 0.047 8.0 ± 4.8 0.12 ± 0.2 
Linoleic (18:2) 1.0 ± 0.12 0.4 ± 0.56 0.85 ± 0.20 1.7 ± 1.2 0.17 ± 0.03 
Oleic (18:1) 0.55 ± 0.16 0.37 ± 0.04 0.50 ± 0.13 1.0 ± 0.5 0.17 ± 0.04 
Total NSFA 6.5 ± 1.6 3.6 ± 0.81 4.5 ± 0.24 8.2 ± 1.2 0.53 ± 0.33 
Cholesterol 26 ± 2.6 4.2 ± 0.32 18 ± 1.4 0.07 ± 0.05 5.3 ± 2.7 
4-OH CB 79 (%) e 89 ± 12 76 ± 8.0 89 ± 9.6 106 ± 21 84 ± 13 
a All extracts were made from 1 mg protein and dissolved in 1mL of hexane for GC/MS analysis therefore 
concentration was equivalent to ?M. b LQ: limit of quantification. c Standard deviation from two separate 
experiments, each with duplicate incubation injected twice in GC/MS. d Palmitoleic acid (16:1) was identified 
in M1 and M2 but not quantified due to a lack of standard. e 4-OH PCB 79 original concentration in the 
incubation mixture was 2 nmol/mg protein 
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Per milligram original microsomal protein (mg-eq protein), the four methods 
extracted 12–24 nmol SFA, 3.6–8.2 nmol NSFA, and 0.1–26 nmol cholesterol. The 
M1 produced the highest quantity of coextractants, whereas the M2 limited the 
amount of SFA and NSFA extracted to almost 50% compared with M1 (Table 2). M3 
had slightly lower quantities of SFA, NSFA, and cholesterol compared with the 
extract obtained with M1. 
Furthermore, the phenolic extract obtained with M4 contained only detectable 
quantities of cholesterol, but the extraction roughly doubled the amount of SFAs 
and NSFAs, particularly that of arachidonic acid. Now that the coextractants have 
been identified and quantified, their relevance in disruption of the competitive TTR 
binding assay will be analyzed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chromatogram from silylated derivatives of a standard mixture (A) and of a S9 microsomal blank  
extracted with M1(B). Silylation internal standard (IS) was CB 209; surrogate standards were 4-OH CB 79, 2-
OH BDE 66, and 6-OH BDE 47. Fatty acids were named with their common name. 
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ANSA fluorescence displacement assay 
The ANSA fluorescence displacement assay was optimized for ANSA-TTR binding. 
The intensity of ANSA bound to TTR was optimal when performed in a round-
bottom 96-well plate and the fluorescence measured from the bottom, with a 
380±20 nm excitation filter and a 475±20 nm emission filter. The optimal ANSA 
concentration was 0.6 ?M and TTR 0.5 ?M. Equilibrium conditions were achieved 
after 2 h of incubation at 4°C with gentle shaking before measurement. For more 
detailed results, see Supplementary data 2. 
ANSA in the absence of TTR gives background fluorescence, and neither MeOH nor 
DMSO (<20%) interfered with this background fluorescence. However, the 
fluorescence of ANSA in the presence of TTR was significantly reduced by DMSO 
and by MeOH above 2.5% (Fig. 2). 
 
 
 
 
 
Figure 3. Association binding of ANSA to 0.5 ?M TTR 
in phosphate buffer (black) and in phosphate buffer 
with 2.5% MeOH (gray). Data represent the 
calculated [ANSA] bound concentration ± SD of two 
independent experiments in triplicate. Lines 
represent the predicted values (solid) ± 95% 
confidence intervals (dashed) after the data were 
adjusted to a Hill model. 
Figure 2. MeOH (circles) and DMSO (triangles) effect 
?????????????????????????????????????????????????????
??????????? ?????????????????????????????????????????
the average fluorescence relative to an ANSA-TTR 
solution ± SD of three independent experiments in 
triplicate. The zero relative fluorescence represents 
the ANSA blank without TTR. * indicates significant 
differences (p < 0.05) after an ANOVA with 
Dunnett’s post hoc comparison. 
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From the titration of ANSA into 0.5?M TTR, the ANSA Kb was calculated to be 
1.06±0.13x106 M?? (Fig. 3). There was indeed a significant interaction between the 
effect of 2.5% MeOH and the effect of ANSA concentration (ANOVA, P<0.05); 
MeOH increased fluorescence at high ANSA concentrations (> 6?M). However, the 
overall effect of 2.5% MeOH on the ANSA titration into TTR was not significant (p < 
0.01) and particularly not at lower ANSA concentrations (Fig. 3). ANSA Kb in the 
presence of 2.5% MeOH was 0.97±0.08x106 M?? which was, in consequence, not 
significantly different from the one without MeOH (p < 0.01). Therefore, 2.5% was 
chosen as maximal solvent concentration for further ANSA-TTR experiments. 
Using a dose-response design, T4 reduced the fluorescence signal from 0.6 ?M 
ANSA plus 0.5 ?M TTR in a dose-dependent manner with an IC20 of 80±16 nM, an 
IC50 of 265±8.2 nM (Fig. 4A) and a limit of detection of 60±12nM T4. The T4 binding 
constant was 6.0±0.2x106 M-1  (Table 3). The repeatability was typically 5%, and the 
reproducibility was 9% when the same lot of TTR was used and was up to 15% 
when experiments were performed with different TTR lots. Figure 4B shows the full 
ANSA-TTR displacement curves for the four OH-CB 77 and OH-BDE 47 metabolite 
standards. Their relative potencies compared with that of T4 are given in Table 3. 
TTR competitive binding of coextractants 
The S9 coextractants identified in the extracts of the four extraction methods all 
displaced ANSA from TTR with the exception of cholesterol and stearic acid (Figs. 
5A and B). The SFAs significantly displaced ANSA fluorescence from 1 ?M on, with 
dodecanoic acid and myristic acid fully displacing ANSA at 30 ?M, whereas palmitic 
acid only partially displaced it (Fig. 5A). NSFAs had a significant effect already from 
0.3 ?M and completely displaced ANSA fluorescence at 30 ?M (Fig. 5B). Inhibition 
Figure 4. Fluorescence displacement curve of T4 (A), PCB 77, and BDE 47 OH-metabolites (B) titrated into a 
??????????????????????????????????????????????????????????????????????????????????????????????????????????
ANSA-TTR solution ± SD of at least three different experiments in triplicate. Lines represent the predicted 
values after the data were adjusted to a Hill model. 
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potencies of fatty acids were 5 to 30 times lower than that of T4 and 2–10 times 
lower than the OH-metabolites. The fatty acid TTR binding constants are one order 
of magnitude lower compared with T4 (Table 3). Given the TTR finding potency of 
the SFAs and NSFAs and their concentrations in the extract, it is important to 
further reduce the coextracted levels in the metabolic extract. 
 
TABLE 3 
ANSA-TTR displacement parameters for T4, co-extractants 
and selected metabolites from CB 77 and BDE 47.  
Group Compound Range (?M) 
IC 20 
(?M) a 
IC 50 
(?M) a 
Kb 
(106 M-1) T4Eq 
Hormone T4 0.001-5 0.12 0.26 ± 0.1
b 6.0 1 
SFA Dodecanoic (12:0) 0.01-300 3.0 11 ± 0.94 0.2 0.02 
 Myristic (14:0) 0.01-300 1.5 6.5 ± 0.75 0.24 0.04 
 Palmitic (16:0) 0.01-300 1.0 n.d.c 3.1d 0.12d 
 Stearic (18:0) 0.01-300 >300 >300 - <0.001 
NSFA Arachidonic (20:4) 0.01-300 0.40 2.3 ± 0.25 0.76 0.12 
 Linoleic (18:2) 0.01-300 1.8 6.5 ± 0.83 0.24 0.04 
 Oleic (18:1) 0.01-300 0.72 3.3 ± 0.38 0.48 0.08 
 Cholesterol 0.01-30 >30 >30  <0.01 
PCB metabolites 4’-OH CB 79  0.001-5 0.26 0.51 ± 0.02 3.10 0.52 
BDE metabolites 2'-OH BDE 66  0.001-5 0.13 0.23 ± 0.02 5.51 0.93 
 6-OH BDE 47  0.001-0.5 0.48 0.63 ± 0.02 2.50 0.42 
 4-OH BDE 42 0.001-5 0.97 0.29 ± 0.02 5.36 0.93 
a Concentration in the ANSA displacement assay plate which produced  the 20 or 50% inhibition compared 
with the maximal inhibition of T4 
b T4 IC20 was 80±16 nM,  and it was used to calculate the extracts bioassay T4 equivalents (T4-Eq) 
c n.d.: not determined 
d Kb and T4Eq calculated at the IC20 level 
 
Figure 5. Competitive TTR binding by SFAs (A), NSFAs, and cholesterol (B) titrated into a solution of 0.6?M 
ANSA and 0.5?M TTR. Data represent the average of fluorescence intensity relative to an ANSA-TTR 
solution ± SD of at least three different experiments in triplicate. Lines represent the predicted valuesafter 
the data were adjusted to a Hill model. 
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Reduction of coextractants in the metabolic extract 
A new extraction method M5 was developed to limit the coextractant 
concentrations and their effects in the TTR competition assay. The new method 
included protein denaturation and lipid flocculation with the addition of 10% 
dextran at pH < 2, liquid-liquid extraction, and a LRA minicolumn.  
 
The addition of 10% dextran at pH < 2 already reduced SFAs 50% compared with 
M3 to 6 nmol/mg eq protein and NSFAs to 2 nmol/mg eq protein. The LRA 
minicolumn improved this removal further. Figure 6 shows the elution profile of 
coextractants and OH-POP metabolites through the LRA minicolumn. The 
metabolites eluted from 0.4 to 2 ml (Fig. 6). SFA eluted constantly from the column, 
whereas NSFA and particularly oleic and linoleic acids eluted mainly between 1.2 
and 2.4 ml. Arachidonic acid did not elute before 4 ml (Fig. 6) and therefore could 
be reduced to 0.12 nmol/mg-eq protein, which corresponds to a reduction of more 
than 21 times compared with M1 (Table 2). With M5, 5 to 10 times less SFAs and 7 
to 20 less NSFAs were extracted than with any of the other methods tested (Table 
2). Cholesterol concentration was five times lower than with M1, three times lower 
than with M3, but considerably higher compared with M4 (Table 2). 
A 0.5 mg-eq protein/ml microsomal blank extract prepared with M5 and spiked 
with 3 nmol T4/mg-eq protein produced a displacement curve that was not 
significantly different from that obtained spiking MeOH with a similar amount of T4 
(Fig. 7). However, the undiluted microsomal extract significantly competed with 
ANSA-TTR binding above 0.25 mg-eq protein/ml with a competitive potency of 0.3 
nmol T4-Eq/mg-eq protein (Fig. 8). 
 
 
Figure 6. Elution profile of a standard mixture 
through an 80-mg LRA minicolumn. 
Concentrations of OH-metabolites, cholesterol, 
SFA, and NSFA were obtained after GC/MS 
analysis of eluates. In the M5, the first 0.4 ml is 
discarded as is everything after 2 ml. Data 
represents average ± SD from two independent 
experiments each with four separate columns. 
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Figure 8. Competitive TTR binding of serially diluted 
M5 extract (0.5 mg-eq protein/ml) of S9 incubation 
blank (circles), S9 incubation spiked with 2 nmol T4-
Eq of 4-OH CB 77/mg-eq protein (triangles) or with 
0.3 nmol T4-Eq/mg-eq protein of an OH-metabolite 
mixture (containing 4-OH CB 77, 2-OH BDE 66, and 
6-OH BDE 47) and extracted with the M5 method. 
Data represent the average fluorescence relative to 
???? ???????? ???? ???? ??? ???? ????????? ?? ??? ??? ???
least two separate extracts in triplicate. * indicates 
significant differences of incubation blank 
compared with the ANSA-TTR control, and # 
indicates differences of spiked incubations 
compared with the incubation blank (P < 0.05) after 
an ANOVA with LSD post hoc comparison. 
Figure 7. M5 extract effect on the T4 displacement 
curve. A solution of 4 ?M T4 in MeOH (circles) or    
3 ?M T4 in 0.5 mg-eq protein/ml microsomal blank 
extract obtained with the M5 method (triangles) 
was serially diluted into a solution of 0.6 ?M ANSA 
and 0.5 ?M TTR. Data represent the average of 
fluorescence intensity relative to an ANSA-TTR 
solution ± SD of at least three different experiments 
in triplicate. Lines represent the predicted values 
after the data were adjusted to a Hill model. 
Figure 9. Effect of CB 77 and SBDE 47 metabolic 
incubation extracts. Microsomal incubation blanks 
with DMSO (circles), with CB 77 (triangles), and with 
BDE 47 (squares) were extracted according to the 
M5 method; the 0.5 mg-eq protein/ml extracts 
were diluted up to 68 times and titrated into a 
solution of 0.6 ?M ANSA and 0.5?M TTR. Data 
represent the average of fluorescence intensity 
relative to the maximum of an ANSA-TTR solution ± 
SD of at least two separate extracts in triplicate. * 
indicates significant differences when comparing 
with incubation blank in DMSO (p < 0.05) after an 
ANOVA with LSD pos hoc comparison. 
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TTR competitive binding by extracts with bioactivated CB 77 and BDE 47  
Finally S9 microsomes were incubated during 90 min with 10 ?M CB 77 or BDE 47 
and extracted with the newly developed M5 method. The extracts were chemically 
analyzed and tested in the ANSA TTR displacement assay (Table 4). MS details of 
silylated metabolites are presented and discussed in Supplementary data 1. In vitro 
metabolism of CB 77 produced mainly 4-OH CB 79, which accounted for 68% of the 
total metabolite fraction, followed by 20% of 5-OH CB 77 and 16% of 2-OH CB 77. 
The most abundant metabolite from BDE 47 was 4?-OH BDE 49 with 48% of the 
total followed by 3-OH BDE 47 and 5-OH BDE 47, which accounted for 25% each, 
and trace amounts of 2?-OH BDE 66 and 4-OH BDE 47.  
Considering the final concentration of metabolites, the calculated metabolic rates 
were 33 and 6 pmol mg protein-1min-1 for CB 77 and BDE 47, respectively. 
Metabolic extracts from both CB 77 and BDE 47 reduced ANSA fluorescence in a 
dosedependent manner, but the differences with the dilution range of the 
incubation blank were small and not always statistically significant (Fig. 9). 
Incubations stopped at t = 0 were not significantly different from incubation blanks 
(solvent controls; data not shown). At the T4 IC20 level, the bioassay T4-Eq was 0.3 
nmol T4-Eq/mg-eq protein for the CB 77 metabolic extract and 0.6 nmol T4-Eq/mg-
eq protein for the BDE 47 bioactivated extract. 
TABLE  4 
Mean concentration (nmol/mg eq protein) of CB 77 and BDE 47 OH-metabolites in the extract 
after microsomal incubation and their respective concentrations in the MeOH extract and final 
concentration in the ANSA displacement assay.  
             Extract Assay plate 
Solvent Hexane MeOH Buffer +  2.5% MeOH 
Volume 1 mL ????? ?????? 
Conc. factor 1 20 1/40 
Protein-eq conc. 1 mg/mL 20 mg/mL 0.5 mg/mL 
2-OH CB 77 0.10 ± 0.02 2.0 0.1 
4-OH CB 79 0.41 ± 0.08 8.2 0.2 
5-OH CB 77 0.12 ± 0.03 2.4 0.1 
Sum OH-PCBs 0.60 ± 0.10 13 0.3  
(0.14 T4Eq)a 
6-OH BDE 47 <L.D   
5-OH BDE 47 0.05 ± 0.02 1.0 0.03 
2’-OH BDE 66 <L.D   
4-OH BDE 47 <L.D   
4'-OH BDE 49 0.10 ± 0.01 2.0 0.05 
3-OH BDE 47 0.06 ± 0.01 1.2 0.03 
Sum OH-BDEs 0.21 ± 0.02 4.2 0.11  
(0.38 T4Eq) a 
a Calculated T4 equivalents  from the chemically analyzed metabolite concentrations multiplied by the T4 
equivalent factors from our own study or from literature (Hamers et al. 2008). 
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Despite the interference at higher extract concentrations, spiked S9 microsomal 
incubations were extracted and successfully quantified. An extract spiked with 2 
nmol T4-Eq of 4-OH CB 77/mg-eq protein produced 2.3 T4-Eq/mg-eq protein, and 
the extract spiked with 0.3 T4-Eq OH-metabolite mixture/mg-eq protein.  
Discussion 
  
A method was developed to reduce the concentrations of the coextractants from 
bioactivated mixtures of PCB and BDE that disturb the TTR binding assays. With an 
optimized method for silylation, the identities and concentrations of extracted fatty 
acids and OH-metabolites were obtained, and their TTR binding potencies were 
quantified in a downscaled, nonradioactive TTR binding ANSA assay in a 96-well 
plate. The greatly improved removal of especially fatty acids from the microsomal 
extracts allows quantification of the TTR binding potency of the in vitro produced 
metabolites at the IC20 level. 
Optimization of the S9 Extraction Method 
The published metabolite extraction methods also are efficient in extracting lipids 
including free fatty acids, cholesterol, and acidic phospholipids, which are neutral 
at low pH. The observed fatty acid composition was very similar to that reported 
for human liver microsomes and trout S9 liver fractions, whereas the sum of fatty 
acids and cholesterol was only 4–10% of the total reported lipid content (Belina et 
al., 1975; Escher and Fenner, 2011; Waskell et al., 1982). Therefore, M1, M2, and 
M3 are already efficient at limiting the coextracted fatty acid content. 
Nevertheless, fatty acids can also be produced by hydrolysis of coextracted 
phospholipids. This was observed in the increase of NSFAs and particularly the 
arachidonic acid content in the M4 extract (Table 2). Neutral phospholipids such as 
phosphatidylserine have a higher arachidonic acid concentration (Waskell et al., 
1982); it was likely hydrolyzed under the highly basic conditions during the final 
extraction step in M4 increasing the coextracted free fatty acid. The addition of 
dextran in M5 partially reversed the transfer equilibrium of free fatty acids to the 
organic phase by their retention in the flock; the LRA minicolumn selectively 
retained heavier NSFA. And finally, lipolytic conditions were avoided in the newly 
developed method. 
Interaction of coextractants with TTR binding 
The inhibitory effect of fatty acids and particularly NSFA on the competitive 
protein-binding assay has long been known by clinicians who tried to develop a 
method to determine the free T4 in plasma by testing its binding potency to 
transport proteins. The most potent inhibitors of T4 binding to TBG and TTR are 
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short-chain SFA and long-chain NSFA (Shaw et al., 1976). We confirmed this with 
our downscaled ANSA displacement assay (Table 3). The fatty acids’ binding 
constants obtained here were similar to reported values (Tabachnick and Korcek, 
1986), but their IC50 were lower than previously reported values (Shaw et al., 
1976). These differences are commonly due to variation in protein source and 
purity (Nilsson et al., 1975). Although triglycerides have been found not to interfere 
with the assay (Shaw et al., 1976; Simon et al., 2010), the influence from the small 
coextracted amount of phospholipids is uncertain. Under M5 conditions, however, 
the LRA minicolumn is expected to completely retain both triglycerides and 
phospholipids.  
It was not known whether the fatty acid disruption of the T4-TTR binding is the 
result of their direct interaction with T4 (Shaw et al., 1976; Simon et al., 2010) or 
due to their interaction with the TTR binding sites (Tabachnick and Korcek, 1986). 
As the ANSA-TTR fluorescence displacement assay presented here does not require 
the presence of T4 and FA did not interfere with ANSA fluorescence, it is suggested 
that the observed inhibitory effect is caused by interaction of the FA with the TTR. 
Considering reported results with the T4-TTR RBA and results presented here, it is 
reasonable to suggest that observed assay disturbances are a combined effect of 
two mechanisms: a direct interaction of FA with T4 at high fatty acid concentrations 
(observed in the RBA assay) and TTR competitive inhibition by FA at lower 
concentrations (observed here). This would explain observed U shapes with muscle 
extracts in the RBA competitive binding assay (Simon et al., 2010). In summary, a 
method that does not include T4 for the competitive binding measurements, like 
the ANSA-TTR fluorescence displacement assay, is one step further reducing the 
disturbing action of coextractants.  
The obtained ANSA-TTR binding constant (1.06×106 M-1) in the 96-well ANSA assay 
was in agreement with previously published values between 1 and 36×106 M-1 (Cao 
et al., 2010; Cheng et al., 1977; Nilsson et al., 1975). The calculated T4 binding 
????????? ????? ?? ???? ????? ???? ???? ?????? ??? ?????????? ?????? ????????? ?????
published data (10×107 M-1) for the ANSATTR assay with cuvettes (Cao et al., 2010; 
Nilsson et al., 1975). Lans et al. (1993) reported a considerably lower T4 binding 
constant (2×107 M-1) in the RBA. This difference in relative binding affinity was 
reflected in the obtained T4 IC50, which was 3 to 10 times higher in the ANSA assay 
than previously reported values (Cao et al., 2010; Lans et al., 1993; Marchesini et 
al., 2008; Meerts et al., 2000). These differences could also be attributed to 
variations in protein sources. However, despite the lower sensitivity obtained in the 
96-well plate ANSA displacement assay, the T4-relative potencies for OH-POP 
metabolites were in agreement with literature (Cao et al., 2010; Lans et al., 1993; 
Marchesini et al., 2008; Meerts et al., 2000). In addition to the advantage of 
Chapter 3 
 80 
excluding potential interaction of FA with T4 from TTR competitive binding 
incubations, the ANSA displacement assay has several other advantages compared 
with previously used methods (Lans et al., 1993; Marchesini et al., 2006): (1) It does 
not require radioactive materials, (2) the cumbersome and sometimes not 
reproducible immobilization of hormone to the biosensor chip is not needed, and 
(3) expensive biosensor equipment is not required. The downscaling of the ANSA 
fluorescence displacement method into a 96-well plate format brings the additional 
advantages: (1) reduction of amounts of chemicals needed, (2) considerable 
reduction in analysis time, and (3) possibility for high throughput.  
Presence of Interfering Coextractants 
A typical microsomal incubation mixture (1 mg protein in 1 ml) is mostly 
concentrated in 50 ?l of MeOH or DMSO (so the coextractants are 20 times 
concentrated) followed by 40-times dilution in the TTR competitive assay solution. 
Thus, the final dilution factor usually is 2. Under these conditions, an undiluted 
extract obtained with M1 would have a concentration in plate of 12 ?M SFA and 
3.3 ?M NSFA (Table 2), which is well above their IC50s in the ANSA displacement 
assay (Table 3). The newly developed method reduced the amount of coextractants 
by 10 times compared with M1. An extract obtained with the modified method 
(M5) and finally diluted twice as mentioned above will contain less than 2.0 ?M SFA 
and 0.26 ?M NSFA, which are concentrations below the IC50 for these compounds 
in the ANSA displacement method (Tables 2 and 3). When the extract is tested 
“undiluted,” some interference with the analysis is to be expected. As can be seen 
from Figure 8, the blank microsomal extract will reduce ANSA binding at 
concentrations above 0.25 mg-eq protein/ml. This means that an extract diluted 
four times will have a FA below their competitive concentration, thus enabling an 
undisturbed analysis. This was corroborated by the results of Figure 7 where the 
ANSA displacement by T4 in microsomal extract, prepared according to M5, was 
equal to the one in MeOH. This performance in a microsomal extract in a TTR 
competition assay is a considerable improvement compared with previously 
published results with fish and plasma, in which larger dilution regimes and 
cumbersome clean-up procedures were used (Simon et al., 2010, 2011).  
The metabolic profile and metabolic rates of CB 77 were in accordance with 
published results (Murk et al., 1996), except that 6-OH-CB 77 was not detectable 
(Table 4). Similarly, the obtained results agreed with proportions and metabolic 
rates published for BDE 47 (Hamers et al., 2008; Harju et al., 2007). Metabolic 
extracts from CB 77 and BDE 47 reduced ANSA fluorescence significantly above 
0.12 mg-eq protein/ml. However, due to the effects of the coextractants at 
concentrations above 0.25 mg-eq pr/ml it is not possible to prepare a full dose-
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response curve with the amount of metabolites produced under the chosen 
conditions. Therefore, quantification has to be performed at a concentration 
around or below the IC50 for PCB and PBDE OH-metabolites (Table 4). The 
calculated bioassay T4-Eq from the bioactivated CB 77 and BDE 47 was higher in 
comparison with the chemically obtained values (Table 4). An effect often seen 
with bioassays as also OH-metabolites present in levels below the limit of chemical 
detection will be contributing to the response in the bioanalysis.  
Conclusions 
SFA and, particularly, NSFA were identified along with cholesterol as the major 
coextractants upon OH-PCB and OH-BDE extraction from a PCB 77 and BDE 47 
metabolic incubation with S9 liver fraction. The observed effect from the metabolic 
extracts in the ANSA fluorescence displacement assay is mainly due to the 
coextracted free fatty acids. A method to strongly reduce the coextraction of 
matrix components by including fat flocculation, liquid-liquid extraction, and a LRA 
minicolumn was developed. The extract obtained was used in the downscaled 
ANSA-TTR competitive fluorescence displacement assay to quantify the T4 
equivalents from samples spiked with OH-metabolites. GC-MS analysis of silylated 
derivatives was suitable to quantify the production of T4-like OH-metabolites from 
the model POP compounds. With bioactivated CB 77 and BDE 47 it is now possible 
to make a dose-response curve up to 50% ANSA-TTR inhibition. To make a full 
dose-response curve, the efficiency of the biotransformation should be further 
enhanced. The developed new extraction and clean-up method can also be applied 
to other biological matrices such as plasma or tissue extracts. 
Supplementary data 
Supplementary data are available online at http://toxsci.oxfordjournals.org/. 
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Abstract 
In scientific literature, several estrogenic compounds are reported to induce 
responses in vitro that are significantly higher than that of estradiol (E2). These 
supramaximal (SPMX) estrogenic effects do not occur consistently and seem to 
differ depending on the cellular models applied. This study analyzes the possible 
underlying causes, mechanisms, and drivers for SPMX estrogenic effects in in vitro 
functional assays reported in the peer-reviewed literature. For the 21 natural and 
industrial chemicals identified as SPMX inducers, the culture and exposure 
conditions varied greatly among and between the assays. Detailed information on 
assay characteristics, however, sometimes lacked. Diethylstilbestrol, genistein, and 
bisphenol A were selected to build a database. The meta-analysis revealed that the 
occurrence of SPMX effects could be related to a number of specific assay 
characteristics: (1) the type of serum used to supplement the exposure medium, (2) 
the end point used to quantify the estrogenic potency (endogenous or transfected), 
(3) the number of estrogen response elements, and (4) and the promoter’s nature. 
An SPMX response was not reported for expression of endogenous genes, assays 
that used African green monkey kidney (COS-1) cell line or with chloramphenicol 
transferase as the reporter gene. There were no indications that solvent 
concentration in culture, exposure period, or cell model influenced the occurrence 
of an SPMX effect. It is important to understand the mechanism behind this 
phenomenon because in vitro assays for estrogenicity are used extensively to 
characterize and quantify the estrogenic potency of compounds, mixtures and 
environmental extracts.   
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Introduction 
There has been considerable effort over the last two decades to develop in vitro
assays capable to screen and assess the estrogenic activity of environmental 
pollutants, industrial chemicals, natural chemicals, and estrogenic pharmaceuticals 
(reviewed by Charles, 2004; Mueller, 2002, 2004; Sato et al., 2004; Scrimshaw and 
Lester, 2004; Zacharewski, 1997). These assays include competitive ligand-binding 
assays (Berthois et al., 1986; Korach et al., 1978; Migliaccio et al., 1992), cell 
proliferation assays (Maggiolini et al., 2001; Parez et al., 1998; Soto et al., 1995), 
induction of protein expression (Gehm et al., 1997; Parez et al., 1998), and 
recombinant receptor/reporter gene assays using various mammalian cell lines 
(Jausons-Loffreda et al., 1994; Legler et al., 1999; Miller et al., 2000; Pons et al., 
1990; Ranhotra and Teng, 2005; Wilson et al., 2004) and yeast strains (Arnold et al., 
1996; Routledge and Sumpter, 1996). 
One interesting and often ignored feature of many in vitro assays is the 
‘‘supramaximal effect,’’ occurring when the response for a particular ligand is 
significantly higher than the maximal response obtained for estradiol, the natural 
occurring ligand. Figure 1 displays three types of agonistic responses that can be 
distinguished: agonists that induce a supramaximal (SPMX) effect, compounds that 
induce ‘‘submaximal’’ responses, significantly lower than that of E2, and those with 
responses in between supra- and submaximal responses, named ‘‘maximal.’’ The 
presence of SPMX effects is not consistently reported in scientific literature, and 
sometimes the reports seem to be contradictory. Figure 1 also shows a ‘‘putative 
supramaximal’’ curve, where the response is reported as high as E2 maximum but 
without actually showing its maximum while the shape of the curve suggests that 
an SPMX response could have been reached at higher concentrations. For 
interpretation of the assay results, it is important to know whether this effect is 
related to a real suprastimulation of the gene expression that might also occur in 
vivo or whether it is an artefact from the assay applied.  
An SPMX estrogenic response can be traced back at least to 1994 when Makela et 
al. (1994) discuss ‘‘the exceeded 17?-estradiol–induced activation’’ of both zeranol 
and zeralenone using an MCF-7 cell proliferation assay. Different names have been 
coined for the same effect by different authors; for instance, ‘‘superagonism’’ 
(Gehm et al., 1997, 2004; Legler et al., 1999; Ter Veld et al., 2006), ‘‘superagonist’’ 
(Basly et al., 2000; Harris et al., 2005; Levenson et al., 2003; Mueller et al., 2004), 
‘‘superinduction’’ (Freyberger and Schmuck, 2005), ‘‘supramaximal’’ (Van Lipzig et 
al., 2005a, 2005b; Wilson et al., 2004), and recently ‘‘overactivation’’ (Soto et al., 
2006).  
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Many authors only mention the presence of a maximal response greater than that 
induced by estradiol (Buterin et al., 2006; Han et al., 2002; Kitamura et al., 2005; 
Kuiper et al., 1998; Kuruto-Niwa et al., 2002, 2005, 2007; Makela et al., 1994; Van 
Der Woude et al., 2005; Wilson et al., 2004), while others do not describe it in their 
results or mention it in their discussion even when evidently an SPMX response was 
obtained. Interestingly, reports of the SPMX estrogenic effect are not consistent 
among publications even for compounds analyzed with the same system. SPMX 
effects also have been observed in other reporter gene assays particularly for 
dioxinlike compounds as the Dioxin Receptor mediated Luciferase reporter gene 
assay (Jonker et al., 2006; Murk et al., 1996; Vrabie et al., 2009).  
The mechanism for an SPMX effect response remains obscure, only a few authors 
have discussed possible explanations and no one its implications. Stimulation of the 
estrogen receptor (ER) and/or coactivators expression or effects on luciferase 
stability have been suggested as potential underlying mechanisms in T47D cells 
stably transfected with a luciferase reporter gene (Legler et al., 1999). In addition, 
some authors have used this later statement to support their observations without 
adding further insights on the mechanistic explanation (Harris et al., 2005; Kuruto-
Niwa et al., 2002; Wilson et al., 2004).  
It has been questioned whether the ER is actually involved in the SPMX effect. This 
is based on the low affinity for the ER of compounds like bisphenol A (BPA) or 
resveratrol, while at the same time, a SPMX effect is observed on functional in vitro
assays (Ashby et al., 1999; Freyberger and Schmuck, 2005; Gehm et al., 1997). 
However, several authors have demonstrated the ability of fluvestrant (ICI 
182,780), an ER antagonist, to completely block the response supporting the idea 
that an SPMX response is ER mediated (Gehm et al., 1997; Mueller et al., 2004; Van 
Lipzig et al., 2005b).  
Figure 1. Simulated dose-response shapes as 
they appear in in vitro literature compared to 
E2 (filled squares) for which the maximum is 
set at 100%. Data represent submaximal 
induction (filled diamonds), maximal induction 
(filled triangles), SPMX induction (open circles 
and open squares), and putative SPMX 
induction (open diamonds). All simulated SEs 
are ± 10% of the percentage of relative 
response.  
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To our knowledge, only two papers have been published that have considered in a 
systematic manner the SPMX effect problem. Gehm et al. (1997) reported the 
SPMX effect of resveratrol in MCF-7 cells on the transiently transfected luciferase 
reporter gene induction and on cell proliferation but not on the induction of 
progesterone receptor mRNA measured by reverse transcription-PCR. They 
suggested that the resveratrol SPMX effect might depend on the target gene and 
the cell type. In addition, using the MDA-MB-231 ER-negative cell line, they 
demonstrated the requirement of both an ER and an estrogen response element 
(ERE) in the same reporter gene construct to obtain a resveratrol SPMX effect 
(Gehm et al., 1997). Further on, they studied resveratrol SPMX activity with a 
number of MDAMB- 231 subclones stably transfected with a variety of intact, 
mutated, or none ER??expression vectors and one or two consensus EREs-tk81-Luc 
reporter gene plasmids (Gehmet al., 2004). Among theirmost important 
conclusionswere the independence of resveratrol SPMX effect on the transfection 
procedure and its dependence on the cell type, the target gene, the number ofEREs 
in the clone construct, and the integrity of both activation function domains. The 
last finding led to the suggestion that the greater activity of ‘‘resveratrol-liganded 
ER’’ compared to ‘‘E2-liganded- ER’’ may result from enhanced interaction of these 
two domains. Increased cofactor binding to genistein (GEN) and/or 
quercetinboundERwas recently suggested as a cause for anSPMXresponse in ER-
U2OS-Luc reporter gene assay (Sotoca et al., 2008).  
Chrysene metabolites and specifically 2-hydroxy-crysene (2-OHCHN) SPMX 
behavior was investigated using the ER-CALUX assay (Van Lipzig et al., 2005b). 
Besides the blockage effect by the antiestrogenic compound ICI discussed 
previously, the authors studied the interaction with the aryl hydrocarbon receptor 
(AhR) and the ER nuclear concentrations under different patterns of stimulation. 
They found that coincubation with the AhR antagonist 3´,4´-dimethoxyflavone 
(DMF) could not block the 2-OHCHN SPMX effect, which suggest that a ‘‘putative 
role for the AhR in the increased estrogenic response of 2-OHCHN can be 
excluded.’’ However, DMF at low concentrations induced an increase in E2 and 2-
OHCHN luciferase activity. Besides, higher ER nuclear concentrations were 
observed with DMF alone or in combination with 2-OHCHN compared to controls. 
The suppressive effect of the AhR on the ER nuclear concentration and the ER-
dependent transcriptional activity is well known (Safe et al., 1991). Therefore, the 
authors suggest that SPMX estrogenic effect could be partially due to a decreased 
ability of the AhR to inhibit ER expression, resulting in higher ER concentrations or 
enhanced ER transcriptional activity. Freyberger and Schmuck (2005) supported 
this suggestion based on SPMX effects of resveratrol and other flavonoids in MCF-7 
cells. Since these compounds have been characterized as AhR antagonists, they 
Chapter 4 
 90 
claimed the same AhR inhibition mechanism and thus explain the increased 
flavonoids estrogenic signaling.  Nonetheless, based on the SPMX effect of BPA 
obtained with a U2-OS cell line supposedly devoid of endogenous steroid 
receptors, it has been proposed that cross-reactivity of different receptors can be 
excluded. Instead of this, a possible modulation of the several kinases involved in 
the ER activation has been suggested as a potential mechanism (Ter Veld et al., 
2006).  
In summary, there is neither clear explanation given in literature for the 
mechanism of action causing the SPMX estrogenic effect nor has the discussion 
over the regularly observed SPMX effects in in vitro assays been consistently 
addressed. As the quantification of the estrogenic activity of environmental 
contaminants, both individually as well as in mixtures (Murk et al., 2002), is based 
on the response relative to that of estradiol, an SPMX effect could lead to 
overestimation of the estrogenic hazard of the evaluated substance and/or 
mixture. Besides, reported SPMX effects are not consistent either across studies or 
among compounds. Therefore, SPMX is an intriguing and relevant phenomenon to 
toxicology and toxicological risk assessment, and a systematic approach is needed 
to understand the conditions for the SPMX effect to occur. Especially whether it is 
an assay-based artifact or a real-life toxicological effect. A better understanding of 
the SPMX estrogenic effect will help to unravel its possible causes, determine 
future research, and suggest proper precautions when applying in vitro assays for 
estrogenicity risk characterization procedures. For this purpose, a literature meta-
analysis of publications with functional estrogenic in vitro assays was performed. 
Compounds with responses above estradiol maximal response were identified. 
Three of the most frequent SPMX effect inducers—diethylstilbestrol (DES), GEN, 
and BPA were selected to study further. A database was built with 134 entries 
compiling the nature, characteristics, and responses of these three compounds on 
functional in vitro assays. A relative response meta-analysis was performed using a 
response variable. Correlations of SPMX effect with assays nature and 
characteristics were established and discussed.  
Materials and Methods 
Compound selection.?Scientific reviews from 1997 to 2006 related to in vitro assays 
for estrogenic substances were collected and evaluated for compounds with 
responses above the maximal response observed for estradiol (Charles, 2004; Gray 
et al., 1997; Mueller, 2002, 2004; Scrimshaw and Lester, 2004; Soto et al., 2006; 
Zacharewski, 1997). As a result, a total of 42 scientific papers were reviewed to 
identify compounds that exerted the SPMX effect. Synthetic hormones, plasticizers, 
flame retardants, pesticides, and natural substances were found to show responses 
above the estradiol maximal response in one or more studies. Out of this group of 
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SPMX inducers, an industrial, a natural, and a synthetic compound were chosen to 
build the database. Based on the availability of sufficient reports to allow analysis, 
DES, GEN, and BPA were selected. Nonylphenol was not included in the scope of 
this research although it has been broadly studied during the last decades 
(Bandiera, 2006) and has shown SPMX effect under given circumstances. The 
reason to exclude it was the inconsistencies found in scientific literature regarding 
exact identity of the nonylphenol used. For instance, some papers analyzed the 
technical mixture (CAS no 84852-15-3), while others analyzed the pure compound 
with linear or side alkyl chain. The main problem was that many papers did not 
state clearly what kind of nonylphenol was analyzed or did not provide a CAS 
number. 
Database development for the three selected compounds. A scientific literature 
search was performed using the bibliographic databases: PubMed, CAB Abstracts, 
Web of Science, and Scopus. The search strategy used several combinations of the 
following keywords: compound names or abbreviations, cell model, and end point–
specific names or abbreviations. Papers which reported in vitro analysis of a 
selected compound were collected whether or not an SPMX effect was observed. 
In addition, relevant articles concerning the selected compounds were collected 
from the reference and citation list of each publication. All publications in English 
peer-reviewed journals until March 2007, complying with the following inclusion 
criteria, were taken into consideration for the database development:  
? Estrogenicity studies of the selected compounds in functional in vitro cell 
models, so competitive ligand binding assays were excluded. 
? Studies in which 17?-estradiol was used as a standard. 
? Studies in which exposures were performed without phenol red as this gives 
estrogenic interferences (Berthois et al.); effectively, this means studies since 
1986. 
? Studies which provide sufficient data or graphics to establish the quantitative 
relationship between the compound and estradiol maximal responses. 
The compound, assay, and response characteristics that were recorded and 
classified are reported in Table 1. Whenever the assay characteristics were 
referenced, the original publication was collected to obtain the appropriate 
information. Each database entry is the assay’s characteristics of a specific 
compound with a given cell model and a given end point reported in a study. 
Therefore, a paper which analyzes a variety of compounds or uses a variety of cell 
models will appear with more than one entry. 
Response variable normalization.? In order to perform an analysis of the 
relationship between compound maximal responses and assay characteristics, the 
compound’s maximal response was expressed as a percentage relative to the 
estradiol maximal response for the same entry arbitrarily set to 100%. The 
response of the solvent control was set to 0%. The SDs at the maximal response of 
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both estradiol and the compound studied were expressed as percentage relative to 
the estradiol maximum as well. To be able to decide whether a compound 
response is significantly higher than the maximum response of estradiol, the 
compound’s relative response was expressed as a t value (tc) calculated according 
to Equation 1, assuming two independent sample means with equal sample sizes. 
The obtained tc was compared with the one-tailed tabulated t value (critical value) 
which depends of the number of experiments reported (degrees of freedom) in the 
original publication. The response was classified as submaximal for a negative tc 
lower than the critical value, as SPMX for a positive tc higher than the critical value, 
and as maximal when the null hypothesis could not be rejected (p ??0.05). Several 
publications reported dose-response curves without visible maximum (Fig. 1, last 
curve). These putative SPMX cases were considered as maximal responses during 
the analysis.  ?
Table 1  
Characteristics recorded from each publication. 
Compound Name, CAS No, purity, and provider 
Assay Cell line, original (wild type) or transfected, solvent, solvent percentage, serum 
type, percentage serum, endpoint, exposure period, and measurement method.  
For transfected cell lines: 
Transfection (stably or transiently), ER ????? ????????????? ???? ??? ?????? ???
source (human, mouse, rat, etc), number of ERE’s in reporter construct, ERE 
characteristics, type of reporter gene, and reporter/gene characteristics. 
Estradiol response Response units, response of solvent control and estradiol maximal response a, 
standard deviation of E2 maximal response and the number of independent 
measurement were the standard deviation was calculated from. 
Compound response Lowest tested concentration, highest tested concentration, maximal response 
concentration, maximal response compared to E2 maximal response
a and 
compound standard deviation at maximal responsea. 
Note. E2, 17b-estradiol.a Minimum and maximum responses and SDs were estimated from the figures when 
they were not given by the authors. 
 
 
 
 
Equation 1 
Where tc= t-value calculated for the comparison of compound and estradiol relative response means %Cmax 
= maximal response of the compound relative to maximal estradiol response %E2max = maximal response of 
estradiol minus solvent control arbitrarily set to 100 SE2 = standard deviation of estradiol at maximal 
response relative to estradiol response SC = standard deviation of compound response at maximal response 
relative to estradiol response nC = number of independent assays from which SC was calculated, usually nC=3 
nE2 = number of independent assays from which SE2 was calculated, usually nE2=3. 
 
Database analysis.? The database was split into three data sets: mammalian cell 
entries, yeast entries, and rainbow trout entries to account for species differences. 
A descriptive analysis was performed comparing the proportion of submaximal (tc 
significantly ?0), maximal (tc not significantly different from 0), and SPMX (tc 
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significantly ?0) entries within assay characteristic. The proportion of entries with 
SPMX effect is given within brackets. Because of the limitation of its application to 
the data set, the Kruskal-Wallis nonparametric test using tc as continuous variable 
only was applied to substantiate the qualitative results comparing average tc values 
between groups (p values given within brackets). When considered appropriate, 
subsets of the database were evaluated to underline trends on particular cell 
models or end points. 
Results 
Twenty-one chemicals including DES, dihydrotestosterone, 4-nonylphenol, 4-tert-
octhylphenol, BPA, and some of its metabolites, methoxyclor, 1,1,1-trichloro-2-(2-
chlorophenyl)-2-(4-chlorophenyl)ethane genistein, quercetin, resveratrol, 
zeralenone, zeranol, coumestrol as well as some benzo[a]pyrene, and crysene 
metabolites were identified as SPMX inducers. The complete list is included as 
Supplementary data 1.  
Database development and data quality 
Based on the availability of sufficient reports to allow analysis, DES, GEN, and BPA 
were selected. A total of 127 publications on in vitro estrogenic responses for DES, 
BPA, and GEN could be collected, of which 79 complied with the selection criteria. 
The references of the publications that were not included are listed as 
Supplementary data 2. The 79 studies provided 133 entries: 33 for DES, 64 for GEN, 
and 36 for BPA, summarized in Table 2. Among the entries, 80% were for 
mammalian systems while 16% were results obtained in yeast and 4% in fish 
hepatocyte cultures. 
Analysis of the data quality revealed that only 2% of the publications mentioned 
the Chemical Abstract Service (CAS) Registry Number of the analyzed substance 
while only 14% mentioned its purity. However, 96% included the compound’s 
origin, and through the provider, it was possible to trace the CAS numbers and 
purity in 86 and 88% of the cases, respectively. Important information about the 
assay characteristics was frequently lacking. For instance, 15% did not clearly state 
the solvent used in the analysis whereas 24% omitted its concentration. Serum 
type supplemented into the medium was not provided in 4% of the papers and 13% 
of them lacked its concentration. Information regarding maximal responses and 
SDs were not frequently reported by the authors. Those values were estimated 
from the publication graphs in 91 and 81% of the entries for E2 and compound 
maximal responses, respectively. The complete database is included as 
Supplementary data 3. The highest SPMX responses found were 143% for DES, 
255% for GEN, and 233% for BPA (Beck et al., 2005; Kitamura et al., 2005; Wilson et 
al., 2004).   
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TABLE 2 
Number of database entries and references of maximal induction by the compounds DES, GEN, and BPA compared to E2 per cell model and end point.  
Cell model End point 
DES BPA GEN Total  
no.a Noa References Noa References Noa References 
MCF-7 
Luc 3 
Sanoh et al. (2003), Demirpence 
et al. (1993), and Freyberger and 
Schmuck (2005)  
6 
Freyberger and Schmuck (2005), 
Fujimoto and Honda (2003), 
Kitamura et al. (2005), Matthews 
et al. (2001), and Yoshihara et al.
(2004) 
10 
Freyberger and Schmuck (2005), 
Fujimoto and Honda (2003), 
Harris et al. (2005), Ki et al.
(2003), Maggiolini et al. 2001), 
Le Bail et al. (1998), and Zierau 
et al. (2005) 
19 
Cell prol 6 
Han et al. (2002), Jones et al.
(1998), Kanai et al. (2001), 
Morito et al. (2001), Okubo et al.
(2001), and Olsen et al.(2005) 
8 
Han et al. (2002), Kanai et al.
(2001), Olsen et al. (2005), Brotons 
et al. (1995), Nakagawa and Suzuki 
(2001), Olea et al. (1996), Parez et 
al. (1998), and Samuelsen et al.
(2001) 
14 
Maggiolini et al. (2001), Le Bail 
et al. (1998), Seo et al. (2006), 
Han et al. (2002), Morito et al.
(2001), Kuruto-Niwa et al.
(2007), Makela et al. (1994), Yap 
et al. (2005), Hsieh et al. (1998), 
Hwang et al. (2006), Kinjo et al.
(2004), Matsumura et al. (2005), 
Schmidt et al. (2005), and 
Murata et al. (2004) 
28 
GFP    2 Kuruto-Niwa et al. (2002) and (2005) 3 
Kuruto-Niwa et al. (2002) and 
(2007) and Miller et al. (2000) 5 
CAT      1 Matsumura et al. (2005) 1 
PR prod   3 Olea et al. (1996), Parez et al.(1998), and Krishnan et al. (1993)   3 
HeLa 
 
Luc 2 Ranhotra and Teng (2005) 3 Ranhotra and Teng (2005) and Sato et al. (2004) 4 
Yap et al. (2005), Ranhotra and 
Teng (2005), and Sato et al.
(2004) 
9 
CAT 1 Shelby et al. (1996)   1 Makela et al. (1994) 2 
Cell prol     1 Maggiolini et al. (2001) 1 
T47D 
Luc  1  Wilson et al. (2004) 3 Buterin et al. (2006), Legler et al.(1999), and Meerts et al. (2001) 3 
Wilson et al. (2004), Buterin et 
al. (2006), Legler et al. (1999), 
and Meerts et al. (2001) 
7 
Cell prol     2 Seo et al. (2006) and Zava et al.(1997) 2 
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TABLE 2 - Continued 
Cell model End point 
DES BPA GEN Total 
no.a Noa References Noa References Noa References 
Ishikawa 
Luc 2 Mueller et al. (2004) 2 Mueller et al. (2003) and (2004) 4 Mueller et al. (2003) and (2004) 8 
APhos 2 (Le Guevel and Pakdel (2001) and Wagner and Lehmann (2006)   3 
Wagner and Lehmann (2006), 
Pisha and Pezzuto (1997), and 
Wober et al. (2002) 
5 
U2-OS Luc   2 Ter Veld et al. (2006) 2 Van Der Woude et al. (2005) 4 
H293 Luc 2 Kuiper et al. (1998)   4 Kuiper et al. (1998) and Wang et al. (2001) 6 
COS-1 Luc 4 Ashby et al. (1999) and Pennie et al. (1998) 2 Pennie et al. (1998)   6 
Rainbow 
trout hep Vit prod
 2 Olsen et al. (2005) and Pelissero et al. (1993) 2 
Olsen et al. (2005) and Shilling and 
Williams (2000) 1 Pelissero et al. (1993) 5 
Yeast B-Gal 6 
Morito et al. (2001), Ashby et al.
(1999), Arnold et al. (1996), Beck 
et al. (2005), and Gaido et al.
(1997) 
3 
Yoshihara et al. (2004), Routledge 
and Sumpter (1996), and 
Rutishauser et al. (2004) 
8 
Zierau et al., (2005), (Morito et 
al. (2001), Kinjo et al. (2004), 
Beck et al. (2005), Routledge and 
Sumpter (1996), 
and Collins et al. (1997)  
17 
 GFP 2 Beck et al. (2005) and Bovee et al. (2004)   3 
Beck et al. (2005) and Bovee et 
al. (2004) 5 
TOTAL  33  36  64  133 
Cell models: human epithelial breast carcinoma (MF-7), human cervical cancer (HeLa), human ductal breast carcinoma (T47D), human endometrial adenocarcinoma 
(Ishikawa), human osteosarcoma (U2-OS), human embryonal kidney (H293), African green monkey kidney (COS-1), rainbow trout hepatocytes (Rainbow t hep) and yeast. 
End points: luciferase induction (Luc), GFP, CAT, b-galactosidase (B-Gal), cell proliferation (cell prol), alkyl phosphatase activity (APhos), vitellogenin production (Vit prod), 
and progesterone receptor production (PR prod).  
aAn entry is the report of a specific compound with a given cell model and a given end point. Therefore, a paper which analyzes a variety of compounds or uses a variety 
of cell models will appear with more than one entry. 
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Response variable 
In the mammalian database, 33% of the compound responses fell above the 
tabulated t value indicating SPMX, while from the yeast entries 18% were 
considered SPMX. When discriminating by compound, 13, 32, and 48% of all DES, 
BPA, and GEN entries, respectively, fell above the critical value and, thus, were 
considered SPMX. Table 3 shows the percentage of entries considered SPMX, 
discriminated by cell model and end point.  
Cell model 
The cell model appeared to be an important factor in the occurrence of the SPMX 
effect (Fig. 2A). T47D (78%) and U2-OS (75%) cell lines had more frequent 
occurrences of SPMX compared with, for example, HeLa (42%) or H293 (33%). 
Indeed, significant differences were found between cell model tc averages (p = 
0.033). When only cell models with luciferase induction as the end point were 
selected, again cell model tc averages showed significant differences between cell 
models (p = 0.018), with SPMX proportions of T47D-Luc (86%) and U2-OS-Luc (75%) 
higher than the other cell models.  
Interestingly, estrogenic responses with COS-1 cells never were SPMX; while MCF-7 
cells had entries with values well distributed from submaximal to SPMX relative 
responses (Table 3 and Fig. 2A). Despite the differences, the cell model only 
accounted for a small fraction of the data variation. There was no apparent effect 
of the cell model when each compound was evaluated independently. The relative 
responses for BPA, GEN, and DES in Rainbow trout hepatocytes were always below 
the estradiol maximum response (Table 3). 
 
Figure 2. Percentage of submaximal (sub), maximal (max), and supramaximal (supra) entries of mammalian 
cell lines discriminated by cell model (A): MCF-7 (n = 56), HeLa (n = 12), T47D (n = 9), Ishikawa (n = 13), 
U2-OS (n = 4), H293 (n = 6), and COS-1 (n = 6); and by end point (B): Luc (n = 59), GFP (n = 5), CAT (n = 3), 
cell proliferation (n = 31), alkyl phosphatase activity (APhos, n = 5), and progesterone receptor production 
(PR prod, n = 3). 
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Table 3  
Percentage of entries above the supra-maximal (SPMX) critical valuea discriminated                                      
by cell model and end point. 
Cell model End point %b nc Cell model End point %b nc 
MCF-7 
Luc 16% 19 
Ishikawa 
Luc 50% 8 
GFP 100% 5 APhos 0% 5 
CAT 0% 1 U2-OS Luc 75% 4 
Cell prol 25% 28 H293 Luc 33% 6 
PR prod 33% 3 COS-1 Luc 0% 6 
HeLa 
Luc  56% 
 
9 
Rainbow 
trout hep Vit prod 0% 5 
CAT 0% 2 
Yeast 
GFP 40% 5 
Cell prol 0% 1 B-GAL 12% 17 
T47D Luc 86% 7     
Cell prol 50% 2     
Cell models: human epithelial breast carcinoma (MF-7), human cervical cancer (HeLa), human ductal breast 
carcinoma (T47D), human endometrial adenocarcinoma (Ishikawa), human osteosarcoma (U2-OS), human 
embryonal kidney (H293), African green monkey kidney (COS-1), rainbow trout hepatocytes and yeast.  End 
???????? ??????????? ??????? ?????? ????????????? ???????? ??????? ???????????????? ???????????? ??????? ?-
galactosidase (B-GAL), cell proliferation, alkyl phosphatase activity (APhos), vitellogenin production (Vit 
prod), and progesterone receptor production (PRprod). 
a entries above the SPMX critical value are those with t  values above the one-tailed t, tabulated for degrees, 
of freedom reported in the publication and p<0.05, 
b percentage of entries above the SPMX critical value, 
c number of entries for the given cell model and end point. 
End point 
Despite apparent differences in the proportions of submaximal, maximal, and 
SPMX entries within end points in Figure 2B, no significant differences were found 
between the end points tc averages. However, transfected chloramphenicol 
transferase (CAT) reporter gene cells did not produce SPMX responses on either 
MCF-7 or HeLa cell lines (Table 3). On the other hand, mammalian cells transfected 
with green fluorescence protein (GFP) reporter gene consistently gave SPMX 
responses (Fig. 2B), while the same reporter gene transfected into yeast gave SPMX 
response on three cases out of five (Table 3). There were in addition no differences 
on the SPMX effect occurrence among cell proliferation measurement methods.  
Cell culture characteristics 
Neither solvent nor its concentrations in culture seemed to have a significant effect 
on the three compounds relative maximum responses in mammalian cell lines. All 
mammalian entries together did not show any correlation between relative 
responses and serum concentration. However, within cell proliferation entries, a 
weak trend toward higher tc values was observed with increasing serum 
concentrations in the exposure medium (data not shown). Interestingly, cell 
proliferation assays consistently never gave SPMX responses when human serum 
was used in culture (data not shown but available within Supplementary data 3). 
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Transfected cell lines 
Illustrated by Figure 3A, the proportion of SPMX entries for transfected cells was 
higher (42%) compared with wild-type cells (21%) (p = 0.026). Transfected T47D 
and Ishikawa cell lines exhibited higher SPMX proportions (86 and 50%, 
respectively) compared to the values in proliferation assays with its wild-type cells 
(50 and 0%, respectively). It is interesting to note that the likeliness of obtaining an 
SPMX effect apparently was not influenced by the origin of the ER, whether it was 
endogenous (T47D) or introduced (U2-OS). Among transfected entries, the stability 
of transfection had a significant influence on the occurrence of an SPMX effect (Fig. 
3B). Considering mammalian cell lines, stably transfected cells had a higher SPMX 
proportion (59%) compared to transiently transfected cells (26%) (p = 0.029). 
Particularly for BPA, the SPMX incidence was higher in stably transfected cells 
(70%) compared to transiently transfected cells (10%) (p = 0.028). Also yeast cell 
lines stably transfected gave a higher SPMX proportion (27%) compared with 
transiently transfected ones which do not have a single SPMX entry (p = 0.022).  
There were no significant differences between the proportions of SPMX for the 
three compounds together between cells expressing endogenous receptors (27%) 
compared to cells with transfected receptors, either ER?? (48%) or ER?? (35%), 
despite a visible trend. Only for luciferase induction as the end point was the 
number of entries (59) sufficient to compare SPMX in models with endogenous 
receptors (24%) with those with transfected ER?? (52%) or ER?? (35%). In addition, 
the source of the transfected receptors (i.e., human, rat or mouse) did not 
significantly influence the relative occurrence of SPMX responses.  
 
Figure 3. Percentage of submaximal (sub), maximal (max), and supramaximal (supra) entries of mammalian 
cell lines discriminated by genetical modification (A): wild type (n = 39) and transfected (n = 67); and for 
transfected mammalian cell lines discriminated by the type of transfection (B): transiently transfected (n = 
35) and stably transfected (n = 32). 
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A clear increase in the SPMX proportion was observed with increasing number of 
EREs (Fig. 4A). The tc average values of mammalian cell entries grouped by the 
number of consensus EREs, transfected upstream of the reporter plasmid, were 
significantly different (p = 0.003). Furthermore, in yeast transfected with one 
consensus ERE, the SPMX occurrence was lower than in cells transfected with two 
EREs (p = 0.041) (Fig. 4B).  
 
Also, the context of the promoter within the clone construct was related to the 
incidence of SPMX response of the compounds. When thymidine kinase (tk) was 
present as a promoter, the proportion of SPMX entries were lower compared to 
TATA box and C3 promoters (Fig. 5). 
 
 
 
 
Figure 4. Percentage of submaximal (sub), maximal (max), and supramaximal (supra) entries discriminated 
by the number of EREs in the reporter plasmid used in (A) mammalian cell lines (n1 = 17, n2 = 13, n3 = 36) 
and (B) yeast cell lines (n1 = 12, n2 = 10). 
Figure 5. Percentage of submaximal (sub), 
maximal (max), and supramaximal (supra) 
entries of mammalian reporter cell lines 
discriminated by the promoter type: tk 
promoter (n = 12), TATA box (n = 36), and 
C3 promoter (n = 8), included with the ERE 
into the reporter plasmid construct. 
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Discussion 
The existence of SPMX responses and the putative inconsistency of this SPMX 
occurrence in in vitro assays for estrogenicity present a challenge for the 
quantification and interpretation of the estrogenic potency of compounds and 
environmental extracts. When the SPMX character of a response is ignored, it could 
lead to overestimation of the relative potency compared to the current standard E2 
dose-response. And when the existence of an SPMX dose-response is recognized, it 
is difficult to interpret its meaning for estrogenicity assessment. Several ubiquitous 
compounds have been reported to produce an SPMX effect in in vitro assays for 
estrogenicity under diverse (seemingly unrelated) circumstances. As results 
frequently are not consistent across studies, this has led to scientific debates about 
the nature of its cause and relevance for the in vivo situation. This study is the first 
to present a systematic analysis of data published on the estrogenicity of 
compounds that have been reported to induce SPMX effects. The correlation 
between the occurrences of SPMX with assay characteristics has been examined, 
with special attention for cell type, target gene, and clone characteristics.  
Upon entering the published information into a database, the lack of detailed 
information became apparent. For example, unclear compound identification 
including its purity and lack of information on the identity and concentrations of 
reagents in the assays made it difficult to interpret the consequences of the 
absence or occurrence of SPMX effects in published studies. It was impossible to 
include detailed clone construct characteristics like ERE spacing, promoter spacing, 
ERE sequence or source, and reporter sequence or source in the analysis; the 
information provided was not sufficient even when referenced to previous 
published data.  
Another possible source of confusion is the transformation of the response data for 
graphical presentation. For example, when using induction factors, the maximum 
value depends greatly on the control value (commonly the value with relatively the 
greatest variability). In several cases, the absolute data were not available, while in 
other cases the maximum values were not shown and the curve stopped at 100% 
with the shape suggesting a putative SPMX response. To avoid inexplicable 
inconsistencies in future in vitro publications that could perhaps have been related 
to differences in method details, good reporting practices are crucial.  
Three estrogenic compounds were selected—DES, BPA, and GEN—that are 
frequently tested in addition to E2 to validate new in vitro methods for 
estrogenicity and to serve as a reference for other potentially estrogenic 
compounds and samples. Therefore, the total number of publications was 
sufficient for building the database and for investigating the main trends. Many 
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publications did not aim at comparing the full dose-response relationship between 
E2 and other agonists and therefore lacked its maximal response. This was the 
main reason for exclusion of some publications from the database (see 
Supplementary data 2). Heterogeneity of results between publications was 
expected, but in addition, ample data dispersion was found for the variables within 
single categories. For instance, MCF-7 or luciferase entries separately have large 
variations in the occurrence of SPMX and thus in their tc ranges. This confirmed the 
inconsistency in the SPMX effect occurrence and its apparent independence of the 
cell model or end point. None of the variables alone, although significant in some 
cases, could explain the substantial variation in the occurrence of SPMX. This 
actually was to be expected given the limitations in the input data mentioned 
above. Only very dominant explaining variables could have been identified in the 
current meta-analysis of the available literature data. The best explaining variable 
as indicated from this analysis should ideally be further studied under 
experimentally controlled conditions.  
There is a general trend within the database toward a higher frequency of SPMX 
effects with reporter gene assays. The influence of cell culture variables like serum 
type and concentration, exposure period, and solvent concentrations was not 
apparent. The effects of ethanol on the occurrence of SPMX in cell proliferation 
assays and ER??transcriptional activity in human breast cancer cells has previously 
been reported (Fan et al., 2000; Singletary et al., 2001). Bhat et al. (2001) 
suggested that the SPMX effect induced by resveratrol (Gehm et al., 1997) could 
actually be due to the use of ethanol as solvent. The data in our study, however, do 
not support this suggested effect of ethanol. Also the concentration of serum has 
been suggested to influence the occurrence of SPMX (Soto and Sonnenschein, 
1984; Strouken et al., 1994). Again, this indication is not in accordance with the 
results from our study. Our results do nevertheless suggest that no SPMX effect 
occurs when human serum is used, although a limited number of assays with cell 
proliferation as end point used human serum. The suggested influence, however, is 
supported by several reports of different effects on cell proliferation between 
human and fetal bovine serum (McAlinden and Wilson, 2000; Soto and 
Sonnenschein, 1984; Soto et al., 1986). Further experimental analysis of the 
putative influence of serum type on the occurrence of an SPMX cell proliferation 
effect is required to evaluate this issue.  
The frequency of SPMX is higher in transfected cell lines compared to wild-type 
cells with endogenous ERs and end points such as alkyl phosphatase and 
progesterone receptor production in mammalian cell lines and vitellogenin 
production in rainbow trout cells (Table 3). This is in agreement with the previously 
reported suggestion that the occurrence of SPMX depends on the targeted gene 
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(Gehm et al., 1997). This may even explain the visible trend of a cell model 
significant difference, as all entries for U2OS, and seven out of nine for T47D were 
stably transfected reporter gene end points (Table 3). These results indirectly 
suggest an influence of clone characteristics on the SPMX effect occurrence.  
Of the transfected mammalian cell lines, the stably transfected cells showed a 
higher SPMX incidence than the transiently transfected ones. The same difference 
was observed for transfected yeast cell lines. For instance, two seemingly 
comparable assays with 3xERE-TATA-LUC transiently transfected H293 cells were 
performed by different laboratories. While Kuiper et al. (1997) reported GEN 
SPMX, Hwang et al. (2006), however, did not. The differences might be accounted 
for by major differences between the two methods related to transfection method, 
ER source, and plasmid construction.  
We found a significant dependence of the SPMX effect on the number of EREs in 
the plasmid construct of transfected cell lines. No SPMX was described for models 
with only one ERE upstream of the CAT reporter gene. The plasmids of the Luc and 
GFP reporter genes all have two or more ERE’s. Several authors reported increased 
E2 induced response with multiple EREs (Catherino and Jordan, 1995; 
Ponglikitmongkol et al., 1990; Sathya et al., 1997; Tyulmenkov et al., 2000). In 
addition, both the number of EREs and their spacing, proximity to the promoter 
and the promoter nature, are suggested to influence the occurrence of synergistic 
estrogenic responses (Sathya et al., 1997). Synergism could be related to SPMX 
responses, and exposure media contain many compounds of which their possible 
role in inducing estrogenic responses is not known. To our knowledge, there are 
currently no publications addressing the multiple ERE synergistic effect with ligands 
other than E2. Nonetheless, the dependence of SPMX effect on the number of EREs 
and on the nature of the promoter revealed in our meta-analysis may indicate that 
other compounds like GEN and BPA can induce this ERE transcriptional synergism 
as well. In that case, the observed SPMX effects in specific transfected cell lines 
indicate a stronger transcriptional synergism induced by GEN and BPA compared to 
that induced by E2. It is not clear why the compounds did not induce SPMX in COS-
1 cell line. It is important to note that for these cells, only two sources were 
available, both from the same laboratory, so the variation in conditions is limited. 
In both papers, the use of two consensus EREs with the tk promoter is reported. 
Both characteristics are associated here with a lower likeliness for SPMX responses.  
This meta-analysis confirms the inconsistent occurrence of SPMX effects, which 
could be related to a number of specific assay characteristics: (1) the type of serum 
used to supplement the exposure medium, (2) the end point used to quantify the 
estrogenic potency (endogenous or transfected), (3) the number of EREs, and (4) 
the nature of the promoter. It is important to understand the mechanism behind 
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this phenomenon because in vitro assays for estrogenicity are used extensively to 
characterize and quantify the estrogenic potency of compounds, mixtures, and 
environmental extracts. To our knowledge, the influence of significantly different 
maximum responses of compounds in a mixture to the mixture response has not 
been addressed. For the quantification of the estrogenic potency of mixtures, 
concentration addition is assumed (Jonker et al., 2005), but when some 
compounds induce SPMX, this assumption is not valid. In addition, the estrogenic 
equivalency factors are derived from the EC50 value of the compounds of interest 
compared to that of E2. A significantly higher maximum will invalidate the 
equipotent assumption and thus derive a miscalculation of the compounds 
potency. The estrogenic potency of complex mixtures such as environmental 
extracts is determined by diluting the extract to a response, which falls into the 
linear part of the standard dose-response curve. The consequences of the SPMX 
phenomenon could result in overestimation of the estrogenic potency if the SPMX 
is the consequence of a molecular artefact of the cell model. But perhaps the SPMX 
effect only occurs at high concentrations and not at concentrations that could 
occur in blood. To be able to decide how to interpret and deal with the occurrence 
of SPMX in certain cell models, it is important to understand its underlying 
mechanism. Is it an artefact or a mechanism that is relevant for the in vivo 
situation as well? This cannot be resolved by further analysis of already reported 
results but requires dedicated additional research to unravel this intriguing 
phenomenon.  
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Introduction 
In vitro bioassays are increasingly applied to complex extracts to relatively quantify 
estrogenic, androgenic, progestagenic and dioxin-like activity. A casual feature of 
these bioassays is the “supramaximal effect” (SPMX), occurring when the response 
induced by the tested compound is significantly higher compared to the natural 
ligand (Montaño et al. 2010). This effect has been observed after incubation with 
some pure substances on estrogenic receptor (ER) mediated assays (Montaño et al. 
2010), but also after incubation with complex mixtures like oils (Vrabie et al. 2009), 
oil contaminated pore water (Jonker et al. 2006), and sediments (Baston and 
Denison 2011; Murk et al. 1996) on dioxin receptor (DR) mediated luciferase 
reporter gene assays. The causes of this effect are still uncertain; a recent literature 
study of estrogenic SPMX effect inducers pointed towards the characteristics of the 
transfected cell lines (Montaño et al. 2010), while a mechanistic study with 
genistein on an ER-mediated luciferase assay suggested a post-transcriptional 
stabilization of the firefly luciferase reporter enzyme (Sotoca et al. 2010). 
The multi-xenobiotic resistance (MXR) is a phenomenon in which over-expression 
of cellular efflux proteins results in enhancement of protection of organism against 
environmental contaminants (Bard 2000). Cellular efflux pumps like P-glycoprotein 
(P-gp also known as MDR1) are expressed in peripheral and barrier tissues of 
several marine organisms (Kurelec et al. 2000). Diverse environmental 
contaminants inhibit the MXR mechanism in vitro (Georgantzopoulou et al. 2012), 
and in vivo (Anselmo et al. 2012), and some of these contaminants potentiate the 
toxic effect of an efflux pumps substrate (Anselmo et al. 2012).  
P-gp is present in significant amounts in the rat liver hepatoma cell line H4IIE 
(Mehta et al. 1994), which is a common cell line used in the DR-mediated luciferase 
reporter gene assay (DR.Luc) (Murk et al. 1996). We therefore hypothesized that P-
gp efflux pump blockers will potentiate the effect of a dioxin-like agonist and 
perhaps induce a SPMX effect on the H4IIE based DR.Luc assay. To test this 
hypothesis, we adapted the 96-well plate cellular efflux pump inhibition assay 
(CEPIA) (Georgantzopoulou et al. 2012) to the H4IIE.Luc cell line, and measured the 
inhibition potency of verapamil as model P-gp inhibitor, pentachlorophenol (PCP) 
and 2,3,7,8-tetrachlorodibenzo-p-dioxine (TCDD). Then we tested verapamil and 
various environmentally relevant efflux pump inhibitors, alone and in co-exposure 
with TCDD on the DR.Luc assay. 
Materials and methods 
Compounds were >98% pure and purchased from Sigma-Aldrich, except for PCP and 4’-OH-
3,3’,4,5’-CB 79 (4’-OH CB 79) which were purchased from Accustandard and LGC Promochem, 
respectively. All compounds were dissolved in DMSO and then diluted in phosphate buffer saline 
(PBS) for the CEPIA assay or cellular media for the DR.Luc assay, with a final DMSO concentration 
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of 0.2% (v/v) for single exposures and 0.4% (v/v) for co-exposures. H4IIE.Luc cells were a kind gift 
from Prof. Michael Denison and were cultured and plated for  assays as previously published 
(Vrabie et al. 2009). 
Adaptations of the CEPIA assay on H4IIE.Luc cells were based on the previously standardized 
method by Georgantzopoulou and co-workers (Georgantzopoulou et al. 2012). Calcein-AM is a 
nonfluorescent P-gp substrate which can be metabolized by cytosolic esterases into the 
fluorophore calcein. Calcein is not a P-gp substrate, thus upon P-gp inhibition calcein will 
accumulate inside the cell and increase the fluorescence response (Georgantzopoulou et al. 2012). 
???????????????????????????? ????????????????????? alone or with test compounds. Then they were 
supplemented with calcein-AM as a model substrate at final concentrations between 0.05 and 5 
???????????????????????????????????????????????????????????????????????????????? ?????????????
Synergy 2 plate reader at 485 nm excitation and 530 nm emission wavelengths. Standard curves 
?????????????????????? ????????????????-AM exposure for 45 min. 
???? ???? ??????? ??????? ?????????? ?????? ????? ???????? ??? ????? ?????????? ?????? ????? ?????? ?-gp 
pump inhibitors alone and in combination with TCDD at the EC50 and maximum levels (final conc. 
10 and 100 pM respectively, 0.4% DMSO v/v) in 100 μL of fresh media for 24 hours. Inhibitor 
concentrations were chosen according to their in vitro CEPIA inhibitory concentration 
(Georgantzopoulou et al. 2012). Viability was determined by the measurement of the cells 
?????????? ?????????????? ????? ?????????? ??? ??????? ??????????? ???? ?? ?????? ?????????et al. 2011), 
immediately followed by  the luciferase analysis on the same plate as previously published (Vrabie 
et al. 2009). Both measurements were performed in a Biotech Synergy 2 plate reader.  
All experiments were performed in triplicate and repeated twice. Data points represent mean ± SD 
??? ????????? ????????????? ?????? ?????? ??? ????????????? ?????? ??????? ????????? ??? ????? ???? ???
response at 100 nM minus DMSO control. The dose response data were fitted to a Hill equation 
with SigmaPlot 2001 (SPSS Inc.), and 50% inhibitory concentrations (EC50) were calculated from the 
modeled data. ?????????????????????????????????????????????????????????????????????????????????
1B) or Tukey post-hoc comparison (P<0.01) (SPSS, Inc). 
Results and discussion 
H4IIE.Luc  CEPIA assay  
??????? ???? ???? ??? ??????????? ???? ???? ?????? ?????? ????? ?????????? ?????? ?????
determined. After incubation of H4IIE.Luc cells with calcein-AM, a significant 
increase in fluorescence was observed after 180 min with 0.5-???????????????????
??????????????????????????????????????????????????????????????????????????????
observed without inhibitor is likely due to calcein-AM hydrolysis before it is 
withdrawn from the cell. Incubation with the P-??? ?????????? ?????????? ????? ????
induced a significant increase in fluore??????? ?????? ???????????????????????????-
????????????????? ??????????????????????????????????????????????????????????-AM 
for 45 min was chosen to obtain a signal sufficiently high to properly observe 
inhibition.    
?
?
?
?
?
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?
The P-gp inhibition of verapamil, PCP and TCDD was then evaluated with the CEPIA 
assay optimized for H4IIE.Luc cells. Verapamil and PCP produced a dose-related 
increase in calcein fluorescence, while TCDD did not significantly increase the 
fluorescence com??????????????????????????????????????????????????????????????????
??? ????????????? ????????? ?????? ??? ??? ???? ???? ???? ??? ????????????? ?????? ????
visually confirmed under the light microscope and by the cell viability assay (data 
not shown). The EC50 of verapam??? ???? ????????? ??????? ??? ???? ?????????? ????
respectively, which was 3-6 times lower compared to inhibitory concentrations 
reported for P-gp over-expressing Madin-Darby canine kidney MDCKII-MDR1 cells 
(Georgantzopoulou et al. 2012). TCDD is known to induce P-gp mRNA expression 
(Maher et al. 2005) but to the best of our knowledge it is not known whether TCDD 
is a P-??? ??????????? ??? ??? ???? ??? ????? ???? ???? ???????? ??-AM efflux, a 
concentration which is far above the EC50 used for mixture toxicity studies causing 
SPMX effects (Vrabie et al. 2009). 
 DR.Luc assay 
????????????????????????????????????????-mediated response was evaluated in the 
DR.Luc assay. TCDD produced a dose-related response in the AhR-mediated DR.Luc 
assay with a limit of detection of 1.3±2.8 pM, an EC50 of 14±2.0 pM and an ECmax 
Figure 1. Calcein fluorescence and P-gp efflux 
pump inhibition in H4IIE.Luc cells. Calcein 
fluorescence increase over time after 
incubation with calcein-AM plus (A) DMSO  or 
???? ???? ??? ??? ?????????? ?????????? ???????????
Effect of verapamil, PCP or TCDD in the 
H4IIE.Luc CEPIA assay with ?? ??? ???????-AM 
for 45 min (C). Data represents the average of 
????????????????????????????????????????????????
independent experiments performed in 
triplicate. * represents significant differences 
from DMSO controls (P<0.01).  
A B 
C 
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??? ???? ??? ???????? ????? ?????? ??????????? ???? ??????????? ??? ??????????? ?????????
standardized results (Besselink et al. 2004). DMSO and the PCP concentration that 
gave maximal P-????????????????????????????????????????? full TCDD dose-response 
curve (0.4% DMSO) and compared with TCDD alone (0.2% DMSO). If considered 
???????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????SO or 
????????????????????????????????????????????????????????????????????????????????
PCP compared to TCDD plus DMSO was also not significantly different (ANOVA, 
P>0.01). 
 
PCP did not induce a dioxin-like response alone, nor increased the response of 10 
????????????????????????????????????????????????-A, genistein, quercetin, indol-3 
butiric acid, indol-3-acetic acid, and 4-OH CB 79 were tested alone and in co-
exposure in the DR.Luc assay with similar negative results (data not shown). There 
was therefore no evidence that inhibitors of P-gp efflux pumps, at the 
concentrations tested, could induce luciferase production or potentiate that of 
TCDD on the DR.Luc assay.  
A
Figure 2. DR.Luc assay response of P-gp inhibitors. 
AhR mediated luciferase induction of A) TCDD (0.2% 
DMSO, circles), TCDD plus DMSO (0.4% DMSO, 
????????????????????????????????????????????????????
C) ????? ?????????? ?????? ???? ?????????? ??????? ??????
(circles) or in combination with TCDD at EC50 
(triangles) or TCDD at maximal induction (squares). 
????? ?????????? ????????? ?????? ?????? ?????? ????????? ???
TCDD maximum (after DMSO control subtraction) ± 
SD from two separate experiments performed each in 
triplicate. * represents significant difference from the 
TCDD alone at the same concentration (P<0.01). 
C 
B 
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Genistein and quercetin are known for inducing the SPMX effect in the ER-
mediated reporter gene assays with more than 2 ERE’s in the reporter construct 
(Montaño et al. 2010). Quercetin has been reported to inhibit P-gp activity 
(Georgantzopoulou et al. 2012). However both failed to induce AhR-mediated 
????????? ??? ??? ????????? ???? ????????? ???????? ??? ??? ??? ???? ??? ????? ???????? ?????
Therefore the proposed mechanism of post-transcriptional luciferase stabilization 
(Sotoca et al. 2010) does not apply to luciferase produced in the H4IIE.Luc cells and 
might not be the most important mechanism behind the SPMX effect. 
 Conclusions 
The CEPIA assay was successfully adapted to the H4IIE.Luc cell line. The model P-gp 
inhibitor verapamil and PCP were more potent in this cell line compared to results 
obtained with the P-gp over-expressing MDCKII-?????????? ???????????? ???????????
assay conditions there was no evidence that P-gp efflux pump inhibitors modified 
or potentiated the activity of TCDD. Neither genistein nor quercetin, two potent 
SPMX inducers on ER-mediated assays, induced any signal on the DR.Luc assay, nor 
??????????? ???? ??????????? ?????????? ??? ?????? ??????? ????? ??????? ??? ??????? on 
testing the consequences of efflux pump inhibition with an AhR-agonist which is a 
P-gp substrate, as this could result in intracellular accumulation of this AhR-agonist. 
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Abstract 
Bioassays have become an alternative for sediment risk profiling, including 
potential compliance with sediment quality criteria (SQC). Despite their initial 
limited specificity and matrix sensitivity; in vitro functional bioassays have evolved 
through standardization and validation to provide a confident toxicological hazard 
estimate of sediments. Sample preparation proves to be a key aspect for bioassay 
improvement. It is standard practice to use a high single stock concentration of 
extracts to further dilute test concentrations from and perform the analysis. 
However, a high contaminant load in an extract (more than 20 g sediment 
equivalents (SEQ)/mL DMSO) oversaturates solubility in carrier solvents and 
overloads the clean-up columns which may result in residual PAH levels. These 
problems may cause respectively under- or over-estimation of the quantified 
dioxin-like toxic potency. Effects of initial stock concentrations and preparation, 
including sonication assisted dissolution, and exposure period influenced the 
outcome of quantified dioxin-like potency as observed for cleaned nonpolar 
sediment extracts from various locations in Luxembourg.  Sonication assisted 
dissolution of the stock before serial dilution strongly reduced the standard 
variation of the outcomes. Taking into account the aspects revealed in this study in 
addition to already described important issues for quality control, the in vitro 
bioassays based on Bio-TEQs can be applied in a comprehensive monitoring 
program to determine whether sediments comply with health and safety standards 
for humans and the environment. For the generally applied sediment quality 
criteria, advices are given for maximum initial stock concentrations to achieve 
reliable bioassay outcomes.  
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Introduction 
Persistent organic pollutants (POPs) such as polychlorinated biphenyls (PCBs) and 
polybrominated biphenyls (PBDEs) are widely distributed in the environment 
(Eljarrat and Barceló 2009), and constitute a concern for human and wildlife health 
(Carpenter 2006; Legler 2008; Letcher et al. 2010). Due to the lipophilic and 
persistent nature of such POPs they are mainly associated with sediments and 
lipids. Sediments act as a storage compartment serving as “secondary sources” of 
POPs for other environmental compartments and organisms (Heugens et al. 2001; 
Jonker et al. 2006; Moermond et al. 2004; Nizzetto et al. 2010; Vethaak et al. 
2005). 
In response to this problem sediment quality criteria (SQC) have been developed 
to: a) evaluate the need for sediment remediation on impacted sites, b) assess 
potential impacts of dredged waste, and c) regulate discharges to protect human 
health or the environment (Iannuzzi et al. 1995). Assessment of sediment 
compliance with SQC has been and continues to be based on a chemical analytical 
approach (OSPAR 2004; 2008). However, this definition of maximum acceptable 
concentration (action levels, ALs), focuses mainly on acute effects of legacy 
contaminants, ignoring effects from recently identified pollutants and neglecting 
their potential mixture effects (Schipper et al. 2010). In recent years, bioassays 
have been increasingly applied for sediment quality assessment and have become a 
standardized alternative for sediment risk characterization (Besselink et al. 2004; 
Brack et al. 2009; Hamers et al. 2010; Schipper et al. 2010; Stronkhorst et al. 2002). 
However, in vivo bioassays have been criticised for their lack of specificity, their 
sensitivity to matrix components and their poor reproducibility (Schipper et al. 
2010). Therefore, in vitro assays such as the reporter gene assays for dioxin-like 
(DR-Luc) and estrogenic substances (ER-Luc) have been intensively fostered for 
sediment toxicity profiling (Hamers et al. 2010; Schipper et al. 2010). In vitro 
bioassay response-based safe levels are being developed either relating it to 
chemical safety standards or by translating the in vitro toxic potency into potential 
ecotoxicological risk. Two examples are the comparison to guidelines for the DR-
Luc (also referred to as DR-CALUX) activity in marine harbour sediments (Besselink 
et al. 2004; Stronkhorst et al. 2002), and the translation to safe levels for estrogenic 
effects in vivo of ER-Luc responses of estuary sediments and suspended particles 
(Hamers et al. 2010).  
An important prerequisite for the application of in vitro bioassays in a licensing 
system is a high standard of quality assurance and quality control to guarantee the 
quality of the data on which the assessment is to be based (Klamer et al. 2005; 
Schipper et al. 2009; Stronkhorst et al. 2003; US EPA 1995). False positives 
(disqualification) can imply unnecessary high costs, false negatives can imply 
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environmental or human health risks. Therefore, bioassay protocols, sample 
preparation methods and data interpretation must include GLP specifications in 
terms of selectivity, repeatability and reproducibility. Several of these issues 
already have been tackled through improvement on the bioassay performance and 
validation (Besselink et al. 2004; Haedrich et al. 2012; Hoogenboom et al. 2013; 
Houtman et al. 2006b; Van der Burg et al. 2010) and standardization of sample 
preparation (Houtman et al. 2007; Schwirzer et al. 1998; Seiler et al. 2008; Van 
Wouwe et al. 2004). Nevertheless, there are still several issues remaining, which 
could considerably influence the quantification, resulting in an over- or under-
estimation of the toxic potency of samples and invalidate the risk judgement. 
For example, the occurrence of more than maximal responses (supramaximal 
effects, SPMX) has been reviewed for reporter-gene assays for estrogenic 
substances (Montaño et al. 2010), as well as dioxin-like responses in pore water 
(Jonker et al. 2006), crude and refined petroleum products (Vrabie et al. 2009), and 
sediments (Murk et al. 1996), even after thorough clean-up (Baston and Denison 
2011). This effect could lead to an over-estimation of the quantified potency of 
chemicals and extracts (Baston and Denison 2011; Montaño et al. 2010). Despite 
efforts to unveil the underlying mechanisms for SPMX effects (Montaño et al. 2012; 
Sotoca et al. 2010), it is not yet clear whether this is an assay-based artefact or 
represents a real-life toxicological effect. By quantification of the toxic potency at 
lower test concentrations this effect probably can be avoided, especially in cases of 
biphasic dose-response curves as has been shown for the ER-Luc (Montaño et al. 
2010). For FR-Luc responses, however, this needs to be studied further.  
Also sample preparation can alter the quantification of the toxic potency because it 
will inevitably influence the composition of the mixture tested (Seiler et al. 2008). 
Examples are loss of compounds by evaporation, introduction of compounds from 
filters or soxhlet sockets and solvent change implying a different solubility of 
compounds (Windal et al. 2005). An issue related to sample preparation that, to 
our knowledge, has not been properly addressed is the influence of the initial 
sample extract stock concentration on the final quantified toxic potency. It is a 
common practice to concentrate the sample as much as possible to be able to 
quantify the toxicity also in less polluted samples. When it is clearly stated within 
the publications, which regularly is not the case, commonly sediment extracts are 
concentrated to stocks of 10 to 50 g sediment equivalents (SEQ)/mL before 
analysis, which are then serially diluted in carrier solvent and media for exposure 
(Céspedes et al. 2004; David et al. 2010; Grote et al. 2005; Houtman et al. 2006a; 
Schmitt et al. 2011; Schwab et al. 2009; Vondrácek et al. 2001; Wölz et al. 2008; 
2010a; 2010b; 2011). In a few cases the extracts have been concentrated to stock 
solutions below 10 g SEQ/mL (Galluba and Oehlmann 2012; Kinani et al. 2010; 
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Klamer et al. 2005; Louiz et al. 2008; Ocampo-Duque et al. 2008; Sanctorum et al. 
2007; Thomas et al. 2004). In some other cases the extracts have been 
concentrated to stock solutions above 100 g SEQ/mL and as high as 200 g SEQ/mL 
(Besselink et al. 2004; Brack et al. 2008; Chao et al. 2011; Nording et al. 2007; 
Sanctorum et al. 2007). 
Indeed, it has been observed that original extract stock concentrations can 
significantly influence the observed estrogenic potency of waste treatment plant 
effluents (Murk et al. 2002). The authors suggested a loss of compounds during 
solvent exchange when the maximum solubility is approached. When the initial 
stock was more diluted the final estrogenic potency was higher. Also storage 
temperature of the stocks and sonication of stock extracts before further dilution in 
carrier solvent and before exposure are not stated explicitly within the 
experimental section of most publications. Sonication usually greatly enhances the 
dissolution of compounds and therefore modifies the actual exposure 
concentrations in the bioassay. However, so far this effect has not been studied.  
When a sample is cleaned more thoroughly the initial stock concentrations can be 
more concentrated. With an acid silica column the labile compounds are degraded 
and most PAHs are separated from the dioxins and PCBs. The use of an acid silica 
column (Besselink et al. 2004) is a standard clean-up procedure in the analysis of 
dioxin-like potency of sediments. Mostly a standard amount of sample is extracted 
and loaded. However, an overloaded column would allow other compounds to be 
present in the final extract (Schwirzer et al. 1998), including alkylated- and nitro-
PAHs (Dindal et al. 2011, own unpuglished data) which can induce arylhydrocarbon 
(AhR) activity whereas their mechanism of toxicity is totally different from that of 
dioxins (Vondrácek et al. 2001). Most PAHs can be metabolised by cytochrome 
P450 enzymes that are present in H4IIE rat hepatoma cells of the DR-Luc. 
Increasing the time of exposure to 24 hours or more allow more PAHs in the 
sample to be metabolized reducing their influence on the bioassay response 
(Hamers et al. 2000; Vondrácek et al. 2001). Previously, differences in Bio-TEQs 
following 24h and 48h exposures were observed for sediment extracts with 
potencies between 0.04 and 0.10 ng Bio-TEQ/g SEQ obtained with 30 g SEQ/mL 
initial stocks (Vondrácek et al. 2001). 
Considering the influence that actual contaminant load could have on the 
performance of a dioxin-receptor bioassay, we hypothesize that the use of 
concentrated stocks of sediment extracts could potentially cause wrong 
estimations of potency. Hence, this study focuses on the effects of initial stock 
concentrations, including sonication assisted dissolution and exposure time, on the 
quantified dioxin-like potency of cleaned nonpolar sediment extracts. The 
consequences of the ultimate effect on the quantified toxic potency of the 
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sediment are related to safe levels set in sediment quality criteria (SQC) and the 
impact on the management decision process. Suggestions are made to improve 
and standardize sample preparation practise and bioassay-based sediment potency 
quantification minimizing their modulating impact on its risk characterization. 
 
Materials and Methods 
Chemicals. Hexane (Hx, dioxin analysisgrade) and all other solvents 
(chromatographic grade) were purchased fromBiosolve BV (Valkenswaard, The 
Netherlands) or from Sigma-Aldrich Co(Steinheim, Germany). All other chemicals 
(incl. 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) were purchased from Sigma-
Aldrich Co (Steinheim, Germany) unless otherwise stated. All extraction and 
storage materials were exclusively made of borosilicate glass, and 
polytetrafluoroethylene screw cap vials were used when required. All materials 
were prewashed with hexane. Clean sand from Fontainebleu (Paris, FR) was dried 
overnight at 105 oC and extracted twice with the ASE method described below to 
obtain control sand. A portion of 30 g of cleaned sand was spiked with a solution 
containing TCDD in Hex and rotatory mixed for 72 hours for a final concentration of 
10 pmol TCDD/g (3.2 ng TCDD/g). 
Sediment sampling and preparation. Sediment samples were collected in 2010 and 
2011 from various locations at the rivers Alzette, Our, Clerve and Woltz in the 
Grand Duchy of Luxembourg. To test the effects of stock concentration, sonication 
and exposure time, a subset of locations was selected to exemplify sediments with 
a range of contamination profiles from industrial/urban (Alz 1,Alz 10 and Alz 19), 
urban (Alz 17, Our 4), agricultural (Our 3) and woodland (Woltz 1) locations (Figure 
1). Location labels correspond to the sampling position along the river and the 
overall codes from the full sampling campaigns were unchanged to allow 
comparison with other reports and publications (Montaño et al. 2013, submitted). 
Composite samples of 4 cm deep surface sediments were collected manually from 
natural sedimentation zones covering at least 50 m along the river course. At least 
8 sub-samples were mixed (1 kg), transported to the laboratory and stored in glass 
flasks at 4°C. The samples were transferred onto hexane washed aluminium plates, 
frozen at –20°C and then dried using an Alpha 2-4 LSC freeze-dryer (Christ, 
????????????????????????????????????????????????? ?????raction was obtained using 
a sieving machine (Retsch, Germany), and stored at 4 °C in glass bottles in darkness 
until extraction. 
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Preparation of crude extracts. A total of 5g of ???? ??? dried sediment from each 
location, control sand and TCDD spiked sand were extracted with a mixture of 
Hex:acetone (Ac, 3:1, v/v) in an accelerated solvent extraction equipment (ASE200; 
Dionex, Sunnyvale, CA,USA) with three extraction cycles at 100 °C and 2,000 psi 
(Houtman et al. 2007). A mixture of 2 g dried Na2SO4 to eliminate remaining 
humidity and 1 g of Cu powder (Sigma-Aldrich Co., Steinheim, Germany) for sulphur 
removal were added into the ASE eluate collection bottles. The bottles were 
rotated for 30 min, then the extract transferred over a dried Na2SO4 filled funnel to 
remove residual humidity, flushed with additional 10mL Hx:Ac (3:1 v/v) and 
evaporated until near dryness under vacuum. 
Fractionation. Polar and nonpolar fractions were obtained as previously published 
(Legler et al. 2002; Montaño et al. 2013, submitted) with slight modifications. 
Briefly, the dried ASE-extract was washed twice with 1 mL Hx. The hexane portions 
were combined, then filtered through a 1 g Na2SO4 filled Pasteur pipette to retain 
??????? ?????????? ??????????? ???? ??????????? ??? ???? ??? ?????? ?? ??????? ?2 flow 
Figure 1 Sediment sampling locations within the Grand Duchy of Luxembourg 
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(nonpolar fraction). This nonpolar fraction was further cleaned with a multilayer 
sulphuric acid silica column (Houtman et al. 2004), which consisted of 1 g Na2SO4 
on top of 3 g 33% sulphuric acid silica on top of a silanized glass wool plug. The 
column was pre-washed with 8 mL of Hx:diethyleter (DEE, 97:3). The extract was 
transferred onto the column including two rinses wit?? ??? ??? ??? ??????? ???????
before elution with 8 mL of solvent. The eluate of both the sample and the rinses 
were collected into a cleaned tube and evaporated at room temperature under a 
gentle N2 flow to near dryness.  
 
Preparation of stocks. Cleaned nonpolar fractions were re-dissolved in 3 mL of 
hexane. The extract was split into three portions with a different volume; each was 
dried under a gentle N2 flow, and transferred into DMSO with 90 s sonication to 
prepare three stocks with concentrations of 200, 20 and 2 g SEQ/mL (Figure 2). 
Extract stocks were stored at 4 °C until analysis in the bioassay. After 90 s 
Figure 2 Graphical representation of the experimental design. Nonpolar sediment extracts were prepared 
to obtain three initial stocks with 2, 20 and 200 g SEQ/mL. From these initial stocks dilutions were made 
resulting in comparable sediment equivalent (SEQ) concentrations on the assay plate, and were tested in 
the DR.Luc assay. 
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sonication, unless otherwise stated, an aliquot of each stock was serially diluted up 
to 10,000 fold in DMSO to obtain the exposure dilutions. Final SEQ/mL medium 
exposure dilutions from the different initial stock concentrations were as similar as 
possible. The effect of sonication assisted dissolution was tested on extracts with 
initial stock concentrations of 20 g SEQ/mL and 2 g SEQ/mL and not with the stocks 
at 200 g SEQ/mL based on pilot experiments revealing problems with such highly 
concentrated extracts. The effect of exposure period was tested for stock extracts 
with 2 g SEQ/mL. 
DR.Luc bioassays. DR.Luc bioassays were performed with rat hepatoma H4IIE.Luc 
cells (kind gift from Prof Michael Denison) following previously developed assay 
protocols (Legler et al. 1999; Murk et al. 1998). Cell culture conditions, bioassay 
conditions and luciferase assay have been published elsewhere (Besselink et al. 
2004; Vrabie et al. 2009). In short: cells were exposed in triplicate with the addition 
??? ???? ??? ??? ??????? ??????? ??????????? ?????? ??? ???? ???????? ?n a final 
concentration of 0.25% DMSO. Every experiment included a complete TCDD 
calibration curve while in addition each plate contained solvent and standard 
quality controls. Recovery was controlled for each extraction batch with 3 g of 
spiked sand which contained                  3.2 ng TCDD/g of sand.   
Cell viability was determined by the measurement of the total cells’ metabolic 
activitybefore the end of the exposure period with 100 nM resazurin in 200 ?? cell 
media for 2 hours (Montaño et al. 2011). Fluorescence was measured at an 
excitation wavelength of 530 nm and an emission wavelength of 590 nm. Then the 
plates were prepared for the luciferase assay and measured in a Biotech Synergy 2 
plate reader as described before (Vrabie et al. 2009). 
Parameter calculation and estimation of uncertainty. Experimental data were 
normalized to the maximal response given by 100 pM TCDD in the bioassay or to 
their own maximal induction when above that of TCDD as suggested by Baston and 
Denison (2011). The data were fitted to a three-parameter Hill function (Sigma Plot 
(Systat)) which assumes a logistic distribution of the data and provides an 
estimation of the maximum, slope and the effect concentration responsible for 
50% of the luminescence effect (EC50). Based on these parameters the effect 
concentrations responsible for 20% of the effect (EC20) were also calculated for 
each experiment. Bioassay derived TCDD equivalents (Bio-TEQs) were calculated by 
relating the luminescence induced by the extract with that of the positive control 
2,3,7,8-TCDD for the concentrations that gave a TCDD EC20 as well as EC50 
equivalent response. All reported SEQ values are expressed in dry weight. The 
influences of initial stock sediment-equivalent concentration, sonication and 
exposure time on the final Bio-TEQ concentrations were analyzed. 
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Results 
Effect of initial stock concentration 
Figure 3 shows the DR-Luc bioassay responses induced by dilutions of cleaned 
nonpolar sediment extracts that were prepared from 3 different initial stock 
concentrations with 10x concentration difference. The best sigmoidal dose-
response curves were obtained with the most diluted initial stocks whereas with 
the most concentrated (200 g/ml) stocks no good dose-response curve could be 
prepared except for the least polluted Our3 sediment (Figure 3D).  
Figure 3 Effects of the initial stock concentration of cleaned nonpolar sediment extracts on their DR.Luc 
response. Cleaned nonpolar sediment extracts were prepared at initial stock concentrations of 200, 20 and 2 g 
SEQ/mL. These stocks were further serially diluted in DMSO and tested in the DR.Luc assay. Data represent the 
mean ± SD relative response to the maximal obtained by 100 pM TCDD in the DR.Luc assay from two separate 
experiments tested in triplicate. The line represents the predicted values after the data from the stock of 2 g 
SEQ/mL was adjusted to a Hill model. Cells exposed to the highest concentrations from the all the stocks of 200 
g SEQ/mL and from the stock of 20 g SEQ/mL from Alz 19 and Alz 10, showed reduced cell viability to 71% 
compared to controls. 
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Calculation of dose-response parameters from 200 g SEQ/mL of cleaned nonpolar 
extracts from Alz 10, Alz 17 and Our 4 was not possible (Figure 3B and C). The effect 
of initial stock concentration becomes negligible for extracts from less polluted 
sediments with dioxin-like activity lower than 0.4 ng Bio-TEQ/ g SEQ (Table 1) as it 
was the case for Our 3 (Figure 3D). 
Although all experiments from each location had the same extract concentrations 
in the plate, the 200 g SEQ/mL stocks from Alz1 and Alz 19 resulted in a lower 
quantification of the dioxin-like toxic potency compared to the potency from stocks 
with initial concentrations of 20 and 2 g SEQ/mL. Except for samples Alz 1, Alz 19 
and Our 4 the differences between the result obtained with the initial stock of 20 g 
SEQ/mL and those obtained with the initial stock of 2 g SEQ/mL were not significant 
(Table 1). Identical results were obtained when all the Bio-TEQs were calculated 
with the EC20 although with considerably higher standard deviations. 
Table 1 
Dioxin-like activity expressed as Bio-TEQ (ng/g SEQ dry wt)a of the nonpolar fraction of sediments 
obtained with three different initial stock concentrationsb 
Label Location Initial stock concentration in DMSO (g SEQ/mL) 
200 20 2 
Alz 1 Barbuerg 6.9 ± 2.1e 16 ± 3.2 e 40 ± 17 
Alz 10 Bettembourg NC c ±  2.8 ± 0.32 2.1 ± 0.45 
Alz 17 Walferdange NC c ±  1.2 ± 0.23 0.70 ± 0.18 
Alz 19 Steinsel 0.76 ± 0.05 e 1.5 ± 0.14 e 2.1 ± 0.19 
Our 3d Putsheid 0.26 ± 0.06 0.28 ± 0.04 0.21 ± 0.04 
Our 4 Bettel NC c ±  0.64 ± 0.12 e 1.2 ± 0.16 
Woltz 1d Maulusmillen 0.16 ± 0.08 0.24 ± 0.07 0.34 ± 0.06 
a Bio-TEQ (ng/g SEQ) ± SD obtained from at least two separate experiments, assayed with at least four 
concentrations twice in triplicate. 
b In all cases the extracts were sonicated prior to the preparation of serial dilutions. 
c NC: not possible to calculate dose-response parameters 
d calculated with the EC20 
e Significantly different from the results obtained with 2 g SEQ/mL 
Effect of sonication 
Cleaned nonpolar extracts with 20 and 2 g SEQ/mL in DMSO were tested before and 
after sonication. The main effect of sonification was the reduction in standard 
deviation, especially at the higher stock concentration (20 g/mL). The differences 
between the quantified potency of 2 g SEQ/mL extracts with and without sonication 
were negligible except for higher standard deviations without sonication. For 20 g 
SEQ/mL extracts, this effect of lower standard deviation in the sonicated extracts 
was even higher, especially those from the more polluted sediments with Bio-TEQ 
values >1 ng/g SEQ (e.g. Alz 1, Alz 10 and Alz 19). With the more polluted sediments 
the dose-response curves of extracts without sonication suggested a higher potency 
(Figure 4), although the standard deviation then is so high that the values with and 
without sonication overlap (Table 2).   
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Table 2 
Dioxin-like activity expressed as Bio-TEQ (ng/g SEQ dry wt)a of the 20 g SEQ/mL nonpolar fraction of 
sediments with and without sonicationb 
Label Location Sonication 
Without  With 
Alz 1 Barbuerg 272 ± 266 26 ± 5.5 
Alz 10 Bettembourg 0.59 ± 0.22 0.41 ± 0.15 
Alz 17 Walferdange 1.3 ± 0.87 1.1 ± 0.14 
Alz 19 Steinsel 196 ± 324 4.1 ± 1.5 
Our 3 Putsheid 0.36 ± 0.16 0.34 ± 0.08 
Our 4 Bettel 0.78 ± 0.23 0.98 ± 0.14 
Woltz 1 Maulusmillen 0.12 ± 0.11 0.16 ± 0.05 
a Bio-TEQ (ng/g SEQ) ± SD obtained from at least two separate experiments, 
assayed with at least four concentrations twice in triplicate.
b Initial stock concentration was 20 g SEQ/mL. 
Effect of exposure period for highly contaminated sediments 
The luciferase induction by extracts from cleaned nonpolar sediment extracts was 
higher for 6 hours exposure than 24 or 48 hrs (Figure 5). This effect was greater for 
the more polluted locations independent of the initial stock concentration (2 g 
SEQ/mL). The dioxin-like potency values obtained at 48 hours for these three 
locations were closest to chemically measured values (Data not shown). The 
differences between responses at 24- and 48-hours were smaller or even negligible 
for extracts from locations with lower contaminant concentrations (Figure 5b).  
 
Figure 4 Effect of sonication on the dose-response of cleaned nonpolar sediment extracts. Cleaned nonpolar 
sediment extracts obtained with 20 gSEQ/mL stocks, were tested before and after 2 min sonication. Data 
represent the mean ± SD relative response to the maximum response obtained by 100 pM TCDD in the DR.Luc 
assay from two separate experiments tested in triplicate. Decrease of activity above 0.1-1 mg SEQ/mL for Alz 19 
correlated with a reduction in cell viability (Data not shown). 
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Dioxin-like potency of nonpolar sediment extracts from Luxembourgish basins 
Samples from various Luxembourgish basins (Figure 1) with a variety of 
environmental pressures were tested after sonication initially with a stock 
concentration of 20 g SEQ/mL and the potency was quantified after 24 h (or 48 
hours) of exposure (Table 3). Based on indications obtained during sampling, 
sample organoleptic characteristics and especially the extract colour and behaviour 
during clean-up, potentially highly contaminated samples were also tested with a 
stock concentration of 2 g SEQ/mL at 24 and 48 hours (Table 3). 
 
Toxic potencies at control locations such as Clerve 1 and Our 0 were below 0.03 ng 
Bio-TEQ/g SEQ, but Woltz 1 showed an activity of 0.24 ng Bio-TEQ/g SEQ, which is 
considerably higher in comparison. Dioxin-like activity from locations at the Alzette 
river was higher from the point of entrance into the country all the way through 
Esch-sur-Alzette (40 ng Bio-TEQ/g SEQ) and decreased to 1-2 ng Bio-TEQ/g SEQ 
along its further course towards the north of Luxembourg (Table 3). Alzette 
tributaries had activities between 0.2 and 3.2 ng Bio-TEQ/g SEQ. Samples from the 
Our river showed a variable dioxin-like potency along its course but considerably 
lower compared to samples from the Alzette river (Table 3). 
 
 
Figure 5. Effects of the exposure period on the DR.Luc dose response of cleaned nonpolar sediment extracts. 
Cleaned nonpolar extract of sediments were dried under N2 and re-dissolved in DMSO at initial stock 
concentrations of 2 g SEQ/mL. These stocks were further serially diluted in DMSO for exposure and 
measurement in the DR.Luc assay at 6 hours (with conditioned medium), 24 hours and 48 hours. Data represent 
the mean ± SD relative response to the maximal response induced by TCDD after the same exposure period 
obtained from two separate experiments tested in triplicate. 
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Table 3  
Dioxin like toxic potency of nonpolar fraction of sediments from various Luxembourgish basinsa 
Label Location / tributary 
Bio-TEQb 
24 (48) hours 
(ng/g SEQ) 
Label Location 
Bio-TEQb 
24 (48) hours 
(ng/g SEQ) 
Alz 1 Barbuerg 40 (18) c Clerve 1 Kaaspelt 0.027 
AlzT 2 Lallange / Dipbech 0.86 Woltz 1 Maulusmillen 0.24 
Alz 3 Amont Schiflange 8.9 (0.30)c Our 0 Moulin de Kalborn 0.013 
AlzT 4 Kiemelbaach 1.6 (0.85) Our 1 Dasburg-bridge 0.13 
Alz 5 Aval Kiemelbaach 2.2 (1.2) Our 2 Stolzemborg 0.12 
AlzT 6 Lameschermillen / Mess 0.65 Our 3 Putsheid 0.28 
Alz 7 Lameschermillen 5.4c Our 4c Bettel 1.1 (0.12)c 
AlzT 8 Op der Klaus / Kälbaach 3.2c Our 5 Bettelaval STEP 0.066 
AlzT 9 Op Bich / Mierbech 1.7 Our 6 Wallendorf-bridge 0.097 
Alz 10 Bettembourg 2.1 (0.48)c Our 7 Reisdorf / Sûre 0.13 
AlzT 11 Bettembourg / Diddeleng. 0.23 Our 8 Dillingen / Sûre 0.12 
Alz 12 AvalBettembourg 2.7    
AlzT 13 Roeser/Crauthemergruef 0.16    
Alz 14 Avalroeser 0.85    
Alz 15 Hesperange 1.3    
Alz 16 Beggen 1.7    
Alz 17 Walferdange 1.2 (0.16)    
Alz 18 Laag 0.25    
Alz 19 Steinsel 2.1c    
a Alz: Alzett river, AlzT: Alzett tributary, Our: Our river, Clerve: Clerve river and Woltz: Woltz river.                 
T: tributary. Label numbers correspond to the river flow. 
b Bio-TEQ (ng/g SEQ) obtained from at least two separate experiments, assayed with at least four 
concentrations twice in triplicate after 24 and 48 hours of exposure.  48 hours results were included only 
when they were different from the values at 24 hours. Standard deviation within experiments was less than 
28%.  
c Potency calculated with initial stock concentration of 2 g SEQ/mL 
 
 
Discussion 
For a confident bio-assay based toxicological hazard and risk characterisation of 
sediments, it is important that the outcomes of the bio-analysis are reliable, and 
relevant. This study examined the consequences for the quantified toxic potency of 
non-polar sediment extracts depending on the initial stock concentration, sample 
preparation and exposure duration in an in vitro bioassay for dioxin-like potency in 
cleaned nonpolar sediment extracts from various locations in Luxembourg. The 
initial stock concentrations prepared were 2, 20 and 200 g sediment equivalents 
(SEQ)/mL DMSO; from each stock, dilutions were prepared in DMSO and tested in 
the DR-Luc assay. Especially when using the highest (200 g SEQ/mL) initial stock 
concentrations, the quantified Bio-TEQs/g sediment were significantly lower 
compared to those based on the less concentrated initial stocks. The 
underestimation was 2-5 times for the least and most polluted sediments 
respectively compared to the Bio-TEQs based on the 2 g SEQ/mL stock. For the 
most polluted sediments even using the 20 g/mL initial stock resulted in an 
underestimation of the Bio-TEQs. The tendency towards higher quantified potency 
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at lower initial stock concentrations, the extent of the differences and the 
difficulties to obtain a proper dose response at higher initial stock concentrations 
(Table 1) support the hypothesis that part of the active compounds is lost due to 
oversaturation of the DMSO solution and precipitation of a fraction of the original 
amount present in the extraction solvent. Sonication assisted dissolution of the 
stock before serial dilution strongly reduced the standard deviation, but was not 
enough to dissolve all the relevant compounds in over-concentrated initial stocks. 
Sonication was necessary to produce reproducible results. Differences in quantified 
toxic potency due to over-concentration has been previously reported for extracts 
of waste treatment plant effluent (Murk et al. 2002), but to our knowledge this is 
the first report of this effect for sediment in a dioxin-like activity bioassay.  
Due to differences in water solubility between PAHs and POPs of different 
lipophilicity depending on the number of halogens and the substituted positions 
(Huang and Hong 2002; Shiu and Mackay 1986), the ratios between dissolved and 
precipitated compound will differ depending on the degree of overconcentration. 
When the extracts are diluted further, especially without sonication, the precipitate 
is not transferred to the dilution vials. The initial stock concentration of 2 g SEQ/mL 
DMSO was low enough to prevent underestimation of the sediment Bio-TEQs. This 
results in a limit of quantification (LOQ) of 80 pg Bio-TEQ/g SEQ. Depending on the 
required LOQ, the initial stock concentration could be increased to 20 g SEQ/mL 
(LOQ 8 pg Bio-TEQ/g SEQ), and for relatively clean sediments this could even be 
200 g SEQ/mL (LOQ 0.8 pg Bio-TEQ/g SEQ). Observed effects of sonication assisted 
dissolution of stocks before pipetting and exposure strongly suggests its inclusion in 
future testing protocols.  
Not only overconcentration of initial stocks, but also overload of clean-up columns 
can impair quantification of the toxic potencies of sediments. Recently, it was 
demonstrated that extracts obtained by ASE and acid silica clean-up, also used by 
us, contained similar amounts of dioxins compared to more exhaustive analytical 
methods used for high resolution mass spectrometry (Dindal et al. 2011). Acid silica 
clean-up is needed to prevent false-positive responses due to PAHs that activate 
the AhR (Hamers et al., 2000; Puglisi et al., 2007), but do not induce dioxin-like 
toxicity because they are easier metabolised and give rise to other mechanisms of 
toxicity. However, overload of the acid silica column cause AhR active PAHs to run 
through the column and reach the final extract (Dindal et al. 2011; Schwirzer et al. 
1998). The presence of PAHs in the extract of highly contaminated sediments is 
revealed when testing during 6, 24 and 48 hours of exposure as the PAHs can be 
metabolised by the DR-Luc cells that are H4IIE rat hepatoma cells capable of P450 
activity (Figure 5). Quantification of dioxin-like potency at 24 hours or later has 
been suggested as an alternative to exhaustive clean-up as easily biodegradable 
Chapter 5 
 136 
PAHs would be already metabolized (Hamers et al. 2000). When the extracts 
originate from less PAH-polluted sediments (Bio-TEQ below 0.01 ng/g SEQ at 24 
hours) or are more thoroughly cleaned (in our case with 1 g SEQ/ g 33% acid silica 
column) small or no differences can be observed between the dioxin like response 
at 24 and 48 hours (Stronkhorst et al. 2002; Vondrácek et al. 2001). Sediment 
samples with potencies above the intervention value of 1 ng TEQ/g (Iannuzzi et al. 
1995; OSPAR 2007; Stronkhorst et al. 2002) should be retested at longer exposure 
times to verify their dioxin-like activity. Testing of bio-available concentrations can 
also be applied to better assess the risk characterization of highly contaminated 
sediments (Puglisi et al. 2007). 
The sediments in the Alzette basin showed higher DR.Luc activity due to dioxin-like 
compounds compared to other European water bodies (OSPAR 2007), most likely 
due to industrial activities in the south of Luxembourg as the level of pollution in 
this area is well known (Kurtenbach and Gallé 2008). To our knowledge this is the 
first report of dioxin-like activity of sediments from the Alzette River. The Bio-TEQ 
levels up to 48 ng/g are similar to what has been found in small Mediterranean 
rivers near to waste water discharges (David et al. 2010; Kinani et al. 2010), and up 
to 7 ng Bio-TEQ/g during flood events in the Rhine (Wölz et al. 2010a; 2010b). 
Towards the north of Luxembourg the BIO-TEQs are gradually  lower, probably due 
to mixing with cleaner sediments from tributaries. The Our basin sediments are 
considerably less polluted with dioxins compared to the Alzette basin. The Bio-TEQs 
are low in the upper Our sediments, but these increase towards the town of 
Vianden and then slightly decrease until the junction with the river Sûre. These 
sediment Bio-TEQ levels correlate very well with the reported contamination 
profile of fish at similar locations (Boscher et al. 2010; Dauberschmidt and 
Hoffmann 2001; Hugla et al. 1998). 
Sediment risk characterization using bio-analysis  
Several sediment quality criteria (SQC) have been proposed depending on the 
protection goals (Table 4). For example a SQC intervention value of 1 ng TEQ/g 
triggers remedial action (Stronkhorst et al. 2002) and also is a limit for disposal of 
dredged spoils (Iannuzzi et al. 1995). Also governmental agencies and local 
governments have established screening levels as well as thresholds for the 
protection of human and ecological receptors from 0.01-0.61 ng TEQ/g (Reviewed 
by Iannuzzi et al. 1995; Stronkhorst et al. 2002). For in vitro bioassays SQC safe 
levels have been established for the dioxin-like reporter-gene assay from a target 
level of 0.002 ng TEQ/g to a threshold value of 0.025-0.050 ng TEQ/g (OSPAR 2007; 
Stronkhorst et al. 2002). Finally, safe levels for top predators have been estimated 
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to be between 1.75×10-4 and 0.012 ng TEQ/g (Murk et al. 1998; Schipper et al. 
2010) (Table 4). 
To be able to apply the DR.Luc assay to decide whether sediments comply with 
these SQC for TEQs, the initial stock concentration has to be high enough to 
produce a signal equivalent to 3 pM TCDD (approximately EC20) at 0.2% DMSO (but 
in no case more than 0.4).  
Table 4 presents the SEQ/mL exposure medium and consequently the SEQ/DMSO 
that would be needed to significantly quantify the potency of sediment 
contaminated at the level of the SQC. If the risk characterization goal is to know 
whether the sediment potency is above the intervention SQC an initial stock 
concentration of 0.5 g SEQ/mL DMSO will provide suitable results without 
overconcentration problems. Only when the TEQ values also below the SQC need 
to be quantified a higher initial stock concentration is required. 
 
 
Table 4 
Initial stock concentrations derived from different sediment quality criteria (SQC) 
Risk characterization goal SQC ng TEQ/g sediment a 
mg SEQ /ml 
exposure mediumb 
Initial stock 
g SEQ/ml DMSO c 
Sediment intervention valued 1 0.96 0.48 
DR-CALUX threshold value e 0.025-0.05 39-19 19-9.6 
Protection of human and ecological 
receptors f 
0.01-0.61 96-1.6 48-0.79 
Safe sediment levels for wildlife g 1.75×104 -0.01 5.5×103-96 2.7×103-48 
a Data usually reported as ng TEQ/kg but expressed as ng/g for comparison with Tables 1, 2 and 3. 
b Amount of sediment required in plate to produce a signal equivalent to 3 pM TCDD (0.96 pg/mL) 
c Concentration of initial stock needed  for  0.2% DMSO in exposure medium. 
d (Iannuzzi et al. 1995), e (Stronkhorst et al. 2002) f (Iannuzzi et al. 1995) g (Schipper et al. 2010) 
 
To monitor whether at a certain location there is a risk for human and wildlife; then 
the initial stock concentration should at least be 10 g SEQ/mL up to 50 mg SEQ/mL. 
The latter would result in over-concentration problems revealed in this study. 
Although the limit of detection with the DR-Luc is much lower than with chemical 
analytical techniques, it is not sufficient to quantify the really low levels required to 
establish conformity with some safe levels for wildlife without additional and 
rigorous clean-up. For instance a stock concentration of above 2 kg/mL would be 
necessary to produce a response equivalent to the safe sediment level of 3 pg 
TEQ/g organic C (equivalent to 0.18 pg TEQ/g sediment assuming sediment with 6% 
organic carbon) in Eurasian otters for hepatic vitamin A reduction  (Murk et al. 
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1998). Values presented in Table 4 should be of guidance to decide the amount of 
sediment to be used and initial sample stock concentration in DMSO.     
It will be, however, no problem to analyse sediments at the intervention value as 
already 0.5 SEQ/mL DMSO would be enough (Table 4). Even for highly polluted 
locations such as Alz 19 and Our 4, this concentration would not give problems with 
over-concentration-related underestimation of the TEQs/g sediment. . However, 
when Alz 19 and Our 4 potency would be tested at initial stock concentrations of 20 
or 200 g SEQ/ml their toxicity would have been underestimated (Table 1) in a way 
that these locations might not be considered for intervention or banning which 
would be the decision when they are tested at 2 g SEQ/mL (Table 1). The TEQs/g 
sediment of Alz 1 and Alz 10 would be exceeding the intervention level at any 
concentration tested, although testing over-concentrated extracts of relatively 
polluted sediments without sonication might overestimate the toxic potency of the 
sediment. The same will be the case with too high residual PAH levels in highly 
contaminated extracts after 6-24 hours of exposure. Underestimation of the toxic 
potencies (false negative response) is unwanted because of safety risks but 
unnecessary classification of sediments above the SQC may result in unrequired 
expenses for dredging, storage and remediation.  
Most samples from the Alzette river had dioxin-like toxic potencies close to or 
above the intervention SQC (Tables 3 and 4), and some samples closest to the 
France border (Alz 1, Alz 4 and Alz 5) and Our 4 after the city of Vianden greatly 
exceeded the intervention value of 1 ng TEQ/g sediment, even after 48h of 
exposure to reduce the false positive contributions of PAHs. These locations should 
require immediate attention and further studies in the area to determine the need 
for remediation 
 
This study reveals that a higher contaminant load in the initial extracts from 
sediments can affect the reliability of the quantification of the toxic potency 
obtained with the in vitro bioassay. As a result there could be either 
underestimation because of solvent oversaturation and loss of active compounds 
through precipitation, or overestimation because of overload of clean-up columns 
and relative dissolution of the more potent compounds after sonication of the 
over-concentrated extract. In addition to the advice to standard apply sonication 
within the testing protocols, it also is advised to adapt initial stock concentrations 
both to the risk characterization goal as well as to the contamination level of the 
sample. In case of a relatively high dioxin-like toxicity the nature of the dioxin-like 
activity should be confirmed at longer exposure times to reduce the impact of 
possible residual PAHs in the extract.  
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Taking into account these aspects in addition to already described important issues 
such as using a validated dioxin-stock and positive samples for statistical process 
control charts; the in vitro bioassays based Bio-TEQs can be applied in a 
comprehensive monitoring program to determine whether sediments comply with 
health and safety standards for humans and the environments. 
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Abstract 
Traditional sediment risk assessment predominantly considers the hazard derived 
from legacy contaminants that are present in nonpolar sediment extracts, such as 
polychlorinated biphenyls (PCBs), dioxins, furans (PCDD/Fs) and polyaromatic 
hydrocarbons (PAHs). Although in vivo experiments with these compounds have 
shown to be thyroid hormone disrupting (THD), in vitro their THD potency is not 
observed in nonpolar sediment extracts. This is hypothesized to be due to the 
absence of in vitro biotransformation which will result in bioactivation of the 
lipophilic compounds into THD hydroxyl metabolites. This study reveals that indeed 
metabolically activated nonpolar contaminants in sediments can competitively bind 
to thyroid hormone transport proteins. Sediment fractions were incubated with S9 
rat microsomes, and the metabolites were extracted with a newly developed 
method that excludes most of the lipids to avoid interference in the applied non-
radioactive 96-well plate TTR competitive binding assay. Metabolic activation 
increased the TTR binding potency of nonpolar fractions of POP-polluted sediments 
up to 100 times, resulting in potencies up to 240 nmol T4 equivalents/g sediment 
equivalent (nmol T4-Eq/g SEQ). Without bioactivation, medium polar and polar 
fractions also contained potent TTR-binding compounds with potencies from 1.6 to 
17 nmol T4-Eq/g SEQ. This demonstrates that a more realistic in vitro sediment THD 
risk characterization should also include testing of both polar and medium polar 
sediment extracts for THD, as well as bioactivated nonpolar sediment fractions. 
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Introduction 
Sediments furnish support, provision and regulation services which are 
fundamental to the well-being of aquatic ecosystems (Gerbersdorf et al. 2011). 
However, they also serve as storage and secondary sources of persistent 
contaminants (Nizzetto et al. 2010), entailing an important route of exposure for 
aquatic food chains starting with benthic organisms including mollusks (Verslycke 
et al. 2005), fish (de Boer et al. 2001; Moermond et al. 2004; Montaño et al. 2011; 
Schipper et al. 2009; Zimmer et al. 2011), birds (Bosveld et al. 2000), and mammals 
(Leonards et al. 1997; Murk et al. 1998; Nyman et al. 2003), which ultimately will 
lead to human exposure (De Mul et al. 2008; van Leeuwen et al. 2007). Especially 
sediments in industrial and harbor areas have shown to possess high levels of 
persistent organic pollutants (POPs), such as polychlorinated biphenyls (PCBs), 
dioxins and furans (PCDD/Fs), polybrominated diphenyl ethers (PBDEs) and 
polyaromatic hydrocarbons (PAHs) (Houtman et al. 2006; Sanctorum et al. 2007). 
The relevance of bioassays in hazard, impact and risk assessment of sediments has 
been increasingly addressed (Schipper et al. 2010). In vitro assays for general 
toxicity, genotoxicity, mutagenicity and endocrine disruption, have been proposed 
within integrated effect-based frameworks for site-specific sediment quality 
assessment (Hamers et al. 2006; Schipper et al. 2010) and effect-directed analysis 
(EDA) (Brack et al. 2007).  
Risk assessment of organic contaminants has focused traditionally on nonpolar 
compounds such as PCBs, PCDD/Fs and PAHs, but polar compounds have been 
increasingly reported to be important in the overall sediment toxicological potency 
(Brack et al. 1999; Di Giorgio et al. 2011; Houtman et al. 2006; Legler et al. 2002; 
Legler et al. 2003), particularly after the application of EDA (Brack et al. 2002; Brack 
et al. 2005; Higley et al. 2012; Lübcke-von Varel et al. 2011). They rightly argue, 
that polar fractions comprise a significant amount of hazardous compounds and 
should be considered for sediment risk assessment (Lübcke-von Varel et al. 2011). 
Although nonpolar (lipophilic) POPs such as PCBs and PBDEs have been shown to 
induce steroidogenicity and thyroid hormone disruption in vivo, the nonpolar 
fractions of sediments in which they are present hardly exert any in vitro toxic 
effects (Higley et al. 2012). Indeed, alterations of thyroid hormone-dependent cell 
proliferation on the T-screen assay (Gutleb et al. 2005) and severe perturbations of 
thyroid hormone-dependent metamorphosis of in vivo exposed amphibians (Gutleb 
et al. 2007a; Gutleb et al. 2007b) have been observed after exposure to nonpolar 
sediment extracts from various contaminated locations in The Netherlands; despite 
the seemingly low potency of nonpolar sediment extracts (Lübcke-von Varel et al. 
2011). 
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We therefore hypothesize that an important overlooked aspect of in vivo sediment 
hazard assessment is the importance of metabolic activation of lipophilic 
contaminants. Several toxicological studies have demonstrated that endocrine 
disruption from nonpolar compounds occurs via metabolic activation to more 
hormone-like compounds capable of exerting a range of toxic effects (Boxtel et al. 
2008; Gutleb et al. 2010; Meerts et al. 2004; Usenko et al. 2012). Well-known 
examples are the increased estrogenic effect of methoxychlor (Legler et al. 2002) 
and the thyroid hormone disruptive capacity of hydroxylated (OH-) metabolites 
from PCBs and PBDEs (OH-PCBs and OH-PBDEs) (Freitas et al. 2011; Lans et al. 
1993; Marchesini et al. 2008; Meerts et al. 2000; Schriks et al. 2007). 
Lipophilic pollutants that are characteristically present in the nonpolar sediment 
fractions are taken up, accumulated, and biomagnified through the food chain 
(Kelly et al. 2008). In the liver they are transformed via phase I metabolism into OH-
compounds which are structural analogues of the thyroid hormones (Marsh et al. 
2006; Morse et al. 1995). Interestingly, these hormone-like OH-metabolites are 
retained in plasma due to their capacity for binding to thyroid transport proteins 
like transthyretin (TTR), thyroxin-binding globulin (TGB) and albumin (Hamers et al. 
2008; Lans et al. 1994; Marchesini et al. 2008). This binding protects them from 
further degradation and excretion, whereas they are transported via these proteins 
to various tissues and over selective barriers to the brain and the placenta (Meerts 
et al. 2002; Morse et al. 1993). OH-PCBs and OH-PBDEs accumulate in plasma of 
birds, cetaceans and other mammals including man, at levels often higher than 
their respective parent compounds (Montaño et al. 2013). 
The need for inclusion of metabolic activation has been acknowledged already for 
decades (Meerts et al. 2000). Indeed, it has been a priority within the development 
of in vitro testing alternatives (Coecke et al. 2006; Murk et al. 2013). Exogenous 
biotransfomation systems, however, only transform a relatively low percentage of 
the parent compounds into OH-metabolites (Morse et al. 1995; Murk et al. 1994). 
When the parent compounds are not separated from the metabolites they may 
interfere with the assay, for example by being cytotoxic to cells before the amount 
of metabolite is high enough to induce a measurable effect (Schriks et al. 2006). In 
addition, co-extractants from the enzymatic preparations can interfere with the 
bioassay (Hamers et al. 2008; Montaño et al. 2012; Simon et al. 2010). Recently, a 
method was developed that efficiently extracts OH-PCB/PBDE metabolites while 
limiting the co-extraction of lipids and almost eliminating the interferences with 
the TTR binding assay (Montaño et al. 2012). This extraction method coupled to an 
improved fluorescence based TTR competitive assay (ANSA-TTR) was successfully 
developed and validated with standards of POPs (Montaño et al. 2012). This 
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development has opened the possibility to test TTR binding potency of 
metabolically activated extracts. 
The current research investigates the role of metabolic activation on TTR 
competitive binding potency of polar and nonpolar sediment extracts from highly 
or less contaminated sediments in Luxembourg. The extracts were either roughly 
split into a lipophilic and polar fraction using solvent partition fractionation, or 
fractionated into eight sub fractions with increasing polarity by normal phase HPLC. 
The model compounds CB77 and BDE47 and the sediment fractions were tested for 
TTR binding potency before and after metabolic activation with rat S9 microsomes 
as positive controls. The TTR competitive binding potency of the metabolic extracts 
was tested in a recently developed non-radioactive 96-well plate ANSA-TTR assay, 
including removal of lipids from the extracts to avoid interferences in the assay. 
The responses were expressed as nmol thyroid hormone (thyroxine, T4) 
equivalents/g sediment equivalent (nmol T4-Eq/g SEQ). 
Materials and Methods 
Chemicals. The model compounds 3,3´,4,4´-tetrachlorobiphenyl (CB77, 99.0%) and 
2,2´,4,4´-tetrabromodiphenylether (BDE47, 98.8%) were purchased from Sigma-
Aldrich Co. (Steinheim, Germany) and Chiron AS (Trondheim, Norway), 
respectively. The CB77 metabolite 4´-OH-3,3´,4,5´-CB79 (4´-OH CB79) was 
purchased from LGC Promochem (Middlesex, UK). Hexane (Hx, dioxin analysis 
grade) and all other solvents (chromatographic grade) were purchased from 
Biosolve BV (Valkenswaard, The Netherlands) or from Sigma-Aldrich Co (Steinheim, 
Germany). Stock solutions were prepared in dimethyl sulfoxide (DMSO) and 
methanol (MeOH)?? ?-Nicotinamide adenine dinucleotide ??-phosphate reduced 
tetrasodium salt hydrate (NADPH), 3,3´,5,5´-tetraiodo-L-thyroxin (T4), human 
transthyretin (TTR), lipid removal agent (LRA) and the fluorescent probe 8-anilino-
1-naphthalenesulphonic acid ammonium salt (ANSA) were purchased from Sigma-
Aldrich Co (Steinheim, Germany).  
Concentrations of T4 and ANSA were routinely determined in cuvettes by UV-visible 
spectrometry with a Beckman Coulter DU 800 spectrophotometer. Extinction 
coefficients were 6180 M??cm?? at 325 nm in phosphate buffer (PB) and sodium 
hydroxide (NaOH) at pH 11 for T4 (Nilsson et al. 1975) and 6300 M??cm?? at 350 nm 
in PB at pH 7.5 for ANSA (Cao et al. 2010). All extraction and storage materials were 
exclusively made of borosilicate glass and polytetrafluoroethylene screw cap vials 
were used when required. All materials were prewashed with hexane. Sand from 
Fontainebleu (Paris, FR) was dried overnight at 105oC and extracted twice with the 
ASE method described below to obtain clean sand. 
Sediment sampling and preparation. Sediment samples were collected in 2010 and 
2011 from 30 locations at the rivers Alzette, Our, Clerve and Woltz in The Grand 
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Duchy of Luxembourg. A subset of locations was selected to exemplify sediments 
with a range of contamination profiles and levels from industrial/urban (Alz 1, Alz 
10 and Alz 15), urban (Alz 17), agricultural (Our 3) and woodland (Woltz 1) locations 
(Figure 1). Location labels correspond to the sampling position along the river and 
the overall codes from the full sampling campaigns were unchanged to allow 
comparison with other reports and publications.  
Composite samples of 4 cm deep surface sediments were collected manually from 
natural sedimentation zones covering at least 50 m along the river course. At least 
8 sub-samples were mixed (1 kg), transported and stored in glass flasks at 4°C. The 
samples were transferred into aluminium plates, frozen at –20°C and then dried 
using an Alpha 2-4 LSC freeze-dryer (Christ, Germany) for at least 48 hours. The 
???? ???????? ??????????????? ???????????????? ?????????????????????? ???????????
fraction was stored in darkness at 4oC into glass bottles until extraction. 
Extraction. A total of 5 g of ???????dried sediment from each location and cleaned 
sand were extracted with Hx and acetone (Ac, 3:1, v/v) with accelerated solvent 
extraction (ASE200; Dionex, Sunnyvale, CA, USA) with three extraction cycles at 
100oC at 2,000 psi (Houtman et al. 2007). A mixture of 2 g dried  sodium sulphate 
Figure 1. Sediment sampling sites within the Grand Duchy of Luxembourg. Samples were taken from the 
rivers Alzette (Alz, industrial/urban), Our (agricultural) and Woltz (woodland). 
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(Na2SO4) to eliminate remaining moisture and 1 g of Cu powder (Sigma-Aldrich Co., 
Steinheim, Germany) for sulphur removal were added into the ASE collection 
bottles. The bottles were rotated for 30 min, then transferred over a dried Na2SO4 
filled funnel, flushed with additional 10 mL Hx:Ac (3:1 v/v) and evaporated until 
near dryness under vacuum.  
Solvent partition fractionation. Polar and nonpolar fractions were obtained as 
previously described (Legler et al. 2002). Briefly, the dried ASE-extract was washed 
twice with 1 mL Hx. The hexane portions were combined, then filtered through a 1 
g Na2SO4 filled Pasteur pipette to retain hexane insoluble particles, and evaporated 
??? ???? ??? ?????? ?? ??????? ?2 flow (nonpolar fraction). The remaining acetone 
soluble precipitate was dissolved in acetone, filtered through the same 1 g Na2SO4 
filled Pasteur pipette to re-dissolve the particles carried with the hexane, and 
evaporated under a gentle N2 flow to near dryness (polar fraction). The nonpolar 
fraction was further cleaned with a multilayer sulphuric acid silica column 
(Houtman et al. 2004), which consisted of 1 g Na2SO4 on top of 3 g 33% sulphuric 
acid silica on top of a silanized glass wool plug. The column was activated with 8 mL 
of Hx:diethyleter (DDE, 97:3). The extract was transferred into the column including 
?????????????????????????????????????????????????????? ?th 8 mL of solvent. Both the 
rinse and the eluate were collected into a cleaned tube and evaporated under a 
gentle N2 flow to near dryness. The cleaned nonpolar fraction and the polar 
fraction were transferred into 250 μL of DMSO to obtain extracts at 20 g sediment 
equivalents (SEQ)/mL. Extract stocks were stored at 4oC until bioassays were 
performed. 
GPC-NPC fractionation. ASE-extracts were cleaned up using Gel Permeation 
Chromatography (GPC) equipped with two polystyrene-divinylbenzene columns in 
series (??? ???? ??? ??? ??? x 25 mm, Polymer Laboratories) and with 10 mL/min 
dichloromethane (DCM) as eluent (Houtman et al. 2002; Weiss et al. 2009). The 
major part of the matrix elutes in the first fraction up to ca 18 min following 
injection. Based on the results of the elution profile of test compounds (Houtman 
et al. 2002) the fraction 16:30 – 24:00 min was collected. 
Each GPC fraction was fractionated into eight sub-fractions with increasing polarity 
by Normal Phase (NP) High Pressure Liquid Chromatography (HPLC) as previously 
described (Fernandez and Bayona 1992). A semi-preparative column (Waters 
?????????? ???? ?? ???? ???? ????????? ????? ??? ???? ????? ???? ?????????? ????? ????????
(Weiss et al. 2009); mobile phase initially 100% Hx (5 min), 1%/min of DCM for 5 
min, 4%/min of DCM for 25 min to 100% DCM (10 min) followed by 10%/min of 
acetonitrile (ACN) for 5 min, and then back to 100% DCM (5 min) and finally 
6%/min to 100% of Hx to re-equilibrate (10 min). The fractions collected were at 
time 0-4 min (F 1), 5-17 min (F 2), 18-22 (F3), 23-26 (F4), 27-31 (F5), 32-40 (F6), 41-
54 (F7) and 55-70 min (F8). Fractions were evaporated under a gentle N2 flow to 
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near dryness and then transferred into 250 μL of DMSO to obtain fractions at 20 g 
SEQ/mL. Extract stocks were stored at 4oC until bioassay.  
Metabolic activation and metabolite extraction. In vitro bioactivation of PCBs and 
PBDEs has been described (Murk et al. 1994) and was applied with few 
modifications as published (Montaño et al. 2012). Briefly, incubations were made in 
a borosilicate glass tube with 1 mL PB (100 mM, pH 7.5), S9 fraction (1 mg 
protein/???? ?-napthoflavone and phenobarbital treated rats, Xenotech, KA), and 
10 ?? extract or compound solution to obtain 1% DMSO. The tubes were pre-
incubated at 37°C for 5 min and incubated for 60 min with the addition of 100 ?? of 
10 mM NADPH in PB every 20 min. Metabolism was stopped by denaturation of 
microsomal proteins with 700 ?? of ice-cold MeOH and the metabolites extracted 
according to a recently published low-fat method for metabolite extraction 
(Montaño et al. 2012). Briefly, the fat was flocculated with 50 ?? of 10% dextran 
(Leuconostoc spp., Sigma-Aldrich, Steinheim, Germany) and the protein 
denaturated with 50 ?? of 6M HCl. Metabolites where extracted with 2x1 mL 
Hx:MTBE (1:1, v/v). The extract was transferred into a test tube with 1 mL of 
potassium chloride (KCl) in water (1%, w/w) and after centrifugation transferred 
again into a clean tube. The KCl was re-extracted with 1 mL of solvent and after 
combination of the organic phases reduced to about 50 ?? extract (20 mg 
equivalent (mg-eq) protein/mL) under a gentle N2 flow. The incubation extract was 
further cleaned-up with a lipid removal agent mini-column (Montaño et al. 2012) 
made of 0.8 g of LRA and 0.3 g of Na2SO4 packed on top of a glass wool plug in a 
Pasteur pipette. The mini-column was pre-washed with 2 mL of Hx:MTBE (1:1), 
then the extract was quantitatively transferred into the column and the tube was 
washed with 2x150 ????????:MTBE. The column was further eluted with 1600 ?? of 
the same solvent, which were collected into a prewashed test tube, dried under 
gentle N2 flow, and re-dissolved in 50 ?? MeOH, which corresponds to 20 mg-eq 
protein/mL and 4 g SEQ/mL.  
Every metabolic activation experiment included a blank incubation with DMSO (S9 
blank), recovery controls with various concentrations of spiked 4-OH CB 79, 
metabolic activation controls with spiked CB77 or BDE??? ??? ????? ???? ?????????
controls with either POP or sediment fractions where denaturation was done at 
time zero.  
The enzyme transformation rates (6-30 pmol metabolites per mg protein-1 mL-1) are 
the limiting factor in the metabolic incubation. Therefore, above a certain 
threshold, increasing amounts of metabolically labile POPs in the sample will yield 
the same amount of metabolites and therefore the extracts will produce equal TTR 
binding activity. Serial dilutions of the incubation extract are hence not useful to 
calculate the TTR competitive potency in relation to sediment concentration. 
Instead, serial dilutions of the fractions were prepared in DMSO followed by 
duplicate incubations of each dilution incubated separately to find the 
Increased THD potency of bioactivated nonpolar sediment fractions 
 153 
concentration for which the TTR binding activity was not different from the S9 
blank. 
Sediment fluorescence interference. It was checked whether the sediment fractions 
could possibly give a fluorescence signal that would disturb the ANSA-TTR assay 
measurement. Sediment fractions were serially diluted up to 4000 times in MeOH. 
These dilutions were mixed with 100 ?? PB at pH 7.5 in a round-bottom 96-well 
plate (Greiner Bio-One) and had a MeOH final solvent concentration of 2.5%. The 
fluorescence was measured with a 380 ± 20 nm filter, and the emission was 
measured with a 475 ± 20 nm filter. Sediment fluorescence interfered with the 
ANSA-TTR assay even after the metabolic incubation extraction. Therefore, the 
highest sediment concentration which produced a signal below the MeOH control 
values plus three standard deviations was chosen as the highest concentration to 
be tested in the ANSA-TTR assay.  
ANSA displacement assay. A recently published non-radioactive 96-well plate 
method was used for the measurement of TTR competitive binding (Montaño et al. 
2012). The ANSA fluorophore increases its fluorescent yield when bound to 
transport proteins like TTR whereas the signal is reduced when the ANSA is 
displaced by competition with thyroid hormones and some halogenated phenolic 
contaminants. Sediment fractions, metabolically activated extracts or controls 
diluted in MeOH were mixed ????????????????????????????????????????? PB at pH 
7.5 in a round-bottom 96-well plate (Greiner Bio-One). All tests were performed in 
triplicate and at 2.5% final MeOH concentration. After 2 h of incubation at 4°C, the 
plate was gently shaken for 10 s and measured in a Biotech Synergy 2 plate reader 
(Winooski, VT). ANSA fluorescence was excited using a 380 ± 20 nm filter, and the 
emission was measured with a 475 ± 20 nm filter. Negative controls without TTR, 
ANSA-TTR positive controls, and 0, 100, and 600 nM T4 displacement controls were 
included on every plate to calibrate the different exposure plates.  
Data analysis and statistics. Competitive binding was expressed as T4 equivalents (T4-
Eq), which was calculated with responses between 20% and 70% competitive 
binding by interpolation into a T4 standard curve. The highest stock concentration 
that is tested for all sediment extract fractions is the concentration that can be 
tested without interference from auto-fluorescence in the ANSA-TTR assay. In 
combination with the limit of detection of compounds in the ANSA-TTR assay this 
determines the limit of detection per g of sediment equivalent (SEQ). Therefore the 
limit of detection differs between the samples. The potency of metabolically 
activated fractions was expressed based on the lowest fraction concentration 
capable to produce a significant competitive binding compared with the S9 blank. 
This sediment concentration was equated to the T4 concentration which produced 
a signal at the limit of detection to provide a conservative estimate of the fraction 
potency expressed as nmol T4-Eq/ g SEQ. Comparisons with ANSA-TTR (for S9 blank, 
recovery and positive controls) and comparison with S9 blank (for metabolically 
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activated fractions) were assessed with ANOVA followed by Dunet’s post hoc 
comparison (SPSS Inc.). Graphs were made in SigmaPlot® (SPSS). 
Results and Discussion 
Background fluorescence of sediment extracts 
The highest concentrations of sediment extracts that did not interfere with the 
ANSA-TTR fluorescence measurement at 380 nm varied greatly between samples 
(Figure 2), from: 0.5 (Alz 1) to 500 (Our 3 and Woltz 1) mg SEQ/mL DMSO stock 
(Table 1). For every location the crude polar extracts showed higher background 
fluorescence than the nonpolar extracts (Table 1, solvent fractionation), probably 
due to residual humic substances in the extract and/or total hydrocarbon content, 
particularly substituted PAHs (Law 1981; Patra 2003). 
  
The GPC-cleaned HPLC-NP fractions with the highest fluorescent signal were F2-3 
and F6-7 which corresponded to fractions containing PAHs (F2), nitro substituted 
PAHs (NO2-PAHs, F3), quinones (F6) and nitrogen heterocycles (N-PAHs, F7) 
(Fernandez and Bayona 1992). Fractions with the lowest fluorescence signal 
contain long chain alkyl benzenes and PCBs (F1), Keto-PAHs and quinones (F4-F5), 
OH-PAHs and tertiary N-PAHs (F8) (Fernandez and Bayona 1992).  
 
Figure 2 Background fluorescence in cleaned nonpolar (A) and polar (B) sediment extracts prepared 
with solvent partition. Data represent the relative fluorescence units (RFU) (380nm excitation and 
475nm emission) relative to the control solvent (MeOH) (set  to one) ± standard deviation from two 
independent experiments performed in triplicate. The arrow indicates the maximum concentration 
tested in the ANSA-TTR-assay (also see Table 1). 
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The fluorescence of nonpolar sediment fractions is suggested to indicate the 
degree of contamination with PAHs (Patra 2003). Our results are in accordance 
with this hypothesis, as a decreasing pollution gradient has been reported from 
upstream to downstream Alzette samples (from Alz 1 to Alz 17, Table 1). Our 3 and 
Woltz 1 sediments are from non-industrial areas and have accordingly low PAH-
levels (Zheng et al. 2011). The extracts from solvent and HPLC-NP fractionations 
showed similar profile of responses (Table 1). 
Table 1 
Highest concentration of sediment extract equivalent per mL of DMSO stock (mg SEQ/mL) with a 
fluorescence signal below the solvent control in the ANSA-TTR assay 
  Alz 1 Alz 10 Alz 15 Alz 17 Our 3 Woltz 1 
Solvent fractionation   
Clean nonpolar 0.5 100 100 100 250 250 
Polar 1.2 25 25 25 100 100 
GPC-NPC fractionation   
F1 25 100 100 100 100 500 
F2 0.5 0.5 5.0 5.0 5.0 25 
F3 1.2 100 5.0 100 500 1.2 
F4 1.2 100 100 100 500 500 
F5 1.2 100 100 100 500 100 
F6 0.5 5.0 5.0 100 100 25 
F7 0.5 5.0 25 100 100 100 
F
8 
5.
0 
10
0 
10
0 
10
0 500 5.0 
TTR binding by sediment extract fractions. 
Figure 3 TTR competitive dose responses from sediment solvent fractions. Non auto-fluorescent dilutions of 
nonpolar (A) and polar (B) solvent fractions in the ANSA-TTR assay as relative fluorescence units (RFU) relative 
to the solvent control with ANSA and TTR set at one. Responses for with background fluorescence (above 
given in Table 1) are indicated with a @. The data represent the avg ± std from two independent experiments, 
measured in triplicate. The zero value corresponds to maximum replacement by 600 nM T4 in the MeOH 
control. 
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To determine the TTR-binding potency of compounds present in the sediment 
extract fractions before metabolic activation, at least six non-fluorescent dilutions 
of each sediment fraction were tested in the ANSA-TTR assay. Sand control extracts 
did not displace ANSA-TTR. The limit of detection (LOD) for T4 in the ANSA-TTR was 
60 nM and the maximal SEQ-concentration that could be tested for each sample 
differed based on the back-ground fluorescence (Table 1), hence the LOD for the 
sediment fractions ranged from 0.12 to 120 nmol T4-Eq/g SEQ (Table 2).  
Extract fractions that did displace ANSA-TTR florescence, did so in a dose 
dependent manner, and the extracts that were tested in a concentration above the 
maximum concentration given in Table 1 clearly produced an auto-fluorescence 
increase (Figure 3). Figure 4 presents the TTR-binding potency of the sediment 
extract fractions, which is up to 80 nmol T4-Eq/g SEQ without bioactivation. The 
gradient for decreasing pollution from Alz 1 to Alz 17 clearly is reflected, as are the 
low toxic potencies for the non-industrial areas Our 3 and Woltz 1 that barely gave 
a response above the LOD. For the more polluted Alz 1 and Alz 10 sediments, the 
nonpolar extracts clearly gave a much lower response than the polar extracts 
(Figure 4). 
Figure 4 TTR competitive binding of sediment fractions. Fractions from solvent fractionation (nonpolar and 
polar) and from GPC-NPC fractionation (F1 to F8) were measured in the ANSA-TTR displacement assay at non-
autofluorescent concentrations. Data represent the TTR binding potency expressed as nmol T4 per gram of 
sediment equivalent (SEQ) ± std from two independent experiments measured in triplicate. # represent 
responses below limit of detection (<LOD). ? response beyond figure-axis value. Note the differences in scale 
between the Alz- and the non-industrial locations. 
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Although more detailed, the same results were visible for the GPC-cleaned HPLC-
NP fractions, which were also from <LOD up to 96 nmol T4-Eq/g SEQ (Figure 4). TTR 
competitive binding was primarily observed for F4 to F7 whereas less polar 
fractions (F1 to F3) had none or low activities (Figure 4). It is important to note that 
fractions F2 and F3 were tested at lower SEQ concentrations due to their auto 
fluorescence (Table 1) and this might be the cause of observed levels below LOD 
compared to other fractions. The observed TTR binding potency profile of GPC-NP 
fractions was in agreement with published results from testing the TTR-binding 
potency in a radio-active method with fractions prepared according to an identical 
separation method (Weiss et al. 2009) and with a similar but multi-separation 
procedure (Lübcke-von Varel et al. 2011). In both cases the majority of TTR binding 
activity was recovered in the polar fractions up to 4 nmol T4-Eq/g SEQ (Lübcke-von 
Varel et al. 2011). The active compounds present in the polar sediment fractions 
should be further studied to determine whether they are hazardous. They might be 
natural compounds of plant origin that will be easily metabolized and excreted and 
thus never pose a risk to sediment-associated aquatic organisms and their 
consumers including humans. EDA is currently being applied to identify the 
compounds causing TTR competitive binding in polar fractions (Weiss et al. 
Unpublished). 
TTR binding by metabolically activated sediment fractions 
The S9 blank incubation produced a small but not significant competitive binding to 
TTR. Figure 5 shows that the recovery and response of the spiked 4-OH CB 79 was 
good, as was the ANSA-TTR displacement response of the bioactivated extracts 
from the S9-mix spiked with the positive controls CB77 and BDE47 in agreement 
with recently published results (Montaño et al. 2012). 
TTR binding potency of solvent partitioned polar fractions and all GPC-NP fractions 
except F1 were in general not modified or lower after metabolic activation. 
Residual fluorescence was observed in fractions F2, F3, F6 and F7 even after 
metabolic incubation and low fat extraction; therefore, dilutions below 1 g SEQ/mL 
were used for ANSA-TTR analysis. Metabolic activation of PAHs present in these 
fractions, if any, might have not been detected. 
Table 2 shows the LODs and the potency of the solvent partitioned nonpolar and 
the HPLC-NP F1 fractions before and after biotransformation. The assay LODs after 
biotransformation were higher  mainly because of required additional dilution of 
the S9-extracts (Montaño et al. 2012) and because of residual fluorescence (Table 
2).  
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Table 2  
Limit of detection (LOD) and TTR binding potency before and after metabolic activation of solvent 
partitioned nonpolar and HPLC-NP F1 fractions of sediments expressed in nmol T4-Eq/g SEQ. 
 Solvent partitioned nonpolar HPLC-NP F1 
 LOD a Potency b LOD a Potency b 
 Before After Before After Before After Before After 
Alz 1 120 60 <LOD 60 2.4 12 17 120 
Alz 10 0.60 60 6.1 <LOD 0.60 12 0.89 60 
Alz 15 0.60 6.0 <LOD 60 0.60 12 <LOD 12 
Alz 17 0.60 1.8 3.1 6.0 0.60 12 0.60 240 
Our 3 0.24 1.8 1.0 5.9 0.60 12 <LOD 240 
Woltz 1 0.24 1.8 0.84 5.9 0.12 12 <LOD 12 
a LODs were calculated with the ANSA-TTR limit of detection (see materials and methods) and the maximal 
sediment concentration in Table 1. 
b The potencies are expressed as nmol T4 Eq/mg SEQ. 
 
 
Figure 6 provides two examples of the dose related response of incubation extracts 
from separate fraction dilutions. Increased displacement of ANSA-TTR fluorescent 
binding was observed for all cleaned nonpolar and F1 fractions of sediments after 
metabolic activation (Table 2). An exception was the metabolically activated 
nonpolar fraction from Alz 10 for which the tested bio activated sample had a 
response below the LOD. Most likely due to the use of a 25 times diluted extract 
after metabolic activation compared to the original nonpolar solvent partitioned 
extract to avoid background fluorescence. Higher fluorescence of nonpolar extracts 
after metabolic activation might also indicate the formation of more fluorescent 
Figure 5 ANSA displacement from TTR by 
metabolic incubation controls. DMSO-
spiked S9 blank,, spiked 4-OH CB 79, and 
metabolically activated CB 77 and BDE 47 
were incubated with rat S9 liver fraction 
from which the metabolites were extracted, 
cleaned and transferred into MeOH for 
measurement in the ANSA displacement 
assay at a final concentration of 0.5 mg-Eq 
protein/mL. Data represents the relative 
fluorescence units (RFU) std from at least 
three independent experiments with 
duplicate S9-incubations, measured in 
triplicate. Maximal fluorescence without 
inhibitor is set at 1, maximal displacement 
by 600 nM T4 is set at 0. * is significantly 
different from control (P<0.05). 
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metabolites. This will not be one of the classical POPs such as PCBs and PBDEs as 
the increase in fluorescence did not occur in the HPLC-NP fractionated F1 fraction. 
It would be interesting to apply EDA to identify which fluorescent compounds are 
produced after biotransformation. 
 
Applicability of biotransformation and in vitro testing of sediment extracts 
The TTR competitive binding potencies of solvent partitioned nonpolar extracts and 
HPLC-NP F1 fractions from all locations were 10 to 100 times higher after metabolic 
activation than the potency of the same fractions without activation. This thyroid 
hormone disrupting potency of POPs accumulated in the sediment would have 
been unnoticed without metabolic activation, resulting in an underestimation of 
the toxic hazard for animals exposed to these compounds. For several species of 
aquatic organisms including fish and mammals direct or indirect (via the food 
chain) accumulation of sediment-associated POPs has been shown. They are able 
to metabolize them into OH- POPs right after absorption, after POP mobilization 
from lipid depots during migration (van Ginneken et al. 2009), or during larval 
development before becoming free feeding (Foekema et al. 2012). Once produced 
Figure 6 Examples of displacement of ANSA-TTR fluorescence by metabolically activated HPLC-NP F1 
sediment extracts. Various dilutions of cleaned nonpolar and HPLC-NP F1 fractions were incubated with 
S9 microsomes. Blank corresponds to the S9 blank whereas Neg corresponds to the incubation of the 
highest concentrations of the sediment fraction where incubation was stopped at time = 0. The 
metabolite extracts were diluted in MeOH and measured in the ANSA-TTR displacement assay. Data 
represents an example of the relative fluorescence units (RFU) relative to the positive control with ANSA 
and TTR (equal to one) ± standard deviation from two separate experiments, with duplicated incubation 
measured in triplicate from the HPLC-NP F1 fractions of Alz 17 and Our 3. * is significantly different from 
S9 blank (P<0.05) 
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OH- metabolites tend to be retained in the body bound to TTR where they are 
relatively protected from further metabolism (Montaño et al. 2013) and even can 
cross the placenta and blood brain barrier (Meerts et al. 2002; Morse et al. 1993). 
Because of this, and the many studies relating OH-metabolites to several of the 
observed POP effects (Dingemans et al. 2011; Fonnum et al. 2006), it is vital to 
include the bio activation of POPs in sediment hazard identification and 
quantification. 
The approaches presented in our study allow a semi-quantitative detection of 
potential hormone disrupting POPs that until now were unnoticed. Further 
developments could make the approach quantitative. One of the limitations of the 
currently applied in vitro metabolic activation based on S9 microsomes (Montaño 
et al. 2012) or recombinant CYP enzymes (Erratico et al. 2011) is the low metabolic 
activation efficiencies of about 5% (Murk et al. 1994). Although the presently 
applied low-fat extraction method allows further concentration of the extract than 
before (Montaño et al. 2012) and allowing good classification of the THD potency 
of sediments, it is not yet possible to produce a full ANSA-TTR dose-response curve 
due to the low in vitro OH-metabolite yield. Technical improvements could include 
other methods for biotransformation possibly in combination with specific 
extraction of TTR-binding compounds as happens in vivo. 
We currently applied 2 methods for separation of the nonpolar POPs, solvent based 
partitioning and HPLC-NP based fractionation. The first method is fast, cheap and 
easy but yields more crude nonpolar extracts than the second method that yields a 
more specific nonpolar fraction and also is a good basis for further identification of 
the active compounds. A new fractionation method combining the advantages of 
both methods could reduce the problem of background fluorescence, therefore 
increasing the method sensitivity and dynamic range. However, the currently 
presented methods allow a fast screening of sediments for the risk of potential 
THDCs that are not yet detected with the in vitro and chemical tests currently 
applied.  
Our results demonstrate that metabolic activation of nonpolar POPs present in 
sediments should be considered in a more realistic risk assessment framework of 
sediments. 
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Exposure to chemical mixtures occurs simultaneously, sequentially and chronically 
(Mumtaz 2010). Examples where there is a need of complex mixture assessment are food 
and drinking water compliance with regulations and dredged soils safety. Policy makers 
and governmental agencies are therefore faced with the need to assess the risk of these 
mixed exposure and the potential effects on human and wildlife wellbeing and health. As 
policy makers and risk assessors take decisions upon risk characterization results of 
complex mixtures, the methods applied shall be therefore relevant and reliable. 
This thesis aimed to better understand and further improve the relevance and reliability of 
in vitro bioassays for a bioassay-based risk characterisation of complex mixtures, with 
special focus on POPs in sediments. In a meta-analysis of the scientific literature on the 
presence of bio-activated POPs and other hydroxylated phenolic compounds (HPCs) it was 
shown that these HPCs are present in blood of humans and wildlife at concentrations 
equal to or higher than their parent concentrations and these concentrations are similar 
to those inducing in vivo and in vitro toxicological effects (Chapter 2). The importance of 
metabolic activation on the relevance of in vitro bioassays for complex mixture testing was 
demonstrated through the strong increase of the thyroid hormone disrupting (THD) 
potency of persistent organic pollutants (POPs) and lipophilic sediment extracts after bio-
activation (Chapter 3). To be able to solve the persistent problem of co-extractants from 
microsomal incubations interfering binding of thyroxine (T4) with the plasma carrier 
protein transthyretin (TTR) in the competitive T4-TTR binding assays, first, saturated and 
non-saturated free fatty acids were identified as being the interfering factors described 
and discussed in the literature. Secondly a method was developed to remove them with a 
dedicated sample-clean-up. Finally, it was possible to quantify the potency of metabolized 
POPs to competitively bind TTR in a newly developed non-radioactive microtiter ANSA-TTR 
bioassay (Chapter 3).  
Two aspects to improve the reliability of in vitro bioassays for complex mixtures of toxic 
compounds were studied: 1) the occurrence of supramaximal (SPMX) effects that could 
result in overestimation of the toxic potency (Chapter 4a); and 2) the possible 
consequences of overconcentration of sample extracts during solvent change that could 
result in underestimation of the toxic potency (Chapter 5). The result of a meta-analysis of 
SPMX effects in functional in vitro estrogenicity assays revealed that the likelihood of the 
occurrence of a SPMX effect was strongly correlated to the use of specific reporter-gene 
assays (Chapter 4a). The relevance of this finding was discussed as well as an approach to 
reliably use these assays to quantify estrogenic potencies. To study a possible mechanism 
behind the SPMX mechanism, a 96-well plate cellular efflux pump inhibition assay (CEPIA) 
was adapted for the dioxin-like DR.Luc cells.  Although the cells were sensitive for p-
glycoprotein (P-gp) efflux pump inhibitors, no relationship was found with SPMX effects in 
this cell line (Chapter 4b). The study of the influence of the initial sediment extract stock 
concentration revealed that the use of concentrated stocks, above 20 g sediment 
equivalents (SEQ)/mL DMSO resulted in an underestimation of the obtained bioassay 
TCDD equivalents (Bio-TEQs). Overload of clean-up columns impaired proper quantitation 
of the toxic potency of sediments due to residual contaminants and sonication assisted 
dissolution reduced the results variability in the analyses (Chapter 5).  
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The approaches, methods and concepts developed in this PhD contribute to a more 
realistic and reliable in vitro bioassay-based risk characterisation of nonpolar sediment 
extracts (Chapter 6).  
The importance of being relevant  
When important or costly decisions have to be based on certain testing methods, the 
method relevance is one of the two validation components that are relevant according to 
the international harmonized criteria (OECD 2005). In this thesis the focus for the 
method’s relevance was on the often not considered bio-activation of the lipophilic parent 
compounds which has been recognised to be crucial for the potential toxicological effect 
of pollutants (Coecke et al. 2006; Murk et al. 2013; NRC 2007). 
Relevance of POP bio-activation: evidence from human and wild life exposure 
A lot of evidence is available that  halogenated phenolic compounds (HPCs), including 
naturally, commercially and metabolically produced OH-PCBs, OH-PBDEs, 
pentachlorophenol (PCP), and tribromo-phenols (tri-BPhs), are highly present  in human 
and wildlife plasma (Chapter 2, Bergman et al. 1994; Letcher et al. 2010; Montaño et al. 
2013a; Sandau et al. 2000) and that they are responsible for at least an important part of 
the endocrine disrupting potential of POPs (Dingemans et al. 2011; Fonnum et al. 2006). 
However, metabolites are rarely reported or considered in risk assessment together with 
the parent compounds whereas they are remarkably similar to thyroid hormones (TH) and 
therefore capable to interact and interfere at different levels with the TH system (Murk et 
al. 2013).The cumulative concentration of HPCs in plasma ranged from 0.1 to 100 nM in 
humans, up to 240 nM in birds, 454 nM in fish, 800 nM in cetacean and 7650 nM in 
cetaceans and other mammals. These HPC levels are at effect level in in vitro or in vivo 
bioassays, but in addition a quality of toxicological concern is the fact that these 
compounds can be actively transported to the fetus and brain because they competitively 
bind to T4 plasma transport proteins (Meerts et al. 2002; Morse et al. 1995). When bound 
in these proteins the HPCs are relatively protected against further metabolism. The 
explains why the ratios of metabolites to putative parent compounds were higher for fetal 
tissues such as eggs and umbilical cord, which is of great concern given the sensitivity for 
developmental toxicity of these early life stages.  Binding to the plasma transport proteins 
TTR and thyroid hormone binding globulin (TBG) is not the only way OH-POP and other 
HPCs can interfere with the thyroid hormone system. The HPCs can also interfere with 
enzymes in charge of TH deiodination or conjugations and with the thyroid hormone 
receptor (TR) activity (Murk et al. 2013), and with other endocrine targets such as steroid 
glands and induce alteration of neuronal development (Dingemans et al. 2010; Freitas et 
al. 2011; Song et al. 2008). 
Coastal populations, including birds, typically had higher concentrations of brominated 
HPCs especially of naturally produced ortho OH-PBDEs (Chapter 2, Montaño et al. 2013a). 
This observation confirmed the suggestion that that OH-BDEs found in marine organisms 
and humans originate also from naturally occurring OH-PBDEs and biotransformation of 
naturally occurring MeO-PBDEs (Liu et al. 2012; Wan et al. 2009; Wiseman et al. 2011). 
Inland populations were characterized by higher proportions of meta- and para- OH-PBDE 
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congeners which confirms the existing evidence of metabolism of PBDEs as their source 
(Marsh et al. 2006; Qiu et al. 2007). 
The HPC blood burdens were expressed in molar units to allow comparison with relevant 
in vitro and in vivo effect concentrations which  are within the nM range or even below 
the reported HPC burdens in blood (Chapter 2, Montaño et al. 2013a). Given the revealed 
toxicological relevance of HPCs, it becomes evident that POP bio-activation is important 
for bioassay-based THD risk characterization of POPs.  
Relevance of POP bio-activation: evidence from in vitro bioassay testing  
In order to be able to in vitro test the potential hazard of POPs after in vivo 
metabolisation, an approach had to be developed to get rid of co-extractants from the 
microsomal incubation that interfere with in vitro testing of disruption of thyroid hormone 
binding to plasma carrier proteins. First a thorough chemical analysis was performed to 
identify and quantify the saturated and not saturated fatty acids and with cholesterol 
which were suggested to be the most problematic co-extractants (Chapter 3, Montaño et 
al. 2012a). Next, it was confirmed that the nM concentrations of these co-extractants in 
the microsomal extract were indeed the major cause of interference in the TTR 
competitive binding assay was. To solve this problem, a new clean-up method was 
developed which strongly reduced the residual concentration of free fatty acids by 
including fat flocculation, liquid-liquid extraction, and a lipid removal mini-column. With 
this method a reduction the co-extractant concentrations were reduced up to 20 times 
compared with traditional OH-POP extraction methods (Hamers et al. 2008; Hovander et 
al. 2000; Murk et al. 1994). At the same time the complexity of the clean-up procedure 
was reduced compared to published alternatives (Simon et al. 2010; Simon et al. 2011). 
The extract thus obtained was used in a newly adapted and downscaled non-radioactive 
ANSA-TTR competitive fluorescence displacement assay to quantify the thyroxin (T4) 
equivalents of POP OH-metabolites present in microsomal extracts. This method avoids 
the direct use of T4 when testing extracts, as T4 has been observed to interact with the 
fatty acids as well (Simon et al. 2010). Apart from the benefits of using a non-radioactive 
method; the downscaled ANSA-TTR method is fast (ca. 3 hr instead of overnight) and 
suitable for high throughput screening (Chapter 3, Montaño et al. 2012a).  
Under these conditions, extracts from metabolically activated POPs displaced ANSA-TTR 
fluorescence up to 50%. This allows quantification of the capacity of POPs in lipophilic 
extracts of sediments and other POP mixtures to produce OH-metabolites. This means an 
important step forward in the realistic hazard characterisation of such extracts, as testing 
these extracts without biotransformation would result in false negatives. Negatives 
because hormone-like hydroxylated compounds will not be present in nonpolar fractions, 
false because it is known that several POPs in these extracts such as PCBs and PBDEs are in 
vivo metabolised into hormone-like hydroxylated compounds. . To be able to obtain full 
TTR competitive dose-response curves, the efficiency of the biotransformation should be 
increased from the current 2-5% to ideally up to 10%. (see discussion below). 
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Including bio-activation in in vitro bioassays for risk characterization 
Any in vitro bioassay intended to determine the potential toxic potency of metabolically 
liable compounds or matrices suspected of containing them, shall be evaluated in regard 
to its metabolic capability when assessing its relevance. The failure to involve metabolic 
activation will severely affect the method’s false negative rate. (OECD 2005) 
The importance of POP biotransformation into THD OH-POP metabolites has been 
confirmed (Montaño et al. 2012a; Montaño et al. b, subm.). But POPs are not the only 
ones and the list is non-exhaustive: pharmaceuticals such as acetaminophen, 
carbamazepine and lidocaine; allergens, pesticides such as methoxychlor and vinclozolin 
and environmental contaminants such as PAHs are bioactivated into potent metabolites 
(Coecke et al. 2006; Jacobs et al. 2008). In addition POP are present in a variety of complex 
matrices which would require metabolic activation for a proper risk characterization; 
including: food, feed, cosmetics, biological fluids and tissues, air deposition, soils etc. 
The most important methods for the application metabolizing systems in in vitro bioassays 
are: in silico, in vitro with subcellular systems, in vitro with self-contained systems, and ex 
vivo with perfused tissues (Jacobs et al. 2008). However, it is not an easy task as the 
paucity of published studies involving the use of exogenous metabolising systems for ED is 
problematic, considering its relevance, and reports up to date are still very scarce. 
Two extensive documents prepared for the ECVAM and the OECD reviewed the 
knowledge and the developments of metabolizing systems for in vitro bioassays (Coecke 
et al. 2006; Jacobs et al. 2008). Therefore, here only important aspects of the inclusion of 
metabolizing systems resulting from this thesis will be discussed. 
How to increase the metabolic yield  
The difficulties experienced to measure OH-POP metabolites from biological matrices have 
been attributed primarily to the low metabolic rates obtained in vivo and in vitro after 
exposure to POPs, something also observed in this thesis (Chapters 2 and 3, Montaño et 
al. 2012a; Montaño et al. b, submitted). Reported in vitro metabolic yield of POPs using 
mixed type induced microsomes has been 4-6% for CB77 (Montaño et al. 2012a; Murk et 
al. 1994), 0.3-2% for BDE47, and ranged from 0.2-1.2% for BDE99 (Erratico et al. 2011; 
2012; Hamers et al. 2008; Montaño et al. 2012a). This metabolic yield is barely enough to 
achieve effect concentrations after extraction, concentration in DMSO and re-dilution of 
metabolites in media (Montaño et al. 2012a). Increasing the time of incubation is no 
solution as the maximum is normally achieved during the first 30 minutes (Erratico et al. 
2011; 2012; Harju et al. 2007). An increase in the protein content would also increase 
considerably the potentially disturbing co-extractants (Montaño et al. 2012a), while the 
use of higher parent compound concentrations may cause substrate inhibition and 
increase the risk of toxicity in the subsequent in vitro assay. Also methods have been 
published in which the NADPH is being recycled during the metabolic reactions. This could 
perhaps increase the amount of metabolites formed without an increase in co-extractant 
residues. 
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An alternative method is the use of readily available specific recombinant CYP450 
enzymes. However, the metabolic yields when using enzyme concentrations from 10-30 
pmol/mL (aprox. 0.25 mg protein/mL) for BDE47 and BDE99 were 0.06-0.1%, which is 
considerably lower when compared with microsomes (Erratico et al. 2011; 2012, 
unpublished results). As the preparations have low protein content, an increase in enzyme 
concentration could render a higher amount of metabolites in the incubation extracts. In 
addition, recombinant CZP450, especially obtained in E.coli, contains a very low amount of 
saturated fatty acids, mainly arachidonic acid, in the enzymatic preparation (unpublished 
results). This extractant derive from neutral phospholipids such as phosphatidylserine is 
one of the most potent among the free fatty acids to bind TTR (Montaño et al. 2012a). 
An important aspect to consider when applying activated microsomal and/or cystosolic 
fraction as a metabolizing system is the potential metabolism of the co-extractants via 
their mixed-function oxidases (MFOs). One of the major co-extractants from microsomal 
incubations is cholesterol (Montaño et al. 2012a) which could be metabolized into 
pregnolenone, which can further be converted into steroid hormones. It is very important 
to consider this potential interference when including this metabolizing system into ED in 
vitro bioassays. Once again, recombinants enzymes can become useful as it is possible to 
exclude the steroidogenic activity from the incubation.  
In summary recombinant CYP450 enzymes could provide solutions to some of the 
problems related to co-extractants and be useful for specific applications, but their lower 
metabolic yield will remain a drawback on their application as metabolizing systems for in 
vitro bioassays. In addition, for high throughput purposes this alternative might be 
impractical as several different enzymes will be required to simulate the full potential 
biological activity.  
When testing the activity of microsomal extracts in cellular functional assays, still about 
95% of the parent compounds are present, which could induce cytotoxicity before the 
metabolites are dosed at effect concentrations (Schriks et al. 2006). To be able to reduce 
the presence of parent compounds, the phenolic fraction from the microsomal incubation 
could be isolated (Hovander et al. 2000). The neutral compounds are extracted first under 
acidic conditions, and then the pH is elevated to neutralize the phenolic substances for 
extraction. Besides the considerable reduction of parent compound concentration this 
technique also reduces cholesterol from the final extracts as a big proportion is removed 
in the neutral extraction step (Montaño et al. 2012a). However, the extreme basic 
conditions of the phenolic extraction caused the hydrolysis of phospholipids and 
triglycerides present in the microsomal incubation, and thereby doubled the amounts of 
free non-saturated and saturated fatty acids in the extract (Montaño et al. 2012a). The 
possible impact of these concentrations of fatty acids on the membrane stability and 
physiological functions of the in vitro bioassay cell model need to be studied before 
drawing conclusions based on the bioassay results. 
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Reliable methods for reliable results 
The method reliability is the other component of method validation according to the 
international harmonized criteria (OECD 2005). As with chemical analyses, it is very 
important to be aware of the specificities of any in vitro assay is the first line of action to 
avoid wrong estimation of the quantified potency of complex mixtures and therefore to 
apply the method in a reliable way for the intended application. Anyone applying in vitro 
bioassays should be aware of recommendations provided by validation protocols and the 
studies analysing the assays most critical parameters, aware of phenomena such as the 
SPMX effect and their potential implications, and also be aware of the alternatives to cope 
with these issues to maintain or even improve the reliability of in vitro assays.  
Reliability improvement of in vitro bioassays has learned lessons from comparable 
developments of chemical analyses that started decades ago. Great advances have been 
achieved with standardization, transferability and reproducibility of in vitro bioassays 
(Besselink et al. 2004; Hoogenboom et al. 2013; Hoogenboom et al. 2006; Houtman et al. 
2006; Van der Burg et al. 2010) up to their inclusion in regulatory testing frameworks (EC 
2006; OECD 1992; OECD 2012; OSPAR 1997). Two aspects that could influence the 
outcome of in vitro bioassay based quantification of toxic potencies, but that are not yet 
tackled in current protocols are: 1) the occurrence sometimes of responses higher than 
the theoretical maximum based on the positive control for the assay (a phenomenon 
referred to as supramaximal (SPMX) effect), and 2) the possible consequences of 
overconcentration of sample extracts during solvent change. 
The potential causes of SPMX effect in in vitro bioassays  
An analysis of the peer-reviewed literature resulted in twenty one compounds which were 
reported at least once to produce SPMX effect in functional in vitro estrogenicity assays. 
This group of SPMX inducers included a variety of chemical structures such as synthetic 
hormones, plasticizers, flavonoids and PAH metabolites (Chapter 4a, Montaño et al. 2010). 
Nevertheless, the end-points, culture conditions and assay characteristics varied greatly 
between assays. 
The correlation of assay variables and the likelihood of producing a SPMX of all reports 
from diethylstilbestrol (DES), genistein (GEN) and bisphenol A (BPA) revealed that its 
occurrence could be related to a number of specific assay characteristics: 1) the type of 
serum used to supplement the exposure medium, 2) the end point used to quantify the 
estrogenic potency (endogenous or transfected). Indeed, a higher incidence of SPMX 
effect on reporter-gene assays was observed, and it was related to the plasmid 
construction characteristics, including 3) the type of transfection, 4) the number of 
response elements  and 5) the promoter nature  (Montaño et al. 2010). There were, 
however, no indications that solvent concentration in culture, exposure period, or cell 
model influenced the occurrence of an SPMX effect. 
Weather SPMX effect is an assay based artefact or a real-life phenomenon with 
toxicological relevance, still is unknown. Interestingly the dose-response curve was 
biphasic, where the maximum of the first part is the same as the maximum of the positive 
control (estradiol). For the Dr-Luc assay it has been demonstrated that activation of 
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protein kinase C and inhibition of protein synthesis can synergistically enhance AhR-
dependent gene expression with standards. The SPMX effect produced by genistein on an 
estrogen receptor (ER) reporter-gene assay (T47D.Luc, Legler et al. 1999) was ascribed to 
post-transcriptional stabilization of the firefly luciferase reporter enzyme, increasing the 
bioluminesence signal. Therefore, it was concluded that the SPMX effect is not a 
biologically relevant phenomenon (Sotoca et al. 2010).  
Sediment extracts have been shown to induce SPMX effects in the DR-Luc assay before 
(Murk et al. 1996). However, none of the potent SPMX inducers genistein or quercetin in 
the T47D.Luc assay (Sotoca et al. 2010) induced or increased the signal of TCDD in the 
DR.Luc assay with hepatoma cells (H4IIE.Luc). This reporter gene cell line has a similar 
gene construction and identical reporter enzyme (Chapter 4b, Montaño et al. 2012b). 
These results contrast with the suggestion that the SPMX effect produced by genistein is 
due to post-transcriptional stabilization of the firefly luciferase reporter enzyme increasing 
bioluminisence signal (Sotoca et al. 2010), although it cannot be excluded that post-
transcriptional regulation of firefly luciferase differs between the hepatoma cells and the 
breast cancer cells.  
Another putative explanation for the occurrence of SPMX was tested, namely inhibition of 
the cellular efflux pumps as has been demonstrated for several compounds that also can 
be found in sediment extracts (Anselmo et al. 2012). Cellular efflux pump inhibition has 
been shown to increase the toxicity of substrates for those pumps by increasing their 
cellular concentrations. Under the DR.Luc assay conditions, however, there was no 
evidence that P-gp efflux pump inhibitors modified or potentiated the activity of TCDD. 
Also genistein nor quercetin, the two potent SPMX inducers on ER-mediated assays, 
influenced the luciferase induction by TCDD (Chapter 4b, Montaño et al. 2012b). It is 
important to know whether the SPMX mechanisms are relevant for the in vivo situation as 
well. However, for the potency quantification for environmental samples it seems to be 
most suitable to quantify the toxic potency in the lower part of the dose-response (Sotoca 
et al. 2008). This approach is supported by the fact that the SPMX dose-response curves 
often are biphasic with a maximum of the first part of the curve at the maximum induction 
level of the positive control. 
Unless a full dose response curve is made from complex matrix extracts, it cannot be 
known whether SPMX effects occur. Single dose analysis is common practice in monitoring 
studies, and it is assumed that the dose-response curves of the sample and the standard 
are parallel and most important that the maximal responses are identical (Windal et al. 
2005). When this is not true, which is common for complex matrices, the quantified 
potency is a function of the dose. To avoid this problem multiple dilutions of a sample 
have to be used to calculate a reliable Bio-TEQ concentration as has been shown for the 
DR.Luc assay (Windal et al. 2005).    
In addition a normalization procedure for DR.Luc assays has been proposed for cleaned 
sediment extracts which gave SPMX effects (Baston and Denison 2011). The described 
method for potency quantification of samples inducing a SPMX signal result in a Bio-TEQ 
quantification closer to chemically obtained results (Baston and Denison 2011). 
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Influence of stock concentration in the potency quantification outcome 
Sediment extracts from the Alzette and the Our rivers in Luxembourg, prepared with 
various initial stock concentrations were analysed in the DR.Luc assay. The concentration 
of the initial stock influenced the quantified potency and the use of concentrated stocks, 
above 20 g sediment (SEQ)/mL caused an underestimation of the obtained Bio-TEQs 
(Chapter 5, Montaño et al., subm.a). These results, along with higher variability when 
excluding dissolution assisted sonication from the protocol supported the hypothesis that 
at higher stock concentrations, part of the active compounds are lost due to 
oversaturation of the DMSO solution. This is expected to occur via precipitation of a 
fraction of the original amount present in the extraction solvent. A high initial extract 
concentration can also overload clean-up columns and impair proper quantitation of the 
toxic potency of sediments. Analysis of samples at longer exposure periods was necessary 
for highly contaminated samples to reduce the impact of metabolic liable compounds such 
as PAHs, even when using the lowest initial stock concentration. 
When testing contaminated samples at initial stock concentrations of 20 or 200 g SEQ/mL 
the extract toxicity would have been underestimated in a way that these locations might 
not be considered for intervention or banning, which would be the decision when they 
were tested at 2 g SEQ/mL. On the other hand, testing without sonication assisted 
dissolution or highly contaminated samples at shorter exposure times would cause an 
overestimation of the quantified potency. Underestimation of the toxic potencies (false 
negative response) is unwanted because of safety risks but unnecessary classification of 
sediments above the SQC (false positive result) may result in unrequired expenses for 
dredging, storage and remediation. 
Suitable sample amounts for reliable results 
Because the initial stock concentration has an important influence on the quantification of 
sediment extracts (Chapter 5, Montaño et al. subm.a), method validation should include 
analysis of the suitable range for the initial sample amount, instead of a single value. 
The first step to limit the influence of sample overload is to choose an initial sample 
weight according to the final risk characterization goal. For example when the goal is to 
determine whether sediment toxicity exceeds the intervention value of 1 ng TEQ/g 
sediment, the initial stock concentration should ideally have 0.5 g sediment equivalent 
(SEQ)/ml of DMSO (Chapter 5, Montaño et al. subm.a). The minimal amount of sample to 
be reliably quantified for a sample with potency at or above the intended goal should be 
calculated.  
Furthermore, already available knowledge about the pollution load of a site, sample 
organoleptic characteristics and the extraction behaviour can provide indications of the 
need of a lower initial stock concentration. The ability to compare results based on 
different sample loads depends on the provision of a validated range of initial sample 
amounts for which the quantified result will remain statistically the same. Otherwise, the 
results might not be comparable. 
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Application of the developed approach for risk characterization of 
sediments 
The concepts developed in this thesis in order to better understand the challenges of in 
vitro bioassay application to complex mixtures, and the tools developed to solve these 
issues, were applied to sediment samples from more or less contaminated sites in 
Luxembourg (Chapter 6, Montaño et al. subm.b). Nonpolar sediment fractions were 
incubated with S9 rat microsomes, and the metabolites were extracted with the newly 
developed method that excludes most of the lipids to avoid interference in the applied 
non-radioactive 96-well plate TTR competitive binding assay. Metabolic activation 
increased the TTR binding potency of nonpolar fractions of POP-polluted sediments up to 
100 times, resulting in potencies up to 240 nmol T4 equivalents/g sediment equivalent 
(nmol T4-Eq/g SEQ). 
The information about contamination levels in Luxembourgish Rivers is in general scarce. 
There have been various publications on metals and PCBs contamination in fish in the 
North of Luxembourg (Boscher et al. 2010; Dauberschmidt and Hoffmann 2001; Hugla et 
al. 1998). There are also data on metals, organic matter, estrogenic substances and 
antibiotics on specific basins available (Kurtenbach and Gallé 2008; Pailler et al. 2008; 
2009). In addition, the Centre de Recherche Public – Gabriel Lippmann has surveyed for 
several years the populations of macrobenthos, phytobenthos, macrophytes and fish for 
the Luxembourgish government (data not published) with the purpose to report within 
the Water Framework Directive (EC 2000). 
The profile of dioxin-like activity observed for the Our River was in close agreement with 
PCB analysis in fish (Montaño et al. subm.a). In addition, the Bio-TEQs from both the 
Alzette and the Our rivers were in agreement with the ecological status as determined by 
the global standardized biological index (IBGN), the pollution sensitivity index (IPS) and the 
river fish index (CRP-GL, unpublished results). Interesting examples of this correlation are 
the two tributaries from the Alzette River joining at the industrial area of Bettembourg, 
the Kälbaach and the Mierbech. Most Alzette tributaries showed considerably lower 
dioxin-like activity in comparison to the main stream, with the exception of these two; in 
agreement with a classification of “bad” ecological status. 
The TTR binding potency from nonpolar sediment samples before and after bioactivation 
were also in agreement with the general contamination profile (Montaño et al. subm.b). 
An exception is the particularly higher TTR binding potency after metabolic activation of 
the Our River sample in comparison with the more dioxin-like active Alzette samples. 
However, this location at the Our River has shown particularly high PCB contamination in 
fish (Dauberschmidt and Hoffmann 2001; Hugla et al. 1998). 
  
Chapter 7 
 180 
Concluding remarks 
Finally, we are confronted with the question whether the lessons learned and the 
methods developed have really made the use of in vitro bioassays more relevant and 
reliable towards a realistic risk characterization of complex mixtures. 
Complex mixtures are diverse in nature and composition; however, the concepts 
developed here have a wider application to other anthropogenic and environmental 
matrices as well as to other chemical products and contaminants. These concepts include 
the toxicological importance of bioactivation for contaminant risk characterization 
(Montaño et al. 2013a; Chapter 2), the relevance of including metabolising system in in 
vitro bioassay testing (Montaño et al. 2012a; Chapter 3), and the influence of sample 
preparation, bioassay method parameters and responses on the risk characterization 
outcome (Montaño et al. 2010; Montaño et al. subm. a; Chapters 4 and 5). 
Although the presently applied low-fat extraction method allows higher concentration of 
the extracts than any method applied before (Montaño et al. 2012a; Chapter 3), and 
results in a good classification of the THD potency of sediments, the amount of 
metabolites produced without getting problems with co-extractants is still not enough to 
produce a full ANSA-TTR dose-response curve. The approach served to prove that 
contradictory in vivo and in vitro bioassay results of the POP contaminants present in the 
nonpolar fraction of sediments were derived from the absence of metabolic activation. 
This demonstrates that a more realistic in vitro sediment THD risk characterization should 
also include testing of bio-activated nonpolar sediment fractions. 
Phenomenon such as the SPMX effect and the influence of initial extract concentration of 
samples will influence the results precision and accuracy (Montaño et al. subm.a; Chapter 
5). These aspects in addition to already described important issues to control the bioassay 
reliability enable the application in vitro bioassays based Bio-TEQs to determine whether 
sediments comply with health and safety standards for humans and the environment. 
An important aspect of this thesis has been the convergence of every topic on increasing 
our understanding of toxicological effects and especially of the POPs stored in sediments 
(Montaño et al. 2012a; Montaño et al. subm.a and b; Chapters 2, 5 and 6).  As a result of 
these studies it is evident that the toxic potency of bioactivated POPs cannot be neglected 
when considering their toxicological effects and should be an integral part of future POP 
risk assessment initiatives to prevent serious underestimation of their hazard. 
The research presented in this thesis contributes to a better understanding of the 
challenges that in vitro bioassay applications face for the risk characterization of complex 
mixtures. New tools to reduce the burden of these challenges have been developed. This 
increases the relevance and reliability of the in vitro methods when applied to complex 
mixtures and therefore renders a more realistic assessment. 
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Future perspectives 
As has been discussed above the application of in vitro bioassays for hazard and risk 
characterisation of complex mixtures have good perspectives when a number of 
important aspects for further improvement of relevance and reliability of the assays and 
the relevance of OH-POPs toxicity will be taken care of.  
The most important issues for further research and development are: 
1. Get better insight in the HPC body burdens of the general human population and 
specific groups at risk including fetuses (umbilical cord blood) and young children. The 
scarce information at present indicates relatively high concentrations of OH-PCBs and 
OH-PBDEs that are of concern. 
2. The relevance of and differences in transfer over the placenta and blood-brain barrier 
of OH-PCBs, OH-PBDEs and other HPCs should be further investigated. 
3. Studies on HPC levels in non-arctic top predators and other important piscivorous and 
carnivorous species are warranted, considering that arctic top predators even hold 
HPC body burdens high enough to saturate their total TH transport protein capacity. 
4. Considering the limitations of chemical analysis of HPCs, bioassays such as the ANSA 
assay developed in this thesis should be applied to blood samples as it might reveal 
the real exposure to and possibly greater toxicological relevance of OH-POPs. 
5. For increased efficiency of analysis the nonradioactive ANSA-TTR 96-well plate method 
to quantify thyroid hormone disrupting potency could be coupled to on-line clean-up 
and fractionation columns. 
6. The low fat metabolite extraction method developed could be adapted for application 
to other biological matrices such as blood. This would facilitate body burden 
monitoring mentioned as priority above.  
7. To be able to judge the relevance of the SPMX responses for the in vivo situation and 
in vitro bioassay responses, further research should be devoted to unravel  its 
mechanism including the relationship with the potency to block efflux pumps of 
several SPMX inducing compounds.  
8. The influence of initial sample stock concentration should be evaluated for all 
currently used in vitro bioassays and matrices tested. 
9. The initial sample quantity should be included in the standard operation protocols of 
in vitro assay methods that are applied for decision making.  
10. Alternative approaches to increase metabolic yield should be developed if exogenous 
metabolizing systems are to be coupled to in vitro bioassays for risk characterization of 
complex mixtures. 
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This thesis aims to better understand and further improve the relevance and 
reliabilityof in vitro bioassaysfor a biobased risk characterisation of complex 
mixtures, with special focus on persistent organic pollutants (POPs) in sediments. 
In Chapter 1 the importance of complex mixture characterization in modern society 
is introduced. The methods available, their current advantages and their 
disadvantages for complex mixture testing are described. With the shift from policy 
oriented chemical testing towards the inclusion of in vitro bioanalysis, important 
challenges have to be overcome to ensure a relevant and reliable quantification of 
the toxic potency of complex mixtures. These challenges are explained in the 
introduction, including the status of development and validation of those aspects 
for reliable testing. One of the main advantages that in vitro bioanalysis has to offer 
is the possibility to quantify the toxic potency of compounds for which chemical 
analytical methods have not or hardly been developed, for example because 
standards do not yet exist. Hydroxylated metabolites of POPs are an example of a 
toxicologically relevant group of compounds that can exert endocrine disrupting 
effects, but they cannot yet be routinely analysed. A selection of yet unsolved 
issues are further studied and discussed in this thesis, as outlined in the “approach 
and structure of the thesis”. 
In Chapter 2 a meta-analysis is performed to study the occurrence and relevance of 
hydroxylated (OH) compounds in humans and wildlife. Reported body burdens of 
halogenated phenolic contaminants (HPCs), including OH-POP in different tissues 
from humans and wildlife species, are reviewed in relation to the concentration of 
their putative parent compounds to be able to reveal relevant exposure routes and 
sub-populations at risk. Highest OH-POP levels were found in blood plasma, and 
highly perfused and fetal tissues. Plasma concentrations of analysed known HPCs 
ranged from 0.1-100 nM in humans and up to 240, 454, 800 and 7650 nM for birds, 
fish, cetaceans and other mammals, respectively. Reported metabolite blood 
plasma levels also are compared with relevant toxicological threshold 
concentrations from toxicological studies, and appeared to fully fall within the in 
vitro (0.05–10000 nM) and in vivo (3-940 nM) effect concentrations reported for 
OH-POPs. Given the sensitivity of early developmental stages, and information 
lacking about the general population, it is advisable to determine HPC background 
blood levels in children and fetal tissue .  
Given the toxicological relevance of the OH-POPs, Chapter 3 aims at providing 
solutions to the long standing problem of the in vitro production and analysis of 
OH-POP metabolite thyroid hormone disrupting (THD) potency via binding to 
plasma thyroid hormone binding proteins (THBPs). In sediments and for example 
seafood, the POPs occur as parent compounds that would only become THD after 
metabolisation (hydroxylation). Several methods have shown the competitive 
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thyroxine (T4) T4 displacement potency of pure metabolites. However, in vitro 
metabolization of, among others, polychlorinated biphenyls (PCBs) and 
polybrominated diphenyl ethers(PBDEs) followed by in vitro quantification of their 
potency has encountered drawbacks related to the co-extraction of compounds 
disturbing the T4-TTR competitive binding assay. The present study identifies and 
quantifies the major co-extractants, cholesterol and saturated and non-saturated 
fatty acids (SFA and ?????????? ??????????????????????????????????????????????????
incubation mixture) following various extraction methods. A new method is 
presented to in vitro metabolise parent compounds into OH-metabolites followed 
by selective extraction of metabolites while four-fold reducing co-extraction of the 
disturbing compounds. In addition a microplate-format non-radioactive 
fluorescence displacement assay was developed to quantify the TTR binding 
potency of the metabolites formed. The effectiveness of the in vitro metabolism 
and extraction of the OH-metabolites of the model compounds CB 77 and BDE 47 
was chemically quantified with a newly developed chromatographic method 
analyzing silylated derivatives of the OH-metabolites and co-extractants. Due to the 
mentioned improvements, it is now possible to make a dose-response curve up to 
50% inhibition with OH-metabolites extracted from bioactivated CB 77 and BDE 47. 
Without taking the toxic potencies of bio-activated POPs into account with 
bioanalysis, the hazard and risk posed by POPs will be seriously underestimated. 
The chapters 4 and 5 are committed to tackle the issues of supramaximal (SPMX) 
responses and sample extract concentration which are crucial to reliably quantify 
of the toxic potencies of complex mixtures with in vitro bioassays. 
A SPMX effect is the phenomenon that compounds induce a maximum response in 
an assay that is significantly higher than that of the positive control. As the positive 
control is used to quantify the toxic potency of a sample, this could result in over-
estimation of its toxic potency. As this has been most elaborately reported for in 
vitro estrogenicity assays, a meta-analysis was performed of such assays, 
compounds and conditions in which the effect is observed (Chapter 4a).For the 21 
natural and industrial chemicals that could be identified as SPMX inducers, the 
culture and exposure conditions varied greatly among and between the assays. 
Relevant information on assay characteristics, however, sometimes lacked. 
Diethylstilbestrol (DES), genistein (GEN) and bisphenol A (BPA) were selected to 
build a database. The meta-analysis revealed that the occurrence of SPMX effects, 
could be related to a number of specific assay characteristics: 1) the type and 
concentration of the serum used to supplement the exposure medium; 2) the 
endpoint used to quantify the estrogenic potency (endogenous or transfected 
reporter gene), 3) the number of EREs (estrogen responsive elements) used before 
the reporter gene, and 4) the nature of the promoter’s. There were no indications 
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that solvent concentration in culture, exposure period or cell model influenced the 
occurrence of SPMX. It is important to understand the mechanism behind this 
phenomenon because in vitro assays for estrogenicity are used extensively to 
characterize and quantify the estrogenic potency of compounds, mixtures and 
environmental extracts.  
Several SPMX inducers also have been reported to block cellular efflux pumps in 
vivo and in vitro (Anselmo et al. 2012; Georgantzopoulou et al. 2013). Therefore it 
was hypothesized that efflux pump blockers present in environmental matrices 
could increase the internal concentration of bioassay agonists and thus cause the 
SPMX. In Chapter 4b this hypothesis was tested by adapting a 96-well plate cellular 
efflux pump inhibition assay (CEPIA) to the H4IIE rat hepatoma cell line used for the 
DR.Luc reporter gene assay for dioxin-like compounds. The influence of various 
environmentally relevant efflux pump inhibitors on the 2,3,7,8-tetrachlorodibenzo-
p-dioxine (TCDD) response was tested. Under the DR.Luc assay conditions there 
was no evidence that P-gp efflux pump inhibitors modified or potentiated the 
activity of TCDD. Neither genistein nor quercetin, two potent SPMX inducers on ER-
mediated assays, induced any signal on the DR.Luc assay, nor influenced the 
luciferase induction by TCDD. Future work should be focused on testing the 
consequences of efflux pump inhibition with an AhR-agonist which is a P-gp 
substrate, as this could result in intracellular accumulation of this AhR-agonist. 
It is standard practice to use a high single stock concentration of extracts to further 
dilute test concentrations from and perform the analysis. However, a high 
contaminant load in an extract may oversaturate the solubility of the extracted 
compounds in carrier solvents and overload the clean-up columns which may 
reduce the efficiency of polyaromatic hydrocarbons (PAHs) elimination from the 
extract. These problems may cause respectively under- or over-estimation of the 
quantified dioxin-like toxic potency. Therefore Chapter 5 focuses on the effects of 
initial stock concentrations, including sonication assisted dissolution and exposure 
time, on the quantified dioxin-like potency of cleaned nonpolar sediment extracts. 
Indeed, more than 20 g sediment equivalents (SEQ)/mL DMSO) as initial stock 
concentrations resulted in underestimation of bio-TEQ levels in the sediments as 
observed for cleaned nonpolar sediment extracts from various locations in 
Luxembourg. An overload of extract on clean-up columns caused an over-
estimation of the dioxin-like potency at 24 hours of exposure, probably due to 
limited removal of PAHs that can induce false positive responses in the in vitro 
assays. Sonication assisted dissolution of the stock before serial dilution strongly 
reduced the standard variation of the outcomes. Taking into account the aspects 
revealed in this study, in addition to already described important issues for quality 
control, the in vitro bioassays based bio-TEQs can be applied in a comprehensive 
Chapter 8 
 190 
monitoring program to determine whether sediments comply with health and 
safety standards for humans and the environment. For the generally applied 
sediment quality criteria, advices are given about maximum initial stock 
concentrations to achieve reliable bioassay outcomes. 
The methods and concepts developed for metabolic activation of compounds in 
non-polar sediment extracts and in in vitro analysis of the TTR-competitive binding  
are applied in Chapter 6 to extracts from highly or less contaminated sediments 
collected in Luxembourg.  Nonpolar fractions of sediment extracts were incubated 
with S9 rat microsomes, and the metabolites were extracted with a newly 
developed method that excludes most of the lipids to avoid interference in the 
non-radioactive 96-well plate transthyretin (TTR) competitive binding assay. 
Metabolic activation increased the TTR binding potency of nonpolar fractions of 
POP-polluted sediments up to 100 times, resulting in potencies up to 240 nmol T4 
equivalents/g sediment equivalent (nmol T4-Eq/g SEQ). Without bioactivation, 
medium polar and polar fractions also contained potent TTR-binding compounds 
with potencies from 1.6 to 17 nmol T4-Eq/g SEQ. This demonstrates that a more 
realistic in vitro sediment THD risk characterization should also include testing 
ofboth polar and medium polar sediment extracts for THD, as well as bioactivated 
nonpolar sediment fractions. Without bioactivation THD potency is not observed in 
nonpolar sediment extracts, although in in vivo experiments PCBs and PBDEs, and 
not with dioxins or PAHs, have shown to be thyroid hormone disrupting (THD), 
demonstrating this bio-activation is toxicologically relevant and therefore required 
for sediment hazard characterisation. 
Chapter 7 discusses the implications of our results to improve the relevance and 
reliability of in vitro bioassay applied for risk characterisation of complex mixtures 
from sediments and other matrices. The evidence obtained to support the 
relevance of POP bio-activation is considered both from the exposure perspective 
as well as the toxicity perspective. Various features of the newly developed 
methods and knowledge acquired within this PhD project are discussed in relation 
to in vitro bioassay risk characterization of sediments towards a realistic in vitro 
bioassay-based risk characterization of complex mixtures. Some important aspects 
for the inclusion of metabolizing systems within in vitro bioassay are discussed. In 
addition, alternatives to deal with the SPMX effect and the definition of suitable 
sample amounts to improve in vitro bioassay reliability are offered. The suitability 
of the developed approach application is considered for the risk characterization of 
sediments. Furthermore, an analysis is made to decide whether this thesis have 
made in vitro bioassays more reliable and relevant for risk characterization of 
complex mixtures. Finally, it provides some concluding remarks and aspects for 
further applications and research. 
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Het doel van het voorliggende  proefschrift was het beter begrijpen en  
betrouwbaarder toepassen van in vitro bio-assays voor karakterisering en 
kwantificering van het potentiële risico van complexe mengsels van 
contaminanten, met speciale aandacht voor persistente organische 
verontreinigingen (POPs) in sedimenten. 
 
In Hoofdstuk 1 wordt het belang van karakterisering van het risico van complexe 
mengsels van stoffen in de moderne samenleving geïntroduceerd. De beschikbare 
methoden voor het testen van complexe mengsels van stoffen worden beschreven 
en de voor- en nadelen daarvan besproken. Er is in toenemende mate  aandacht 
binnen het beleidsgericht testen van chemicaliën voor het bij de beoordeling 
betrekken van in vitro bioanalyse. Om een relevante en betrouwbare kwantificatie 
van de toxische potentie van complexe stoffenmengsels zeker te stellen moeten 
echter nog wel belangrijke knelpunten worden opgelost. Hiervoor is gedegen 
kennis nodig van het proces van monsterbewerking tot en met de interpretatie van 
de uitkomsten. Deze aspecten die belangrijk zijn voor betrouwbare bioanalyse 
worden toegelicht in de introductie, evenals de status van ontwikkeling en validatie 
ervan. Als een van de belangrijkste voordelen van in vitro bioanalyse is de 
mogelijkheid om de toxische potentie te kwantificeren van stoffen, waarvoor 
nauwelijks of geen chemische analytische methoden zijn ontwikkeld, bijvoorbeeld 
omdat standaarden nog niet bestaan. Bij voorbeeld gehydroxyleerde metabolieten 
van POPs zijn een toxicologisch relevante groep stoffen die hormoonverstorende 
effecten kunnen uitoefenen, maar deze stoffen kunnen nog niet routinematig 
worden geanalyseerd. In hoofdstuk 1 is een selectie van tot nog toe onopgeloste 
onderwerpen geselecteerd die in dit proefschrift nader worden bestudeerd en 
besproken, zoals aangegeven in de “benadering en structuur van het proefschrift”.  
 
In Hoofdstuk 2 is een meta-analyse uitgevoerd van beschikbare gegevens over het 
voorkomen en de relevantie van gehalogeneerde contaminanten met een phenol 
groep (HPCs) in mensen en dieren in het wild. Gerapporteerde gehaltes in het 
lichaam van HPCs waaronder veel gehydroxyleerde POP-metabolieten (OH-POPs)  
in verschillende weefsels van mensen en wilde dieren, zijn beoordeeld in relatie tot 
de concentratie van hun vermoedelijke moederstoffen. Op basis hiervan kunnen de 
meest relevante blootstellingsroutes en subpopulaties met de hoogste interne 
gehaltes worden opgespoord. De hoogste OH-POP niveaus zijn geconstateerd in 
bloedplasma en in goed doorbloed en foetaal weefsel. Plasmaconcentraties van 
geanalyseerde bekende HPCs lagen tussen respectievelijk 01.-100 nM in mensen en 
tot 240, 454, 600 en 7650 nM voor vogels, vissen, walvissen en andere zoogdieren. 
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De gerapporteerde bloedplasma-niveaus van de HPCs zijn eveneens vergeleken 
met de drempelwaarden voor toxicologische effecten. Het bleek dat de in bloed 
aangetroffen gehaltes volledig binnen de in vitro (0.05 – 10000 nM) en in vivo (3-
940 nM) effectconcentraties voor deze stoffen te vallen. Omdat daar nog niet veel 
over bekend is, gezien de gevoeligheid van vroege ontwikkelingsstadia wordt 
geadviseerd is om beter uit te zoeken wat de gehaltes aan HPCs zijn in bloed van 
kinderen en foetaal weefsel in ook de algemene bevolking.  
 
Gezien de toxicologische relevantie van de OH-POPs, wil Hoofdstuk 3 oplossingen 
geven voor het knelpunt van de in vitro-productie van OH-POP metabolieten en de 
schildklierhormoomverstorende (THD) potentie hiervan via binding aan 
schildklierhormoon transport eiwitten in plasma (THBPs). In sedimenten en in 
bijvoorbeeld vis, schaal- en schelpdieren komen POPs voor als moederstoffen die 
pas THD worden na metabolisatie (hydroxylering). Dit is aangetoond met zuivere 
metabolieten,  maar blijkt erg moeilijk aan te tonen voor de ouderstoffen zoals 
PolyChloor biphenylen (PCBs) en PolyBroom diphenyl ethers (PBDEs) in combinatie 
met in vitro metabolisatie. Wanneer de OH-metabolieten moeten worden 
geëxtraheerd om vervolgens in vitro hun THD potentie te bepalen, bleek co-
extractie van stoffen de TH-TTR competitieve binding assay te verstoren. In de 
huidige studie worden eerst de belangrijkste probleemstoffen geïdentificeerd- en 
gekwantificeerd. De grootste problemen werden veroorzaakt door co-extractie van 
cholesterol en verzadigde en onverzadigde vetzuren (SFA en NFSA). Verschillende 
extractiemethoden en zuiveringsmethoden zijn vervolgens ontwikkeld tot . een 
nieuwe methode waarbij de opbrengst van in vitro gemetaboliseerde OH-
metabolieten wordt verhoogd en de co-extractie van de verstorende stoffen met 
een factor vier wordt verminderd. Daarnaast werd een nieuwe assay op 
microschaal ontwikkeld op basis van niet-radioactief fluorescent substraat om de 
TTR bindings potentie van de gevormde metabolieten te kwantificeren. De 
effectiviteit van het in vitro metabolisme en de extractie van de OH-metabolieten 
van de modelstoffen CB 77 en BDE 47 werden chemisch gekwantificeerd met een 
eveneens nieuw ontwikkelde chromatografische methode om gesilyleerde 
derivaten van de OH-metabolieten en co-extracten te analyseren. Op basis  van de 
bereikte verbeteringen kan nu een dosis-response curve gemaakt met 50% 
remming van de TTR binding door in vitro bio-geactiveerde OH-metabolieten van  
CB 77 en BD 47. Het is erg belangrijk om rekening te houden met de toxische 
potenties van bio-geactiveerde POPs in de bioanalyse, om te voorkomen dat het 
risico van POPs ernstig wordt onderschat. 
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In de hoofdstukken 4 en 5 worden de kwesties van supramaximale (SPMX) 
responsen en overconcentratie van POP-extracten verder onderzocht omdat deze 
de betrouwbaarheid van het kwantificeren van de toxische potenties van 
milieuextracten met complexe mengsels  in in vitro bioassays ernstig kunnen 
beïnvloeden. Een SPMX-effect is het verschijnsel dat stoffen in een assay een 
maximale response veroorzaken die beduidend hoger is dan die van de positieve 
controle. Omdat de positieve controle wordt gebruikt om de toxische potentie van 
een monster aan te relateren, kan SPMX resulteren in overschatting van zijn 
toxische potentie. Omdat SPMX effecten het meest is gerapporteerd voor in vitro 
estrogeniteits assays, werd hiermee een meta-analyse uitgevoerd om te analyseren 
welke eigenschappen van assays, stoffen en condities samenhangen met het 
optreden vandit effect (Hoofdstuk 4a.). Van de 21 natuurlijke en industriële 
chemicaliën waarvoor SPMX werd beschreven, werden diethylstilbestrol (DES), 
genestein (GEN) en bisphenol A (BPA) geselecteerd om een database mee te 
bouwen Soms ontbrak echter essentiële informatie over relevante assay 
karakteristieken. De meta-analyse toonde aan dat het voorkomen van SPMX-
effecten kon worden gerelateerd aan een aantal specifieke assay-eigenschappen: 
1) het type en de concentratie van het serum dat gebruikt werd voor het 
blootstellingsmedium; 2) het eindpunt dat waarmee de estrogene potentie werd 
gekwantificeerd (endogeen of getransfecteerd reporter gen); 3) het aantal EREs 
(estrogen responsieve elementen) dat is gebruikt voor het reporter gen, en 4) de 
aard van de promotoren. Er waren geen aanwijzingen dat de concentratie 
oplosmiddel in kweek, blootstellingsduur of cel model het optreden van SMX 
zouden beïnvloeden. Het is van belang het mechanisme achter dit verschijnsel te 
begrijpen om er om op de juiste wijze met deze in vitro assays de estrogene 
potentie van stoffen, stoffenmengsels en milieu-extracties te typeren en te 
kwantificeren. 
 
Over meerdere SPMX-inducers is tevens gerapporteerd dat zij het cellulaire efflux 
pompjes in vivo en in vitro blokkeren (Anselmo et al. 2012; Georgantzopolou et al. 
2013). Daarom werd de hypothese getoetst of het blokkeren van de cellulaire 
efflux pompjes door stoffen die aanwezig zijn in milieumatrixen, de interne 
concentratie van de andere agonisten in het mengsel zouden kunnen doen 
toenemen en zo de SPMX veroorzaken. In Hoofdstuk 4b werd deze hypothese 
getest door een 96 well plaat cellulaire efflux pomp remmer assay aan te passen 
aan de H4llE rat hepatome cellijn die gebruikt wordt voor de DR-Luc reporter gen 
assay voor dioxine-achtige stoffen. Verschillende milieu-relevante stoffen remden 
inderdaad de P-gp efflux pompjes, maar veroozaakten geen SPMX effect  op de 
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2,3,7,8-tetrachlorodibenzo-p-dioxine (TCDD) respons. Ook de P-gP 
remmersgenesteine en quercetine beïnvloedden evenmin maximale de luciferase-
inductie door TCDD. Mogelijk dat voor het testen van de gevolgen van efflux pomp 
remming een AhR-agonist die een P-gp substraat is moet worden gebruikt, omdat 
dit resulteert in intracellulaire accumulatie van deze AhR-agonist. 
 
Het is standaard praktijk om een hoge stock-concentratie van non-polaire extracten 
te gebruiken om lagere testconcentraties voor de analyse verder uit te verdunnen. 
Bij sterk vervuilde monsters, bijvoorbeeld van sediment, kan mogelijk de 
oplosbaarheid van de geëxtraheerde stoffen overschreden worden waardoor een 
deel van de stoffen neerslaat en dus niet mee verdund wordt. Ook kunnen de 
clean-up kolommen overbelast raken, wat de efficiency van het verwijderen van 
polyaromatische koolwaterstoffen (PAKs)  vermindert. Deze problemen kunnen 
onder- dan wel overschatting van de uiteindelijke gekwantificeerde dioxine-
toxiciteit veroorzaken. Deze effecten worden in Hoofdstuk 5 bestudeert waarna 
oplossingen worden uitgewerkt. Aspecten van de monsteropwerking die moeten 
worden gestandaardiseerd om tot een betrouwbare inzet van in vitro bioassays te 
komen zijn de initiële stock concentraties afhankelijk van het soort monster, de 
inzet van sonificatie voor beter in  oplossing brengen van stoffen uit het mengsel 
en het verlengen van de blootstellingstijd in de DR-Luc assay zodat de invloed van 
de PAKs op de uitkomst te verminderen  . Aanbevolen wordt om nooit met meer 
dan 20 g sediment equivalenten per ml oplosmiddel (SEQ/ml DMSO) als initiële 
stock concentratie te gebruiken om onderschatting van met de bioassay 
gekwantificeerde TEQ (bio-TEQ) te voorkomen. Dit is uitgetest op gezuiverde non-
polaire sedimentextracten van verschillende locaties in Luxemburg. Een overmaat 
van extract op clean-up kolommen veroorzaakte een overschatting van de dioxine-
achtige potentie bij 24 uur blootstelling, vermoedelijk door te geringen 
verwijdering van de PAKs die vals-positieve responses veroorzaken. Sonificeren van 
de stockoplossing wordt altijd aanbevolen voordat hieruit verdeer wordt 
doorverdund. Dit reduceerde de standaardvariatie van de uitkomsten sterk. 
Rekening houdend met de in deze studie bekend gemaakte aspecten en in 
aanvulling op de reeds beschreven belangrijke onderwerpen voor 
kwaliteitscontrole, kunnen de op in vitro bioassays gebaseerde bio-TEQs worden 
gebruikt om vast te stellen of sedimenten gezondheids- of milieu risico’s vormen of 
de getelde milieustandaarden overschrijden 
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De methoden en benaderingswijzen die in dit proefschrift zijn ontwikkeld zijn in 
Hoofdstuk 6 toegepast op extracten van meer of minder vervuilde sedimenten uit 
Luxemburg. Non-polaire fracties van sedimentextracten zijn geincubeerd met S9 
rat microsomen voor bioactivatie van de mogelijk aanwezige POP en de zo 
ontstane metabolieten werden geëxtraheerd met een nieuw ontwikkelde methode 
die de gehaltes van de meest storende matrix componenten (vooral vetten) 
voldoende verlaagd voor verdere bio-analyse. Vervolgens is in vitro analyse 
uitgevoerd met de nieuwe niet-radioactieve 96-wells plaat transthyretine (TTR) 
competitieve binding assay. Door de metabole activatie nam de TTR bindings 
potentie van non-polaire fracties tot 100 keer toe. De meer polaire fracties van de 
sediment extracten waren wel zelf in staat tot TTR-binding, dus zonder bio-
activatie. Naar verwachting bevatten deze stoffen zelf veelal al OH-groepen die 
nodig zijn voor een hormoon achtige werking.  Ook in vivo experimenten met PCBs 
en PBDEs  hebben aangetoond dat deze stoffen slechts 
schildklierhormoonverstorend (THD) zijn na bioactivatie. De resultaten van dit werk 
tonen aan dat voor een meer realistische in vitro risico karakterisering van 
sedimenten zowel het testen van medium-polaire als ook van non-polaire 
sedimentextracten met bio-activatie moet omvatten om onderschatting van de 
THD-potentie te voorkomen. Hoofdstuk 7 bediscussieert de implicaties van de 
resultaten van het gepresenteerde onderzoek om de relevantie en de 
betrouwbaarheid van in vitro bioassay te verbeteren voor risicoschatting van 
complexe mengsels van stoffen uit milieumatrixen.. Verschillende onderwerpen 
van de nieuw ontwikkelde methoden en verkregen kennis binnen dit AIO-project, 
worden besproken in relatie tot in vitro bio-analyse van sedimenten voor een 
realistische in vitro bioassay-gebaseerde beoordeling van de toxische potentie van 
complexe mengsels van contaminanten in de beleidspraktijk. Ten slotte bevat de 
discussie beschouwingen over de perspectieven voor de ontwikkeling van verdere 
toepassing en verder onderzoek. 
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